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SUMMARY
Human essential hypertension is a classic example of a complex, multifactorial, and 
polygenic trait. That a substantial fraction of the variation in blood pressure between 
individuals is genetically determined has been well established by classic epidemiologic, 
twin, and adoption studies, as well as the existence of rare Mendelian forms of 
hypertension. Similar evidence exists for a genetic basis to human stroke and left 
ventricular hypertrophy, unrelated to the effects of blood pressure. Given the 
heterogeneity of the human condition, however, little progress has been made towards 
the identification of the genes involved in these common disease states. Instead, a major 
strategy has been successfully developed using inbred animal models which results in the 
identification of a quantitative trait locus (QTL), a large chromosomal region which 
contains a gene or number of genes responsible for the quantitative trait under 
investigation. Known as a genome wide scan, this strategy involves the high fidelity 
phenotyping of a large segregating F2 population derived by crossing hypertensive and 
normotensive inbred rat strains, and the genotyping of a large panel of dimorphic 
microsatellite markers with a thorough coverage of the entire rat genome.
The research described in this thesis incorporated the use of two genome wide scans to 
identify QTLs containing genetic determinants of hypertensive cardiovascular and 
cerebrovascular disease in the Glasgow SHRSP x WKY F2 cross. The first genome wide 
scan was performed in 140 male and female F2 hybrids (M:F = 65:75). Blood pressure at 
baseline and after 1% sodium chloride administration was measured by radio-telemetry; 
other phenotypes included heart rate, motor activity, and left ventricular hypertrophy.
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This was the first genome scan where physiological phenotypes were measured with a 
radio-telemetry system in an entire F2 cross. The second genome scan was performed in 
59 male and female F2 hybrids (M:F 33:26) phenotyped by the volume of cerebral 
infarction following the experimental occlusion of their middle cerebral artery.
QTLs affecting a given phenotype were mapped relative to microsatellite markers with 
the aid of the MAPMAKER/QTL 1.1 computer package. This resulted in the 
identification of three blood pressure QTLs; two on rat chromosome 2 and one on rat 
chromosome 3. The QTL close to the microsatellite markers D2Mghl2 (suggestive 
linkage with a maximal LOD score of 3.1) and D3Mghl6 (significant linkage with a 
maximal LOD score of 5.6) showed sex specificity being only present in the male F2 
cohort. This was further confirmed by the likelihood ratio test for the difference in the 
locus effect between the sexes. This study was the first to show such sex specificity of 
autosomal QTLs for genetic hypertension. This genome scan also identified a new QTL 
for left ventricular hypertrophy on rat chromosome 14 (suggestive linkage, with a 
maximal LOD score of 3.1).
The second genome scan identified a single highly significant QTL on rat chromosome 5 
for the increased sensitivity to experimentally induced focal cerebral ischaemia, with a 
LOD score of 16.6. This QTL accounted for 67% of the phenotypic variance and was 
blood pressure independent. Sex also had a significant effect with male F2 hybrids having 
larger infarcts than females (p = 0.012), and explained 10% of the phenotypic variance. 
The microsatellite marker in the centre of this QTL was Anp, a marker within the gene 
encoding the atrial natriuretic peptide. DNA sequencing analysis of the coding regions of
X V lll
the Anp gene, and the gene for brain natriuretic peptide {Bnp) which is known to co- 
localise with the Anp gene, revealed no significant nucleotide differences between the 
SHRSP and the WKY strains that are potentially important to their function. 
Consequently the Anp and Bnp genes were not supported as candidates for the QTL for 
severity of cerebral ischaemia.
The identification of the large QTLs is only the first step towards the ultimate goal of 
gene identification. The next step is the production of congenic strains and substrains 
containing progressively smaller chromosomal regions with the final task being positional 
cloning of the causal gene. In this thesis, the process of dissection was begun for the two 
blood pressure QTLs identified on rat chromosome 2 using a speed congenic strategy 
only previously verified in mice. Five congenic strains (SP.WKYgla2a-e) were produced 
by introgressing regions of chromosome 2 from WKY rats into the recipient SHRSP 
strain, and four congenic strains (WKY. SPgla2a-d) were produced by introgressing 
regions of chromosome 2 from SHRSP rats into the recipient WKY strain. The number 
of generations of backcrossing required for each strain to achieve complete 
homozygosity of the background genetic markers in a best male varied between 3 and 5. 
In total 542 progeny were necessary for screening in order to produce the congenic 
strains, an average of 60 animals per strain, 15 animals per backcross. The average 
reduction in background marker heterozygosity mirrored that theoretically expected over 
8 generations utilising the traditional congenic approach. It follows that the presentation 
of nine congenic strains derived for rat chromosome 2 clearly demonstrated the 
applicability of a speed congenic strategy in this species.
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The success of the speed congenic strategy will pave the way for the construction of 
congenic strains of the remaining QTLs identified in this study. Phenotyping these strains 
should further the evidence for, and the genetic dissection of, the QTLs involved. This in 
turn should lead to the construction of sub-strains containing smaller relevant sections of 
chromosome until, via substitution mapping, positional cloning and comparative mapping 
to human chromosomes, the causal genes and their pathophysiologic pathways are 
identified. This will hopefully improve prospects for the prevention and improved 
treatment of these complex traits which are the major causes of morbidity and mortality 
in the UK.
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1. INTRODUCTION
1.1 Complex Cardiovascular Traits
Complex traits, which encompass most cardiovascular as well as other epidemiological 
important disorders, do not exhibit classic Mendelian inheritance attributable to a single 
genetic locus (Lander & Schork, 1994). Rather their inheritance can be described as 
polygenic and multifactorial, displaying the concurrent morbid effects of many genetic and 
non-genetic factors. It follows that unravelling the precise primary genetic determinants of a 
complex trait is a daunting task {Figure 1.1). The effects of individual genes may be 
independent and thus simply additive to the trait, or more complex, characterised by gene- 
gene (epistatic) and gene-environment (ecogenetic) interactions. Gene expression can also 
be gender and/or age dependent. The genetic background may itself be heterogeneous, the 
particular set of genes operative in one affected individual differing from that in another, 
despite similar phenotypic features (Schork, 1997). Success in this effort, however, will 
afford insights into pathophysiology, permit clinical identification of subjects with specific 
inherited susceptibility, and provide opportunities to tailor therapy to specific underlying 
abnormalities (Lifton, 1995).
1.1.1 Hypertension
Blood pressure is the hydrostatic force that blood exerts against the vascular walls. In 
simple mechanical terms it is determined by the amount of blood ejected by the heart and 
the resistance to blood fiow offered by the bottlenecks of the circulatory system, the 
arterioles. The provision of a blood pressure level at which adequate tissue perfusion is 
maintained, however, reflects the interaction of a myriad of neural, hormonal and circulatory
Gene 2 Gene 3
/
Gene 1 \ / Gene 4
Environmental Factor 1
Gene 5
COMPLEX
TRAIT ^  ^  Environmental Factor 2
\
/ \ Gene 6
Gender Age
Figure 1.1 Multifactorial determination of a complex trait (modified from Lifton, 1995). 
Each arrow represents the potential interaction of genetic, environmental and 
demographic factors.
systems and sub-systems, the complexity of which creates enormous potential for a variety 
of mutant genes to induce deleterious effects (Schork, 1997).
Hypertension refers to the maintenance of an excessively high blood pressure (Swales, 
1994). Although without conspicuous symptoms, hypertension can have severe detrimental 
effects on a number of important tissues in the body, including the heart and brain. This so- 
called “end organ damage” contributes to the genesis of various coronary, cerebral, and 
peripheral vascular diseases which account for the leading causes of adult death, morbidity, 
social disruption, and loss of income in westernised societies (Whelton et al, 1994). 
Unfortunately, whilst 5% of those with elevated blood pressure display a potentially 
remediable aetiology (secondary hypertension), such as hormone excess or coarction of the 
aorta, the primary determinants of the more frequent “essential” hypertension remain 
unknown, hindering the efficacy of any preventative and therapeutic measures (Dominiczak 
& Lindpaintner, 1994).
Numerous population studies (Smirk, 1949; Pickering, 1959) have proven blood pressure to 
be a quantitative trait with essential hypertension representing the upper end of its 
distribution. This implies that variation in blood pressure, including essential hypertension, is 
under the influence of several independently segregating genes for each of which the effects 
on blood pressure are generally smaller than the sum of the whole and the effects of 
environment (Kearsey & Pooni, 1996).
All lines of evidence are concordant in supporting the existence of a genetic component in 
the aetiology of human essential hypertension. Epidemiologic studies have revealed highly
significant familial aggregation of blood pressure. Individuals with essential hypertension are 
twice as likely as normotensive individuals to have a parent who is hypertensive, and 
hypertension is 2- to 8-fold more common in the offspring of hypertensive parents than in 
the offspring of normotensive individuals (Perera, et al, 1971; Ibsen, 1984). Table 1.1 
demonstrates that when blood pressure measurements are compared in household members, 
correlations increase with the degree of genetic relationship between the members. Identical 
twins who share all their genes demonstrate higher blood pressure correlations than non­
identical twins who share 50% of their genes (Feinleib et al, 1977). Similarly, correlations 
are higher for first-degree relatives such as sib-sib and child-parent pairs than for more 
distant relatives. Studies of families with adopted and biological children have shown a 
significant correlation in the blood pressure of parents and their biological children that is 
not seen when compared to their adopted children’s (Biron et al, 1976; Mongeau et al, 
1986).
Whilst these findings have led to the estimate that 20-40% of the variation in blood pressure 
can be attributed to genes (Annest et al, 1979; Mongeau, 1989), they are also indicative of 
the multifactorial nature of essential hypertension. Not only does blood pressure not 
typically segregate in families in a fashion consistent with Mendelian transmission but 
spouses have also shown significant correlations despite sharing no genetic material {Table 
1.1, Mongeau et al, 1986). Indeed, a variety of other factors have been shown to 
chronically influence blood pressure, including high salt, low calcium and low potassium 
intake, low levels of physical exercise, exposure to noise and stress, age, gender, and body 
mass (Horan & Lenfant, 1990). It is likely that these only produce elevated blood pressure 
when appropriate, genetically determined susceptibility is present, indicating a specific
Relationship Correlation Reference
Twins, monozygotic 0.54-0.55 Havlik et al, 1979; Feinleib et al, 1977
Twins, dizygotic 0.25-0.40 Havlik et al, 1979; Feinleib et al, 1977
Sib-sib 0.34-0.38 Zinner et al, 1971; Annest et al, 1979
Parent-child 0.16-0.27 Zinner et al, 1971; Annest et al, 1979
Aunt/uncle-niece/nephew 0.05 Weinberger a/, 1981
Spouse-spouse 0.15 Mongeau a/, 1986
Parent-adopted child 0.09 'Qiron et al, 1976
Table 1.1 Estimates of systolic blood pressure correlation coefficients between 
household members (adapted from Mongeau, 1989).
interaction between environmental/demographic factors and certain allelic variants. A classic 
example of such genetic heterogeneity concerns the different responses of blood pressure to 
dietary salt. Both normotensive and hypertensive human subjects have been demonstrated to 
be sensitive or resistant to the blood pressure increasing effects of salt intake (Weinberger, 
1996).
1.1.2 Stroke
Stroke is the third most common cause of mortality and life-long disability following heart 
disease and combined malignancies in Western society (Sharma, 1996). It follows that any 
advancement in both preventive and therapeutic measures would be most welcome. 
Unfortunately, stroke is also a highly variable clinical state. Its cause, late-onset, location, 
and pre-existing disease all contribute to variability in stroke outcome and thus confound 
clear interpretation of its primary determinants (Macrae, 1992).
Stroke describes the sudden onset of a focal loss of neurologic function which lasts longer 
than 24 hours (Dept, of Health, 1994). Occlusion of a cerebral artery causes some 84% of 
strokes, comprising 53% from in situ tlirombosis, and 31% from thrombi originally formed 
in the heart or atherosclerotic neck arteries impacting on the cerebral circulation. 
Haemorrhage accounts for 16%, 10% of which are intracerebral and 6% subarachnoid 
(Kannel & Wolf, 1983). Whatever the cause, a marked focal reduction in cerebral blood 
flow is the common result. The brain derives all its energetic needs from the oxidative 
catabolism of glucose supplied from arterial blood. If the supply of oxygen and glucose is 
interrupted for more than a few minutes, neurones in the most vulnerable areas of the brain
will be irreversibly damaged. The area of the brain where all cell types are dead is termed an 
infarction (Fisher & Garcia, 1996). Most infarcts (-50%) are seen in the cortex, basal 
ganglia and internal capsule supplied by the middle cerebral artery, or MCA (McAuley,
1995). The posterior cerebral artery (PGA) is the next most frequent, followed by the 
anterior cerebral artery, or ACA (Bogousslavsky et al, 1988). In the acute period following 
ischaemia, the infarction is surrounded by a “penumbra”, a region where cerebral blood flow 
is low but sufficient to maintain neuronal survival. Collateral vessels play a vital role in 
preserving blood flow to the penumbra and thereby limiting the extent of the ischaemic 
damage (Heistad et al, 1993).
Historically most strokes have been attributed to hypertension, either by accelerating 
atherosclerosis and thus thrombosis and occlusion of a large cerebral artery, or by 
weakening the vessel wall of smaller penetrating arteries of the brain by a process known as 
fibrinoid necrosis, leading to haemorrhage (Gunel & Lifton, 1996). In a series of 420,000 
adults aged 25-70 years in 9 prospective studies the difference between a diastolic blood 
pressure of 75mmHg and 105mmHg was enough to increase 10-fold the risk of stroke 
(Whelton et al, 1994). However, the aetiology of stroke remains unknown in approximately 
40% of patients despite extensive investigation (Sharma, 1996) suggesting elevated blood 
pressure is not the only prerequisite for a stroke event. Far from all hypertensive individuals 
develop fibrinoid necrosis or experience a stroke, and fibrinoid necrosis and strokes are 
reported in normotensive individuals (Gunel & Lifton, 1996). Indeed, it has been shown that 
similar atherosclerotic occlusion of a major cerebral artery in humans may cause a 
catastrophic stroke or be entirely asymptomatic, with an apparently continuous distribution 
of neurological damage in between (Allen, 1983; Jacewicz, 1992). This raises the possibility
that multiple genetic factors may be important in the pathogenesis of stroke, whether 
contributing to the elevated blood pressure or acting independently.
An increasing body of evidence from human epidemiological and twin studies does suggest 
a genetic contribution to stroke onset (Alberts, 1990). Most convincingly, analysis from the 
Framingham study (Kiely et al, 1993) examining patterns of familial aggregation of stroke 
showed that offspring whose mothers experienced a stroke or a transient ischaemic attack 
were 2.3-fold more likely to experience a similar event than those with negative maternal 
histories. In another study, Graffagnino et al (1994) examined the family histories of 90 
patients with cerebral infarction and found a significant positive family history of stroke in 
47% of patients and 24% of controls. Data from a classic twin study demonstrated 
concordance rates for stroke of 17.7% for monozygotic twins and 3.6% for dizygotic twins 
with a relative risk of 4.3 (Brass et al, 1992), providing strong evidence for a genetic 
component.
Like essential hypertension, these epidemiological studies which have identified a family 
history of stroke have also served to highlight its multifactorial nature. Table 1.2 lists many 
of the lifestyle and risk factors identified so far (Khaw, 1996). Whilst direct associations 
have been reported between some of these factors and stroke, others appear to influence 
stroke by their effect on blood pressure. Indeed many of these factors, including blood 
pressure, fibrinogen, and obesity, are known to have their own genetic and environmental 
determinants either potentially in common with, or distinct from, stroke. This scenario, 
indicative of a highly complex trait, offers a vast array of putative stroke risk genes which 
demand further investigation.
Major Implicated
Age Alcohol
Gender Potassium
Body Mass Fruit & Vegetables
Blood Pressure Total Calories
Cigarette Smoking C O -3  Fatty Acids
Diabetes Fibre
Physical Activity White Cell Count
Obesity Fibrinogen Level
Dietary Sodium Albumin Concentration
Saturated Fat Blood Homocysteine Level
Table 1.2 Biological and lifestyle factors for stroke (adapted from Khaw, 1996).
1.1.3 Left Ventricular Hypertrophy
The heart adapts to the abnormal sustained haemodynamic burden that hypertension 
imposes with a compensatory growth of the myocardium (Straurer et al, 1994). This 
primarily involves enlargement of the myocyte cross-sectional area (Anversa et al, 1986), 
the actual number of myocytes increasing only when a critical heart weight of approximately 
500g is reached (Linzbach, 1960). This response maintains systemic perfusion until a time 
when ventricular dysfunction evolves despite continued hypertrophy, the result of which is 
heart failure, myocardial infarction or arrhythmia (Pfeffer et al, 1982). As such hypertensive 
left ventricular hypertrophy (LVH) has proved a major independent risk factor for 
cardiovascular mortality and morbidity (Dominiczak et al, 1997).
Although elevated blood pressure is the most important determinant of LVH (Kannel, 
1983), the blood pressure level does not always parallel the degree of hypertrophy in 
humans (Dominiczak et al, 1997) indicating the existence of a more complex relationship 
than a simple dose-response effect. Indeed, the distribution of cardiac mass within 
populations of unselected normotensive or hypertensive individuals appear to be continuous 
for the most part (Nunez et al, 1996), with 50% of hypertensives without any sign of 
cardiac hypertrophy (Gross & Jeger, 1949; Devereux et al, 1987). It follows that as this 
unexplained variance in LVH can not be totally explained by haemodynamics, it is also 
likely to include the additional effects of as yet unidentified genetic and non-genetic 
determinants (Nunez et al, 1996).
The quantitative distribution of cardiac mass within populations supports the view that any 
heritable effects are likely to be polygenic. Unfortunately, there is a lack of robust data on 
the extent and importance of inherited variability in the response of the heart to 
hypertrophic stimuli. This is not surprising since large families with hypertension have been 
studied with respect to blood pressure rather than cardiac phenotype. The most convincing 
data on the heritability of cardiac mass comes from various twin studies (Nunez et al,
1996). In the largest of these, Verhaaren et al (1991) analysed 254 11-year old white twins, 
finding that genetic variance accounted for 63% of the total variance of cardiac mass in 
boys and 71% in girls. They found that genes that control LV mass include those which 
regulate LV mass alone and others which affect both LV mass and body weight. In boys the 
genetic effects were for the most part due to the latter, whereas in the girls the former 
predominated. Again this serves to highlight the existence of both several independently 
modifying cardiac mass genes and the multifactorial influence of environmental and 
demographic factors as befits a complex trait.
1.2 Genetic Dissection of Human Hypertensive Cardiovascular Disease
From the evidence cited above it is clear that complex human cardiovascular diseases such 
as essential hypertension all have important genetic components, although the genes 
responsible, and their specific interaction with environmental and demographic factors, 
remain mostly unknown. Human studies have pursued two main routes to gene 
identification; the in-depth deconstruction of rare Mendelian forms of cardiovascular disease 
and the similarly intense interrogation of numerous candidate genes.
1.2.1 Mendelian Disorders
Part evidence to support an appreciation of essential hypertension, stroke and LVH as a 
genetically determined group of illnesses has been based on the observation of a number of 
uncommon syndromes which display a Mendelian inheritance pattern indicative of a 
monogenetic disorder {Table 1.3). Although these syndromes occur rarely, considerable 
effort has been devoted to the identification of the genes responsible. The reasons for this 
are several (Lifton, 1996). Firstly, the effects of segregation of single alleles in families can 
be easily discerned, thereby simplifying the molecular genetic analysis necessary. Secondly, 
these disorders generally result in a severe disease state, making phenotypic selection easier. 
Finally, it is hoped that the genes and physiologic pathways involved in these severe forms 
may also be involved in the cardiovascular disease states more commonly seen in the 
general population. It follows that understanding these disorders may not only be of 
importance to the families that are affected but could also provide more broadly relevant
diagnostic and therapeutic tools (Karet & Lifton, 1997).
Mendelian Forms o f  Disordered Blood Pressure
At present, three Mendelian forms of human hypertension have yielded mutations which
impart large elevating effects on blood pressure levels:
1) - Glucocorticoid remediable aldosteronism (GRA) was first described (Sutherland et al, 
1966) as an autosomal dominant form of potentially severe early onset hypertension with 
the cardinal symptom being a therapeutic response to glucocorticoid administration.
Syndrome Chromosome Gene(s)
Hypertension
Glucocorticoid-remediable hyperaldosteronism 8q22 CYP11B1/CYP11B2
Apparent mineralocorticoid excess 16q22 HSD11B2
Liddle’s syndrome 16pl2-pl3 SCNNIB/SCNNIG
Gordon’s syndrome Iq31-q42 Unknown
17pll-q21 Unknown
Isolated pheochromocytoma Ip Unknown
Multiple endocrine neoplasia, type IIA lOqll.2 RET proto-oncogene
Multiple endocrine neoplasia, type IIB lOqll.2 RET proto-oncogene
Male pseudo-hermaphroditism 10q24.3 CYP17
Female pseudo-hermaphroditism 8q22 CYPllBl
von Hippel-Lindau syndrome 3p26-25 VHL tumour 
suppressor
Neurofibromatosis, type I 17qll.2 NFl gene
Hypertension plus brachydactyly 12p Unknown
Ischaemic Stroke
CADASIL 19ql2 Notch 3
MELAS Mitochondria tRNA-3243
Inherited homocystinuria 21q22.3 Cystathionine p- 
synthase
Haemorrhagic Stroke
Hereditary haemorrhagic telangiectasia-1 9 Endoglin
Hereditary haemorrhagic telangiectasia-2 12ql3 Activin receptor-like 
kinase 1
Cerebral cavernous malformation 7q22 Unknown
Hereditary cerebral haemorrhage with 21 Amyloid precursor
amyloidosis-Dutch type protein
Hereditary cerebral haemorrhage with 
amyloidosis-Icelandic type
20 Cystatin C
Polycystic kidney disease 16pl3.3 Polycystin
Marfan syndrome 15q3 Fibrillin
Cardiac Hypertrophy
Familial hypertrophic cardiomyopathy seven loci Myofibril proteins
Friedreich’s Ataxia 9q X25 (Frataxin)
Fabry’s disease X a-Galactosidase
Table 1.3 Mendelian forms of human cardiovascular diseases (adapted from Hamet et al, 
1998; Gunel & Lifton, 1996, & Nunez et al, 1996).
Affected subjects have variable elevated plasma aldosterone levels in conjunction with 
suppressed plasma renin activity, and secrete high levels of 18-oxocortisol that unaffected 
individuals produce in negligible amounts (Sutherland et al, 1966; Ulick et al, 1990). Using 
18-oxocortisol secretion as a phenotype, a large GRA kindred demonstrated linkage to a 
segment of chromosome 8 harbouring CYPl 1B2, or the aldosterone synthase gene (Rich et 
al, 1992; Lifton et al, 1992a). This gene is 95% identical in DNA sequence to another 
involved in steroid biosynthesis, the 11 P-hydroxylase gene (CYPllBl), which also lies on 
chromosome 8 (Lifton et al, 1992b). Unequal crossing over between the aldosterone 
synthase and l ip-  hydroxylase genes results in a chimeric gene duplication fusing proximal 
sequences of 11 P-hydroxylase onto more distal sequences of aldosterone synthase (Pascoe 
et al, 1992; Lifton et al, 1992a). The presence of this novel mutation cosegregates with 
GRA at a recombination fraction of zero and is thus clearly responsible for the clinical 
features observed in affected individuals.
2) - Apparent mineralocorticoid excess (AME) is an autosomal recessive form of Mendelian 
hypertension also associated with defects in steroid metabolism. Inactivating mutations in 
the renal isozyme of the 1 ip-hydroxysteroid dehydrogenase (HSD11B2) gene, which 
normally converts cortisol to cortisone, create hypertension by failing to provide affected 
subjects with protection against the potent mineralocorticoid effect of cortisol (Mune et al, 
1995; Stewart a/, 1996).
3) - Liddle’s syndrome (pseudoaldosteronism), an autosomal dominant form of 
hypertension, is related to abnormalities in renal ion transport and is clinically characterised 
by the suppressed secretion of aldosterone, suppressed plasma renin activity and
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hypokalaemia (Shimkets et al, 1994). Initially linked to a short segment of human 
chromosome 16, subsequent research identified that constitutive over-activation of the 
aldosterone-regulated epithelial sodium channel (expressed in the renal nephron) arises from 
a mutation in the P subunit (SCNNIB) of this channel (Shimkets et al, 1994) and/or a 
mutation truncating the carboxy terminus of the y subunit (SCNNIG) of the channel 
(Hansson et al, 1995). Both lead to hypertension via increased renal salt and water 
absorption independent of mineralocorticoid action.
The molecular causes of three rare inherited forms of hypotension have also been reported. 
Autosomal recessive pseudohypo-aldosteronism type 1 (PHA-1) is a mirror image of 
Liddle’s syndrome with causative mutations in the a- and P-subunits of the epithelial 
sodium channel (Chang et al, 1996). Gitelman’s syndrome, characterised by hypokalaemic 
alkalosis with elevated renin and aldosterone, hypomagnesemia, and hypocalciuria maps to a 
region on chromosome 16 inseparable from the gene encoding the renal thiazide-sensitive 
sodium-chloride co-transporter (NCCT) present on the surface of the distal convoluted 
tubule cells (Simon et al, 1996a). Bartter’s syndrome features salt wasting, hypokalaemic 
alkalosis and hypercalciuria and is due to mutations in the renal sodium-potassium-chloride 
co-transporter gene (NKCC2) that is expressed apically in the thick ascending limb of 
Henle’s loop (Simon et al, 1996b). Given the common genetic heterogeneity observed, it 
seems likely that these alleles which lower blood pressure may be of equal importance in 
determining blood pressure levels (Karet & Lifton, 1997).
It is noteworthy that all the above mutations, whether elevating or lowering blood pressure, 
do so through a common pathway {Figtire 1.2), affecting salt and water reabsorption in the
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Figure 1.2 Common pathway of all mutations contributing to blood pressure variation 
identified so far - the regulation of salt reabsorption by the kidney (adapted from Karet & 
Lifton, 1997). Genetic conditions affecting this pathway are given in italics. All 
abbreviations are described in text.
kidney (Lifton, 1996). Mutations causing GRA, AME and Liddle’s syndrome all result in a 
constitutive increase in renal sodium absorption, whereas mutations causing PHA-1, 
Bartter’s and Gitelman’s syndromes reduce blood pressure by causing renal salt wasting. No 
causal gene has yet been identified for an autosomal dominant form of severe hypertension 
plus brachydactyly which has been described in a single, large Turkish kindred (Biliginturan 
et al, 1973). Linkage analysis concerning families with this disease have localised the 
genetic defect to a region of chromosome 12p in between markers D12S364 and D12S87 
(Schuster et al, 1996). The eventual identification of the genetic cause may elucidate new 
mechanisms of blood pressure elevation as this is uniquely a non salt-sensitive syndrome; 
the renin-angiotensin system and sympathetic nervous system have been shown to respond 
normally in this kindred (Biliginturan et al, 1973).
Mendelian Forms o f  Stroke
As Table 1.3 shows, convincing evidence of an underlying genetic predisposition to human 
stroke independent of blood pressure is also provided by the existence of several well- 
documented Mendelian forms which do not require hypertension as a permissive factor 
(Gunel & Lifton, 1996). Of these, most is known of the genetic basis of cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
Originally mapped to chromosome 19ql2 in two families (Toumier-Lasserve et al, 1993), 
analysis of 13 additional pedigrees placed the CADASIL locus within a 2cM interval 
bracketed by the markers D19S199 and DI9S253 (Ducros et al, 1996). The defective gene 
was subsequently identified as Notch3 (Joutel et al, 1996). Members of the Notch gene
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family encode evolutionary conserved transmembrane receptors, and are involved in cell 
fate specification during embryonic development (Artavanis-Tsakonas et al, 1995). The 
NotchS gene includes 33 exons encoding a protein of 2321 amino acids and its extracellular 
domain contains 34 epidermal-growth-factor-like (EGF-like) repeats. Clustering of 
mutations within the two exons encoding the first five EGF-like repeats has been observed 
and all lead to a loss or gain of a cysteine residue and therefore to an unpaired number of 
cysteine residues within a given EGF domain. These findings suggest that aberrant 
dimérisation of NotchS, due to abnormal disulphide bridging with another protein, may be 
involved in the pathogenesis of this disorder (Joutel et al, 1997). Further molecular analysis 
of the human Notch3 receptor carrying CADASIL mutations will determine the molecular 
pathogenesis underlying the CADASIL phenotype (Goate & Morris, 1997), whilst a study 
of the CADASIL gene in the general stroke population will determine any involvement it 
may have in more common forms of stroke.
Mendelian Forms o f Cardiac Hypertrophy
A number of primary inherited disorders are also associated with left ventricular 
hypertrophy independent of each other and of secondary stimuli such as hypertension {Table 
1.3). Most is known of familial hypertrophic cardiomyopathy (FHC), a genetically 
heterogeneous autosomal dominant disorder which has been linked to seven disease loci so 
far; cardiac troponin T, cardiac myosin binding protein-C, cardiac P-myosin heavy chain, a- 
tropomyosin, ventricular myosin essential light chain, ventricular myosin regulatory light 
chain and cardiac troponin I (ICimura et al, 1997). These seven genes all encode 
components of the myofibril and as such it has been proposed that sacromere
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disorganisation may play a role in the pathogenesis of the disease, the abnormal protein 
impairing the correct packaging of proteins into functional macromolecular structures 
(Nunez et al, 1996). Whilst classical FHC causes death at an early age several molecular 
genetic studies have shown that some FHC causing mutations are compatible with a long 
lifespan (Watkins et al, 1992; Anan et al, 1994). It follows that carriers of mutations of the 
FHC-type may be more common in hypertensives and the general population then currently 
appreciated.
Taken alone, all the rare mutations identified above prove beyond doubt that genetic defects 
can produce human cardiovascular disease. The question now stands as to whether they 
play a role in the more common forms of each disease. It follows that their impact on 
clinical outcome must now be assessed by studies in the heterogeneous general population 
just as for any other candidate gene.
1.2.2 Candidate Gene Analysis
The general premise of a candidate gene approach is that the pathophysiological process of 
interest is due to the altered expression or structure of a gene product which in turn is 
reflected by changes in the gene. The selection of a candidate gene requires prior knowledge 
of the physiologic pathways known to influence the disease state (Dominiczak & 
Lindpaintner, 1994) and is therefore based either on the known, or suspected, function of 
the gene, sequence homology with other known genes, interaction of the protein product 
with another protein, or tissue specificity of expression. Once selected the direct search for 
molecular variants of the candidate gene is followed by linkage studies using affected sibling
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or relative pairs and/or association studies contrasting the allele frequencies between large 
cohorts of unrelated cases and controls (Lifton, 1995). Most studies of human polygenic 
multifactorial cardiovascular disease have employed a candidate gene approach.
Essential Hypertension
In light of the common pathway shared by all the functional variants identified in Mendelian 
forms of disordered blood pressure {Figure 1.2), it is not surprising that the vast majority of 
candidate genes tested for a contribution to human essential hypertension have been chosen 
from those encoding enzymes and peptides of the renin-angiotensin system, or related to 
water and sodium handling. These include the renin gene (Jeunemaitre et al, 1992a); the 
angiotensin-converting enzyme, or ACE gene (Jeunemaitre et al, 1992b), and the 
angiotensin II receptor ATi gene (Bonnardeaux et al, 1994). However, only the 
angiotensinogen (AGT) gene has provided mutually reinforcing lines of evidence supportive 
of a causative role.
AGT is secreted by the liver, cleaved sequentially by renin and ACE, eventually producing 
the active hormone angiotensin II (All), which promotes a rise in blood pressure {Figure 
1.2). That this gene plays a role in the development of hypertension was initially supported 
by the observation that plasma angiotensinogen levels cosegregate with blood pressure in 
families (Watt et al, 1992). Additionally, transgenic mice overexpressing the rat 
angiotensinogen gene develop hypertension (Kimura et al, 1992), knockout mice with a 
disrupted agt gene lack angiotensinogen and develop low blood pressure (Kim et al, 1995), 
and mice carrying from zero to four copies of the normal mouse agt gene display plasma
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angiotensinogen levels which increase progressively with the number of agt copies and 
correlate with increases in blood pressure (Kim et al, 1995; Smithies, 1997).
The human ^ G r  gene has been localised to chromosome lq42-43 and specific mutations in 
the gene, most commonly the M235T polymorphism which encodes a change of amino acid 
from methionine to threonine, have shown positive linkage and association with essential 
hypertension in several human populations (Jeunemaitre et al, 1992c; Caulfield et al, 1994; 
Caulfield et al, 1995; Schmidt et al, 1995). Indeed, a recent meta-analysis summarising a 
total of 11 association studies of the /IGTM235T variant with hypertension in 14 Caucasian 
populations (Kuntz et al, 1997) found a significant association between the ^GT M235T 
allele and hypertension in five of the studies. Whilst the remaining six studies failed to 
confirm these findings, when the AGT M235T-allele frequency was pooled using the 
common odds ratio estimator of Mantel-Haenszel it became significantly associated with 
hypertension. The strength of this association increased in those with more severe 
hypertension, positive family history or recruitment of cases from referral centres. This 
variant has been shown to be in tight linkage disequilibrium with a guanine-to-adenosine 
transition -6bp upstream of the initiation site of transcription, which may result in an 
increased transcription rate (Inoue et al, 1997).
Stroke and Left Ventricular Hvpertrophv
Excluding the reported associations in small numbers of cases with rare Mendelian diseases 
where stroke or left ventricular hypertrophy is part of the phenotype (Natowicz & Kelley, 
1987; Nunez et al, 1996) very few studies have investigated the molecular genetics of either
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in the wider human population. Of those which have, the majority of the candidate genes 
have been genetic components of lipid metabolism, the clotting cascade and the renin- 
angiotensin-aldosterone system which are directly implicated in secondary risk factors such 
as atherosclerosis, myocardial infarction and hypertension. Whilst worthy of investigation, 
these remain compounding factors only, with their own potentially unrelated genetic 
determinants. For example, whilst evidence clearly links the AGT M235T polymorphism 
with essential hypertension (Jeunemaitre et al, 1992c; Caulfield et al, 1994) and cardiac 
hypertrophy (Ishanov et al, 1997), an association has not been shown with cerebrovascular 
disease (Barley et al, 1995). However, attention is beginning to turn to candidate genes 
putatively involved in free radical determination of eventual infarct size (the nitric oxide 
synthases and superoxide dismutases), blood-brain barrier breakdown (the matrix 
metalloproteinases), maintenance of cardiac infi-a-structure (myofibrillar genes), and those 
others identified by the dissection of related Mendelian traits (Sharma, 1996).
1.2.3 Limitations
Until proven otherwise by candidate gene analysis, it seems likely that single gene disorders 
of cardiovascular diseases will cumulatively explain only a small fraction of the total genetic 
variance in the general population, thereby necessitating continued analysis of their more 
common forms with less clear-cut modes of inheritance (Karet & Lifton, 1997). 
Unfortunately the strategy of applying a candidate gene approach in the human population 
has not enjoyed a great deal of success in identifying important disease susceptibility genes 
(Mitchell & Dyke, 1997). The reproducibility is poor between different populations and, 
even within the same or ethnically similar populations, different results have been obtained
17
depending on whether an association study or a linkage study was employed (Kuntz et al, 
1997; Brand et al, 1998). Such observations serve to highlight the numerous 
methodological limitations imposed by the complex, polygenic, and multifactorial nature of 
human cardiovascular diseases.
The first major limitation lies in the fact that candidate genes are, by necessity, derived from 
the relatively small pool of genes recognised so far compared with the estimated total 
number of genes (> 50,000) in the human genome (O’Connor et al, 1996). It follows that if 
the disease-relevant genes are, as is likely, among the unknown majority, they will never be 
found by this approach (Dominiczak & Lindpaintner, 1994).
Secondly, the use of blood pressure as the phenotype in human studies has been a source of 
criticism since it is known that this phenotype is not stable, fluctuates greatly throughout the 
day and is particularly effected by stress (Lander & Schork, 1994). Furthermore, diagnostic 
thresholds for hypertension can vary from country to country and are arbitrary, having been 
based on cut-off points at which therapeutic interventions have been perceived to be of 
benefit in reducing health risks rather than on true qualitative demarcations. It follows that 
while the optimal method of determining “the” blood pressure of an individual in population 
studies remains to be determined, technical differences between clinics may produce 
artefactual data.
Association studies do not concern familial inheritance patterns but are case-control studies 
based on a comparison of unrelated affected and unaffected individuals from a population. 
An allele at a gene of interest is said to be associated with the trait if it occurs at a
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significantly higher frequency among affected compared with control individuals. Positive 
associations can arise if the allele is a cause of the disease, in which case the association 
should be found in all populations, or if the allele is in linkage disequilibrium with a disease 
causing allele (Mitchell & Dyke, 1997). Unfortunately the presence of an association can 
also arise as an artefact of population admixture as any trait present at a higher frequency in 
an ethnic group will show positive association with any allele that also happens to be more 
common in that group. It follows that association studies are only meaningful if performed 
within relatively homogeneous populations, which are rare (Lander & Schork, 1994).
Classical parametric linkage analysis involves proposing a model to explain the inheritance 
pattern of phenotypes and genotypes observed in a pedigree. It is the method of choice for 
simple Mendelian traits because the allowable models are few and easily tested. However, 
fitting such a precise model that adequately explains the inheritance pattern in common 
complex traits is impossible (Lander & Schork, 1994). Some members of a family may 
present the putative susceptibility gene and not the trait (incomplete penetrance), or present 
the trait and not the gene (phenocopy), either because of the polygenic and heterogeneous 
diversity of the disease and human population at large, epistatic and ecogenetic interactions, 
environmental factors alone, or phenotypic misdiagnosis. Model-free non-parametric 
methods relying only on allele sharing by affected first-degree relatives have been 
developed, the idea being that affected relatives should show excess allele sharing even in 
the presence of incomplete penetrance, phenocopy, and genetic heterogeneity (O’Connor et 
al, 1996). However, allele-sharing methods are often less powerful than a correctly 
specified linkage model as the relatively late-onset of most complex diseases leads to a 
shortage of sib-sib and parent-offspring pairs.
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It follows that all the above methodological difficulties imposed by trying to study directly 
the genetic determinants of complex human cardiovascular traits have given major impetus 
to the use of similar, but inherently simpler, paradigms in experimental animal models of 
genetic hypertensive cardiovascular disease, where the importance of heredity factors has 
long been clearly and unquestionably demonstrated (Tanase et al, 1970; Lindpaintner,
1993).
1.3 Genetic Models of Hypertensive Cardiovascular Disease
Animal models, and in particular the rat, offer several advantages for genetic research. Their 
low cost, ease of handling and breeding, access to sophisticated measurements, short 
generation time, and large litters all serve to remove some of the complexity inherent in 
studying human subjects and families (Lovenberg, 1987). This has been extended further by 
the production of inbred, genetically homogeneous rat models of hypertensive 
cardiovascular disease exhibiting particularly relevant phenotypes (Dominiczak & 
Lindpaintner, 1994).
The approach most commonly used to develop inbred models of hypertensive 
cardiovascular disease has been to measure blood pressure in a large number of non-inbred 
animals and then selectively breed those having the highest blood pressures (Kurtz et al,
1994). In each successive generation the offspring with the highest blood pressures are 
brother x sister mated to produce an inbred strain. After 20 generations of brother x sister 
mating the offspring should be homozygous at >99% of loci and therefore all animals within 
the strain nearly isogenic (Rapp, 1983). This solves the problem of aetiological
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heterogeneity such as is present in the human disease state, while also allowing the 
production of a large number of progeny. Moreover, the ability under conditions of 
standardised animal husbandry to control confounding environmental factors provides the 
opportunity to investigate far more complex environmental and genetic interactions than is 
ever possible in even the most closely supervised clinical trials (Dominiczak & Lindpaintner,
1994).
A useful parallel to the diversity found in human hypertensive cardiovascular disease is 
maintained by the existence of a number of commonly used in-bred strains {Table 1.4). Each 
of these rat strains has some unique pathophysiological features linked to the development 
of the disease and thus resemble disorders found in subgroups of hypertensive subjects 
worthy of independent genetic investigation, including left ventricular hypertrophy and 
stroke (Ganten, 1987). In particular, development of rat models derived from the 
spontaneously hypertensive rat are now widely used for hypertension-related diseases and 
others (Yamori & Swales, 1994).
1.3.1 The Stroke-Prone Spontaneously Hypertensive Rat
In 1963, Okamoto and Aoki reported the production of a colony of spontaneously 
hypertensive rats (SHR) by selective in-breeding of individual normotensive Wistar-Kyoto 
(WKY) rats with elevated blood pressure from the Animal Center Laboratory, Kyoto 
University Faculty of Medicine, Japan (Yamori & Lovenberg, 1987). The typical lesions 
often associated with human hypertensive cardiovascular disease, including cerebral 
(infarction, haemorrhage), myocardial (infarction, fibrosis) and nephrosclerotic (benign.
2 1
Name and Origin of Strain Systolic Blood Pressure (mmHg)
Spontaneously Hypertensive Rat (SHR) 200
Kyoto, Japan
Stroke-Prone Spontaneously Hypertensive Rat (SHRSP) 230*
Kyoto, Japan
Milan Hypertensive Rat (MHS) 175
Milan, Italy
Dahl Salt-Sensitive Rat (SS/Jr) 170
Brookhaven, USA
Lyon Hypertensive Rat (LH) 180
Lyon, France
Sabra Hypertensive Rat (SBH) 185
Jerusalem, Israel
Genetically Hypertensive Rat (GH) 180
Dunedin, New Zealand
Table 1.4 Genetically inbred hypertensive rat strains in common use. *Refers to mean 
systolic blood pressure recorded in Glasgow colony of SHRSP (Davidson et al, 1995).
malignant), were all observed in SHR after three months of age, indicative of their potential 
as a good model for the human condition (Okamoto & Aoki, 1963).
The SHR were separated into 3 main substrains in 1971 and at that time it was confirmed 
that the incidence of spontaneous cerebrovascular disease was different among these - high 
in substrain A (80%) and low in B and C (50%) - despite the similar blood pressures. 
Suspecting the involvement of independent genetic factors in the pathogenesis of stroke, 
Okamoto and co-workers undertook successive selective breeding of substrain A by 
maintaining the offspring only from the SHR which died with stroke. This resulted in the 
production of a stroke-prone spontaneously hypertensive rat, or SHRSP (Okamoto et al, 
1974).
The SHRSP displayed a rapid onset of hypertension after birth and by three months of age 
had a systolic blood pressure of 230mmHg, compared to the 125mmHg of the normotensive 
WKY control. The SHRSP had a high tendency to naturally develop cerebrovascular 
lesions, particularly in the anteromedial and occipital cortex and the basal ganglia, with over 
90% of all males suffering stroke while on a Japanese diet of high salt, low potassium and 
protein (Nagaoka et al, 1976). In contrast to regular SHR strains which were known to be 
resistant to salt, the SHRSP were found to be salt sensitive (Yamori et al, 1981).
Given the immediate interest in the SHRSP and its relatives for hypertension and stroke 
research, they were rapidly distributed around the world. In particular, WKY may have been 
issued from Japan as early as the FIG generation (Kurtz et al, 1989). This world-wide 
distribution, prior to complete in-breeding (F20 required at least), has resulted in significant
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genetic heterogeneity between different colonies (Matsumoto et al, 1991; Samani et al, 
1989; Kurtz et al, 1989; Nabika et al, 1991). Whilst this does not effect their utility, it does 
necessitate an awareness of the source of the SHRSP, SHR, or WKY, when making any 
comparison of experimental results obtained by different research groups.
There are numerous pathophysiological similarities between hypertensive cardiovascular 
disease in SHRSPs and human subjects which promote their application to genetic studies, 
although classical atheroma does not develop (Frohlich, 1986). For example, in common 
with human essential hypertension, male SHRSPs have higher blood pressures than females. 
Left ventricular hypertrophy is also a common feature of the SHRSP (Yamori et al, 1979). 
Furthermore, their intracerebral perforating arteries show fibrinoid necrosis similar to that 
observed in severe clinical hypertension (Yamori et al, 1976a). Whilst the most 
preponderant site for stroke in SHRSP is the cortical region (69.8%), the next highest is the 
basal ganglia (24.5%), in common with humans. Indeed, a branch of the middle cerebral 
artery (the lenticulostriate artery) is responsible for basal ganglia lesions in both the SHRSP 
and humans.
It follows that the SHRSP represents the most suitable in-bred model of human 
hypertensive cardiovascular disease in which to begin the dissection of the specific genetic 
determinants of hypertension, stroke and left ventricular hypertrophy, their interactions, and 
the influence of environment, in particular salt. However, as indicated by the studies of the 
Mendelian forms of human hypertension, any success in elucidating the causal phenomena is 
as dependent on strong and defined phenotyping as on the appropriateness of the genetic 
approach. For this reason, great efforts are being made to provide an error free, high fidelity
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and wholly encompassing method of continuous blood pressure measurement. In addition, 
clearly quantifiable models of organ damage, such as experimental focal cerebral ischaemia, 
are also being considered as alternative phenotypes.
1.3.2 Measurement of Blood Pressure in the Rat
In genetic studies the greatest consideration must be given to the circumstances under 
which blood pressure is measured (Kurtz et al, 1994). If measurements of blood pressure 
are obtained in stressed animals not only will they have an added element of environmental 
artefact but one may be selecting largely for stress-induced hypertensive genes rather than 
those contributing to spontaneous hypertension in a less stressful environment. There are 
three commonly used methods of measuring blood pressure in the rat; tail-cuff 
plethysmography, in-dwelling arterial catheter and radio-telemetric monitoring.
Originally described by Byrom & Wilson (1938), the most commonly used indirect method 
of blood pressure measurement involves the use of a cuff for the occlusion and slow release 
of blood flow in the tail of the rat as well as a variety of techniques to ascertain the 
occluding pressure. Whilst this permits quick and inexpensive repeated measurements on a 
large number of animals, this method possesses several prerequisites known to induce stress 
(Bunag, 1983). Firstly, the recording procedure requires considerable restraint. Secondly, a 
system for warming the rats before using a tail-cuff is absolutely essential. Recording at 
room temperature the blood flow through the tail arteries is too low to allow reliable 
reading (Sponer et al, 1988). However, as rats regulate their body temperature primarily by 
changing blood flow in their tails (Rand et al, 1965), heating to approximately 34°C ensures
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that arterial pulsations during deflation of the cuff are easily detected. Both factors can 
introduce pronounced pressor effects and thus errors which falsely exaggerate the incidence 
of experimental hypertension.
That this method is of limited value for detailed genetic analysis is made clearer by the fact 
that it is unable to provide long-term continuous monitoring and measurements of any 
parameters of blood pressure other than systolic. Should diurnal variation in blood pressure 
or any other component be under different genetic control to systolic pressure, it will be 
missed using this method. It follows that whilst it may still be useful for an initial screening 
of a genetic strain, the stress induction involved and its narrow parameters are likely to 
introduce damaging artefacts when attempting the identification of subtle additive effects in 
ecogenetic and epistatic interactions.
The most commonly used method to directly examine blood pressure in conscious rats, the 
chronic catheterisation of a major systemic artery, possesses many of the same artefact- 
inducing errors as tail-cuff plethysmography (Bunag, 1983). During surgical implantation, 
the fluid filled arterial catheter’s outer end is externalised subcutaneously to emerge at the 
nape. This is connected to pressure transducers which have been calibrated with a recording 
device. Whilst this method gives accurate and direct measures of systolic, diastolic and 
mean arterial pressure it is invasive, the trauma of the operation and anaesthesia inducing 
stress. Furthermore, maintenance of infection free post-operative animals and unclogged 
cannulae represent significant problems. Stagnation of blood flow resulting after arterial 
cannulation encourages the formation of blood clots and fibrous outgrowths which can clog
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up the catheter. Emboli from carotid catheters may cause renal infarction while those from 
iliac or femoral catheters may result in hind-leg paralysis (Bunag, 1983).
Radio-telemetry systems for chronic implantation have progressed over the last 30 years 
from simple devices allowing the measurement of one physiological parameter (Mackay, 
1970) to more complex systems capable of simultaneously monitoring several 
cardiovascular variables (Rubenson et al, 1984), including systolic, diastolic, pulse and 
mean arterial blood pressure, heart rate and motor activity. As a consequence of continued 
advances in miniaturisation techniques, telemetry units small enough to be implanted inside 
the abdominal aorta and remain inside the rat body cavity are now available. The Dataquest 
IV system (Data Sciences International) consists of the implantable transmitter which 
measures the pressure, the receiver panel, which detects the signal from the implantable 
transmitter and converts it to a form readable by computer, the pressure reference module 
which measures atmospheric pressure to be converted to a gauge pressure, and the data 
acquisition software which accepts data from the reference module and receivers, converts 
the telemetered pressure to mmHg, subtracts atmospheric pressure from the telemetered 
pressure and stores the data for retrieval, plotting and analysis.
Whilst implantation of the transmitter does require invasive surgery, the capacity for long­
term monitoring (measurement is continuous night and day and sampling as frequent as 
every five minutes over a six month period or more) allows time for blood pressure and 
heart rate to stabilise post-operatively. For example, Davidson and co-workers (1995) 
observed a necessary 12 day period before collection of haemodynamic measurements for 
data analysis. There is no requirement for heating, and the animals are unrestrained and free
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to move within their cages placed over the receiver panel. It follows that several studies 
have begun to indicate that radio-telemetry is an accurate and reliable, if expensive, means 
of determining cardiovascular parameters in long-term studies, yielding chronic 
measurements that are repeatable and free of stress-induced artefacts (Brockway et al, 
1991; Guiol et al, 1992; Bazil et al, 1993).
The considerable utility of radiotelemetry in genetic research has already been 
demonstrated. Davidson et al (1995) performed two large reciprocal crosses, with the 
SHRSP as a male progenitor of one and with the normotensive WKY a male progenitor of 
the other. The resulting F2 hybrids were phenotyped using radiotelemetry Their major 
finding (Figure 1.3) was a highly significant elevation of systolic, diastolic and mean arterial 
pressure at both baseline and after salt-loading in male F2 hybrids with the Y chromosome 
originating from the SHRSP grandfather (Ys) compared to those hybrids with the Y 
chromosome originating from the WKY grandfather (Yw) . These results suggested that the 
SHRSP Y chromosome contains a locus or loci which contribute to hypertension in this 
model, an association which has been confirmed by the production of congenic strains 
utilising the SHR (Turner et al, 1991; Ely et al, 1993). Previous studies had shown 
conflicting evidence on the contribution of the Y chromosome locus or loci to the 
hypertension in genetically hypertensive models (Ely & Turner, 1990; Hilbert et al, 1991; 
Vincent et al, 1994). It is conceivable that the artefacts associated with the methods used to 
record blood pressure in these studies (tail-cuff and direct femoral artery catheter) were 
responsible for the discrepancies.
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1.3.3 Experimental Focal Cerebral Ischaemia in the Rat
Animal models of stroke have provided an invaluable contribution to the current 
understanding of the pathogenesis of cerebral ischaemia by removing variables which 
confound the interpretation of human stroke data (Macrae, 1992). The severity, duration, 
location and cause of the ischaemia can be controlled, co-existent disease states and 
variations in cerebrovascular anatomy avoided, and physiological parameters such as blood 
pressure, blood gases, temperature and plasma glucose, all of which influence the magnitude 
of the ischaemic lesion, closely monitored and controlled.
A wide diversity of animal species have been used to study cerebral ischaemia but the 
majority of experiments are now carried out in rats, not least because of the relatively low 
cost, the small brain size suited to fixation methodology, and the close similarity between 
the anatomy of the arterial supply to the cerebral hemispheres in the rat and man (Yamori et 
al, 1976a). Each has anterior, middle and posterior cerebral arteries which give rise to 
cortical and basal perforating branches. In the rat, all three arteries are derived mainly from 
the internal carotid arteries but connect via an azygos interior cerebral artery and via 
posterior communicating arteries to form a modified circle of Willis. The middle cerebral 
artery (MCA) supplies the lateral part of the cerebral hemisphere through its cortical 
branches, whilst the penetrating branches supply the putamen, the caudate nucleus, the 
outer globus pallidus, the posterior limb of the internal capsule and the common radiata 
(Adams & Victor, 1989). Both the size of the MCA and the territory are larger than those 
of the anterior cerebral artery (AC A) and posterior cerebral artery (PC A).
2 8
The permanent occlusion of the middle cerebral artery (MCA) in the rat is the definitive 
model of focal cerebral ischaemia and one of the most relevant animal stroke models to man 
as this is reported to be the vessel most commonly affected in human stroke syndromes 
(Berkow & Fletcher, 1987; Mohr et al, 1986; Karpiak et al, 1989). The standard 
subtemporal approach (Tamura et al, 1981) involves microbipolar coagulation of the MCA 
proximal to the lenticulostriate arteries, reducing cerebral blood flow to below 
25ml/100g/min within the core territory of the MCA. This produces, without mortality, a 
significant, reproducible infarction in both the frontal cortex and lateral part of the caudate 
nucleus equivalent to a massive hemispheric ischaemic stroke in man. A range of 
autoradiographic and histopathological methods have been developed that quantify in a 
precise anatomical manner the severity of the ischaemic insult (Osbourne et al, 1987). Area 
and distribution of the ischaemic infarction are normally assessed at eight coronal levels 
throughout the MCA territory and these data are computed to provide a total volume of 
ischaemic damage.
A subsequent variation in the model included the use of alternative strains of rat in order to 
improve the reproducibility of the infarct size or to incorporate a recognised risk factor such 
as hypertension (Duverger & MacKenzie, 1988). The SHR and SHRSP have been shown to 
have much larger and less variable infarcts after MCA occlusion than most, if not all, other 
strains {Figure 1.4), including the WKY (Coyle, 1984; Coyle, 1986; Brint et al, 1988; 
Duverger & MacKenzie, 1988; Gratton et al, 1998). They display a greater infarcted 
surface area at any given coronal section and the caudal limit of the infarction is situated 
more posteriorly.
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Figure 1.4 Cerebral infarction in the SHRSP and WKY following MCA occlusion showing 
the bimodality of this phenotype. MCA territory stained with haematoxylin and eosin to 
show the location and extent of ischaemia.
It was initially thought that the inherent hypertension was solely responsible for this 
increased susceptibility to focal cerebral ischaemia in the SHRSP. Vascular hypertrophy, a 
physiological adaptation of the vasculature to maintain circumferential wall stress relatively 
constant under high blood pressures, was believed to infringe on the vascular lumen 
(internal diameter), decreasing functional compliance and thus aggravating the infarct 
process (Folkow et al; 1973; Baumbach & Heistad, 1989). However, the reduction in the 
external diameter observed in cerebral arterioles (Baumbach & Heistad, 1989) cannot be 
wholly attributed to vascular hypertrophy. If hypertrophy increased the stiffness of 
arterioles, external diameter might be reduced, but hypertrophied cerebral arterioles actually 
become more distensible (Baumbach et al, 1988). In fact, it has been shown that 
hypertrophy of the vessels may actually protect against stroke as when vascular hypertrophy 
is reduced by chronic sympathetic denervation in SHRSP the incidence of spontaneous 
cerebral haemorrhage and infarction increases rather than decreases (Sadoshima et al, 1981 
& 1983).
That hypertension is of secondary importance in determining susceptibility to cerebral 
infarction in SHRSP has been reinforced by other observations. Large infarcts after MCA 
occlusion have been observed to occur in a minority of normotensive rats suggesting that 
whatever governs infarct susceptibility it can be dissociated from hypertension and 
presumably occur with variable frequency in normotensive populations (Duverger & 
MacKenzie, 1988). Similarly, Coyle (1986) observed that chronic hypertension does not 
uniformly predispose rats to infarction as -10% of young and adult SHRSP and SHR suffer 
small infarcts or none at all after distal, single point MCA occlusion, and correlation 
between pre-occlusion blood pressure and infarction size is poor. Coyle (1984) noted that
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rats made hypertensive by deoxycorticosterone acetate and salt administration fail to 
develop large infarcts after MCA occlusion, whilst adult SHR in which hypertension is 
treated early and continuously with the angiotensin-converting enzyme inhibitor cilazipril 
develop infarcts that are only at most 20% smaller than the very large infarcts in the 
untreated hypertensive cohorts (Slivka, 1991; Fujii et al, 1992). Furthermore, SHRSP suffer 
larger infarcts in early youth before either hypertension or pathological changes in the 
vasculature become established (Coyle & Jokelainen, 1983; Gratton et al, 1998).
Several lines of evidence have subsequently led Baumbach & Heistad (1989 & 1991) to 
propose that infarct susceptibility in SHRSP arises from a detailed remodelling of cerebral 
arterioles and vascular collateral blood flow that is associated with, but not directly linked 
to, the vascular lesions of chronic hypertension. Collateral blood supply in all rats is by 
numerous small diameter pial surface collaterals of the MCA anastomosing with rami of the 
ACA or PC A to form an extensive network which plays a vital role in preserving blood flow 
following the occlusion of a major cerebral artery and thus limiting the volume of ischaemic 
damage (Coyle & Jokelainen, 1983). Coyle & Heistad (1986) identified that only five 
minutes after MCA occlusion blood flow through collateral vessels was significantly less in 
SHRSP than in WKY, clearly implicating collateral impairment as a major contributor in the 
creation of the large cerebral infarcts observed in SHRSP This is supported indirectly by 
neuroprotection studies where drugs with flow-enhancing properties (e.g. L-type calcium 
channel blockers) are found to be more effective in SHR and SHRSP than NMDA 
glutamate antagonists with proven efficacy in normotensive strains (McCulloch, 1996; 
Sauter & Rudin, 1995). Indeed, whilst no difference has been observed in the number of 
ACA-MCA anastomoses, or their distribution, the internal diameter measured in SHRSP is
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only 60% of that in WKY and a strong correlation exists between lumen diameter and of 
cortex spared ischaemic damage at the zone of anastomoses (Coyle, 1986). As to the cause 
of remodelling, and its interrelationship with hypertension, much research remains to be 
completed, although the demonstration of geometric disorganisation of medial layers of 
cerebral vessels in the SHRSP independently of blood pressure (Arribas et al, 1996) does 
suggest a genetic component.
That infarct susceptibility in the SHRSP may have a genetic cause led Coyle and co-workers 
(1984) to investigate its pattern of inheritance in a F2 generation and series of subsequent 
backcrosses derived by crossing a male outbred normotensive Wistar (NW) rat vÀth several 
SHRSP females. They showed a bimodal distribution of this phenotype and by observing the 
frequency of infarcting and non-infarcting animals concluded that susceptibility to 
experimental ischaemia is inherited through a single gene locus best described as autosomal 
recessive (Coyle et al, 1984). Subsequently Gratton et al (1998) observed that the 
distribution of infarct volumes in the first filial (FI) generation produced by crossing in-bred 
SHRSP and WKY rats virtually matched that in parental SHRSP, strongly suggesting a 
dominant mode of inheritance for this phenotype. Possible reasons for the two different 
conclusions may include Coyle’s use of outbred normal Wistar rats in place of inbred WKY 
rats, and a less severe, more distal occlusion in much younger animals (Gratton et al, 1998). 
That a role exists for genetic factors in spontaneous stroke of SHRSP had previously been 
highlighted by the stroke-resistance of the related SHR despite similar hypertension and diet 
(Okamoto et al, 1974). Indeed, by studying the latency to stroke, or age of stroke 
occurrence, on a high salt diet, Nagaoka and colleagues (1976) observed this phenotype 
was characterised by a polygenic inheritance. It seems likely therefore that the genes
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governing latency to stroke could well be unrelated to those governing infarct size and that 
the pathophysiological mechanisms may be quite different.
1.4 Genetic Dissection of Hypertensive Cardiovascular Disease the Rat
The successful development of experimental inbred strains of hypertensive cardiovascular 
disease presents a usefiil adjuvant to the genetic study in humans. They preserve the 
polygenic character of the disorder whilst providing a reduction in complexity due to the 
lack of genetic heterogeneity, the standardisation of environmental influences, and the 
availability of high fidelity phenotyping as described above. Indeed, crude biometric 
estimates from breeding experiments in various hypertensive strains have shown the number 
of independent genes affecting blood pressure to be between 2 and 6 (Rapp, 1983). This 
reasonably low number of loci suggests the feasibility of identifying the effects of these 
genes, as well as those independently influencing stroke and left ventricular hypertrophy, in 
such models (Harrap, 1994).
Traditionally genetic research using inbred hypertensive rat strains was undertaken in a 
solely comparative fashion by contrasting them with a control (Lander & Schork; 1994). A 
variety of biochemical, anatomic and histological characteristics have been used as 
phenotype parameters for this approach, and over a 100 differences found (Dominiczak & 
Lindpaintner, 1994). Unfortunately most of these have subsequently proved unrelated to the 
pathogenesis of hypertension or its sequelae (Yamori, 1982). Rather, these differences have 
evolved as a consequence of genetic drift (random selection and fixation of alleles unrelated
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to the regulation of blood pressure) during the process of selective breeding and subsequent 
inbreeding (Rapp, 1983).
In order to tackle this, Rapp (1983) formulated a set of criteria that must be fulfilled for 
differences between normotensive and hypertensive strains to be considered 
pathogenetically important. The most powerful of these is the requirement that the 
(intermediate) phenotype investigated must cosegregate with an increment in blood pressure 
in an F2 or backcross population of rats derived from a cross of the hypertensive and 
control strains, as it allows the distinguishing of random association of two phenotypes from 
fairly solid evidence for a causal relationship between the two (Rapp, 1983). Among 
phenotypic traits that have been shown to cosegregate with blood pressure in the SHRSP 
are noradrenaline induced oscillatory activity and increased lymphocyte potassium efflux 
(Dominiczak & Lindpaintner, 1994). Unfortunately, the confounding question remains 
whether the cosegregating trait represents a causative factor, or is simply a secondary 
phenomenon of the hypertension.
This problem has been solved in recent years by the development of a series of practical 
DNA-based markers which are genetically distinguishable (dimorphic) between the 
hypertensive and the normotensive strains in terms of differences in DNA structure, and 
thereby allow the co segregation of both genotype and phenotype to be tested in a F2 
generation (Lindpaintner, 1992). The earliest markers resulted from the recognition of 
restriction fragment length polymorphisms (RFLPs). Digestion of genomic DNA with 
restriction enzymes results in DNA cleavage at specific sequences in a candidate gene of 
interest. If a dimorphism exists between two strains, the restriction enzyme will cut at
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different sites and the resulting DNA fragments will differ in size. This can be visualised 
after electrophoretic fractionation by hybridisation against complementary molecular probes 
(Jeffreys, 1979).
As a probe for the sequence of interest is required, it follows that RFLP analysis has been 
limited to the cosegregation analysis of several characterised candidate genes with 
hypertension. Given the relative paucity of characterised genes (see Chapter 1.2.3) this may 
mean that a chromosomal region containing a gene of interest is missed. Indeed, even when 
a positive cosegregation is determined it need not automatically implicate this gene as 
pathogenic; rather, it may arise as a result of a close association to the actual disease- 
causing gene which is as yet unknown. For example, whilst a significant association between 
the renin gene marker and hypertension has been found in the Dahl strain of sodium- 
sensitive hypertension (Rapp et al, 1989), similar analyses in the SHR have proved negative 
(Lindpaintner et al, 1990; Kurtz et al, 1990), and there is no evidence from biochemical 
studies for a pathogenic role of the renin-angiotensin system in the Dahl rat.
Alternative strategies without a priori hypotheses regarding candidate genes have been 
made possible by the identification of variable DNA sequences composed of randomly 
organised stretches of the same sequence of nucleotides repeated over and over. These 
sequences are widely dispersed throughout the entire genome, show a high degree of 
polymorphism, and in themselves are usually not associated with any particular gene and 
thus functionally meaningless (Weber & May, 1989). The simplest types of repeats, termed 
micro satellite markers, are characterised by short sequence motifs, such as a two base core 
unit of dCdA, repeated up to a dozen times (Weber & May, 1989). Locus specificity is
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coupled to length polymorphism (Beckman & Weber, 1992) and large numbers of 
individuals are easily typed by polymerase chain reaction (PCR). It follows that a genome 
wide scan utilising both candidate genes and anonymous microsatellite markers to identify 
quantitative trait loci (QTLs) has successfiilly emerged as the first major step towards 
ultimate identification of genes influencing complex traits.
1.4.1 Genome Wide OTL Analysis
A QTL is a broad chromosomal region containing a gene, or set of genes, influencing a 
quantitative trait such as blood pressure, heart weight, or volume of cerebral infarction. The 
main tools necessary for QTL mapping include linkage analysis, a large segregating F2 
population constructed from two inbred strains, high fidelity phenotyping of the F2 cohort 
such as described in Chapters 1.3.2 and 1.3.3, and a large panel of markers which are 
dimorphic between the two inbred strains and complete a thorough coverage of the rat 
genome.
Genetic linkage occurs when two genes or markers are physically close together on the 
same chromosome. During Prophase I of meiosis, homologous chromosomes pair. Each 
consists of two sister chromatids as DNA replication has taken place. Chiasmata form 
between homologous chromatids and crossing over and exchange of genetic material 
occurs. The closer together on a chromosome two genes are, the less likely a chiasma will 
form between them, the less likely they will recombine and the closer the linkage. If genes 
are far away from each other or on another chromosome, they will recombine frequently 
and segregate independently.
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Genetic linkage is measured by the recombination fraction, 0, the number of recombinants 
observed divided by the total number of meiotic events (progeny). If loci are unlinked, 
whether on different chromosomes or far away from each other on the same chromosome, 
approximately half of the progeny will be recombinants, 0 = 50%. If genes are linked, 0 < 
50% and parental combinations will predominate. If genes are very closely linked and no 
recombination events take place between them then 0 = 0%. As the frequency of 
recombination events occurring between two genetic loci is a function of their physical 
distance on a chromosome, the recombination fraction may be converted into distance. This 
distance is expressed in centiMorgans (cM) where one cM represents 1% likelihood of 
recombination, which corresponds to approximately 1-2 million base pairs of the 
mammalian genome (Lindpaintner, 1992).
The principle underlying identification of QTLs by linkage to marker loci is conceptually 
simple. A segregating second filial (F2) population is derived by crossing affected (for 
example SHRSP) and wild-type (WKY) inbred strains to produce a uniformly heterozygous 
first filial (FI) population, which is then brother-sister mated. This is a powerful population 
in which to detect QTLs statistically by linkage analysis as many informative meiotic events 
are available for study. Any marker which is dimorphic has three possible genotypes in the 
F2 progeny; homozygous ss (possessing both alleles from the SHRSP), homozygous ww 
(possessing both alleles from the WKY), and heterozygous ws (possessing one allele from 
both strains). Individuals are scored for their genotype at the marker loci spread throughout 
the genome, and their phenotype for the quantitative trait. If there is a significant difference 
in quantitative trait levels between the genotype groups at a particular marker, one can infer 
the presence of a QTL. Alleles at a locus not genetically linked to the
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causative gene will segregate independently and there will be no statistical association of the 
marker genotypes with the phenotype.
Traditionally, marker loci across the genome have been considered singly using a one way 
analysis of variance (ANOVA) to calculate the contribution of alleles to the genetic 
variation of the phenotypic trait (Sax, 1923; Soller & Brody, 1976), a significance level of p 
< 0.05 indicative of linkage with 95% probability (Rapp & Deng, 1995). However, as a 
given marker may be some distance from a QTL, simultaneous analysis of markers is 
preferable to establish greater significant evidence for the QTL s existence. It follows that 
sophisticated computer packages such as MAPMAKER (Lander et al, 1987) have been 
developed which undertake multipoint maximum-likelihood linkage analysis using an 
interval mapping approach (Lander & Botstein, 1989).
The first task of MAPMAKER is to construct a genetic linkage map with the aid of a 
mapping function. These are used to describe the relationship between recombination 
fraction and genetic map distance, converting 0 into cM distances (Lander et al, 1987). 
Haldane’s mapping function is widely used and is given as 0 = 0.5(l-e’^ “) where © is equal 
to the map distance in Morgans (Haldane, 1919). Alternatively, Kosambi’s mapping 
function may be used as a more realistic formula, o  = 0.25 In (1+20/1-20). This takes 
chiasma interference into account which occurs when the presence of a chiasma inhibits the 
formation of chiasmata in nearby regions (Kosambi, 1943; Coneally & Rivas, 1980).
Once a map has been constructed, MAPMAKER examines each marker for linkage to the 
trait and compares them with adjacent markers. The significance of genetic linkage is
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determined by the logarithm of the ratio of the odds (or likelihood) of obtaining a set of 
linkage data (a QTL) over the odds of obtaining the same data by chance (no linkage). 
Termed a LOD score, it is described as Z = logio [L(0)/L(O.5)] and is calculated at various 
levels of 0 to identify the value at which Z is greatest (Zmax). This is considered the best 
estimate.
Traditionally, the evidence for a putative QTL and the amount of phenotypic variance it 
explains is considered significant when Z was equal to or greater than 3.0, which 
corresponds to 1000:1 odds in favour of linkage. A LOD score of -2 or less indicates 
evidence of exclusion of linkage. More recently. Lander & Kruglyak (1995) have proposed 
stringent LOD thresholds {Table 1.5) to distinguish between suggestive linkage (statistical 
evidence that would be expected to occur one time at random in a genome scan) and 
significant linkage (statistical evidence that would be expected to occur 0.05 times at 
random in a genome scan). Whilst suggestive linkage results may be incorrect, they are 
worth reporting if accompanied by the appropriate label of significance. It also follows that 
as a LOD score of 3.0 may occur by chance 5% of the time, the greater the LOD value the 
greater the confidence in the linkage result.
The multipoint maximum likelihood linkage approach was first used for mapping QTLs 
controlling fruit characteristics in tomato plants (Paterson et al, 1988) and has since been 
successfully applied in mammals (Rise, 1991; Hilbert et al, 1991; Jacob et al, 1991). Its 
success depends on many factors, among them the genetic make-up of the cross. In strains 
such as the SHR with few effective genes, each with a relatively large contribution to the 
overall genetic variance of the phenotype, it will be easier to detect QTLs than in strains
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Mapping Method in the Rat Suggestive Linkage Significant Linkage
Backcross (1 d.f.) /? = 3.4 X 10'^ ; LOD =1.9 /? = 3.4x 10'^ LOD = 3.3
Intercross (1 d.f, co-dominant) /? = 3.4 X 10'^ ; LOD = 1.9 /7 = 3.4x 10'^ ; LOD = 3.3
Intercross (1 d.f, recessive) /? = 3.4x 10'^;LOD = 2.0 = 3.4 X lO'"^ ; LOD = 3.4
Intercross (1 d.f, dominant) /? = 3.4x 10'^;LOD = 2.0 /? = 3.4 X lO’'^ ; LOD = 3.4
Intercross (2 d.f.) p  = 3.4x 10 ^ LOD = 2.8 p  = 3.4x l o t  LOD = 4.3
Table 1.5 LOD thresholds for mapping loci underlying complex traits (adapted from 
Lander & Kruglyak, 1995). d.f refers to degrees of freedom.
such as the genetically hypertensive (GH) rat with a larger number of genes each making a 
small contribution (Okamoto & Aoki, 1963; Smith & Hall, 1958). Similarly the inter­
observation variance of phenotype measurements correlates inversely with the likelihood of 
success in a linkage study due to the introduction of excessive noise (Dominiczak & 
Lindpaintner, 1994), necessitating the development of high fidelity phenotyping. Obviously, 
the quality of genome coverage by the marker panel used, i.e. the even distribution of the 
markers and their spacing, will also critically effect the chances of success in a mapping 
project (Rapp, 1991).
1.4.2 Blood Pressure QTLs
A SHRSPneideibcrg X WKY F2 cross phenotyped for both baseline and salt-loaded systolic 
and diastolic blood pressure by femoral artery cannulation was the first mammalian model to 
undergo genome wide QTL analysis in search of the genetic determinants of high blood 
pressure (Hilbert et al, 1991; Jacob et al, 1991). Screening a panel of 240 mini- and 
micro satellite markers revealed three chromosomal loci which showed LOD scores of over 
3.0. Indeed, both Jacob et al {\99\) and Hilbert et a/ (1991), in utilising the same data from 
the F2 cross, mapped a locus {BPl or BP/SP-1) on rat chromosome 10 which contributed 
significantly to salt-loaded systolic and diastolic blood pressure with LOD scores of over 
4.8 and p-values of less than 0.0001, respectively {Figure 1.5). This locus contains a 
particularly relevant candidate gene coding for the angiotensin converting enzyme (ACE). 
ACE mediates the synthesis of angiotensin II and the degradation of bradykinin, two 
vasoactive peptides involved in the regulation of blood pressure.
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RatMHC6 
RatRHLl 
RatABP6 
RatVAMP13
RatNGFRR
RatGHGP
RatACE
pASC-Hi-8
2cM
20cM
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IcM
8cM
lOK
Chr. 10
a
NaCI
Systolic
NaCI
Diastolic
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Basal
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Figure 1.5 100:1 odds support intervals for the BP-1 locus on rat chromosome 10 
(Hilbert et al, 1991, Jacob et al, 1991). Lines a and b indicate the determined 100:1 odds 
support interval for salt-loaded (NaCI) and baseline blood pressure respectively. RatACE 
represents a marker within the angiotensin converting enzyme gene
Jacob et al (1991) mapped a second locus (BP2) on chromosome 18 which was linked to 
baseline diastolic blood pressure with a LOD score of 3.23 whilst Hilbert et al (1991) 
mapped a X-linked locus contributing to hypertension. Subsequently, additional blood 
pressure QTLs have been identified in the SHRSPizumo (Nara et al, 1993; Nara et al, 1996) 
on chromosomes 1 (basal blood pressure only) and 3 ( basal and salt-loaded). As Table 1.6 
shows, many other groups have identified these same loci in other experimental crosses 
indicating that they are of general relevance in rats. Indeed many additional blood pressure 
QTLs have been located. As a QTL allele may have differing effects when bred onto a 
different genetic background (Rapp & Deng, 1995), these genetic mapping results need not 
be consistent among different crosses and thus clearly demonstrate that hypertension is a 
truly polygenic disease.
Having confirmed the polygenic nature of hypertension, several groups have gone on to 
investigate its complex pathophysiological heterogeneity with the identification of loci that 
may specifically influence the blood pressure response to salt (Hilbert et al, 1991, Jacob et 
al, 1991, Cm et al, 1996), the temporal change in blood pressure (Samani et al, 1996), and 
individual haemodynamic components of blood pressure (Dubay et al, 1993). However, few 
of these have proved wholly comprehensive due to several limitations in experimental 
design. For example all have concentrated on males only whilst it is likely that autosomal 
sex-specific QTLs exist (Ely & Turner, 1990). Secondly, the majority rely on artefact ridden 
methods of blood pressure measurement which may either mask true genetic determinants, 
or mis-report false ones, all of which results in making a complex task doubly so.
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Chr Rat Strains Central Gene/Markers Lod
score
Reference
1 W K Y xS H R S P d zm ) Lsn, Myl2 4.5 Narae^a/, 1993
Lewis X Dahl SS DlMcol, Cytp450 3.4 Gu et al^  1996
Lewis X Dahl SS Sa 2.5 Gu et al, 1996
ACIxFHH Mtlpa 4.2 Browne/a/, 1996
Sabra HR x Sabra HP D1MU2, Sa 4.9 Yagile/ûr/, 1998
Sabra HR x Sabra HP DlM itl, Cytp450 4.7 Yagil e/a/, 1998
Donryu x SHR DlmitS 4.3 Innese/ûf/, 1998
2 Lyon N x Lyon H Cph 7.0 Dubaye/a/, 1993
WKYxDahlSS Nakal 3.4 Deng e/a/, 1994
MNSxDahlSS Camk 2.6 Denge/ûf/, 1994
RI(BNxSHR) D2N35 n/a Pravenec e/a/, 1995
BN X SHR MtJpb 3.0 Schorke/a/, 1995
BN X SHR Gca 6.3 Schorke/a/, 1995
BN X SHR R598 3.0 Schorke/ût/, 1995
BNxGH Gca n/a Harris e/a/, 1995
W K Y xSH R SP (G ia) D2MU6 3.4 Clark e/û[/, 1996
W K Y  X SHRSP(Gia) D2MH14 3.1 Clarke/a/, 1996
WKYxSHR D2Wox7 5.6 Samanie/a/, 1996
Lewis X Dahl SS D2Mcol9 2.9 Garrett e/a/, 1998
3 WKY X SHRSP(km) D3Mghl6 n/a Matsumoto e/aZ, 1995
W K Y  X SHRSP(Gia) D3Mghl6 5.6 Clark e/ûfZ, 1996
WKY X SHRSPdzm) D3Mghl2 6.2 Narae/ûfZ, 1996
Lewis X Dahl SS D3Mgh6 3.0 Garrett e /a/, 1998
4 RI(BNxSHR) 11-6 n/a Pravenec et al, 1995
BN X SHR Npy2 4.6 Schorke/ûfZ, 1995
5 WKYxSHR Mitrl678, Anp, Bnp 4.2 Zhang e /a/, 1996
Lewis X Dahl SS Edn2 4.5 Garrett e/ aZ, 1998
8 BN X SHR R850 5.1 Schorke/ûrZ, 1995
10 WKY X SHRSP(Hd) Ace n/a Hilbert e/aZ, 1991
WKY X SHRSP(Hd) Ace 5.1 Jacob et al, 1991
WKY X Dahl SS Nos2 2.3 Denge/aZ, 1995
MNS X Dahl SS Nos2 6.3 Denge/aZ, 1995
MNS X Dahl SS Ace 4.8 Denge/ûfZ, 1995
BNxGH Ace n/a Harris e/aZ, 1995
Lewis X Dahl SS DlOWoxô 5.5 Garrett e/aZ, 1998
13 Lyon N x Lyon H Renin 5.6 Dubaye/aZ, 1993
WKYxSHR D13MU2 5.7 Samanie/aZ, 1996
16 BN X SHR R220 4.3 Schorke/aZ, 1995
17 Sabra HR x Sabra HP D17Mgh5 3.4 Yagil e/ aZ, 1998
18 WKY X SHRSP(Hd) Rrl094 3.2 Jacob et al, 1991
19 RI(BNxSHR) D19MU7 n/a Pravenec e/ aZ, 1995
X WKYxSHRSP(Hd) Per-Ha-2/Per-Ha- 7 n/a Hilbert e/aZ, 1991
Table 1.6 QTLs for blood pressure. Normotensive strain cited first on all occasions.
1.4.3 Non Blood Pressure Dependent OTLs
Whilst the identification of QTLs influencing left ventricular hypertrophy and stroke does 
not currently match the number located for blood pressure, it has proven a worthwhile 
exercise with the isolation of a several putative susceptibility and/or severity loci confirming 
a role for genetics in both these phenomena. For example, three blood pressure independent 
QTLs for susceptibility to spontaneous stroke have been mapped to chromosome 1 {STR- 
7), 4 (STR-3) and 5 (STR-2) in a SHR x SHRSPHeideiberg cross by Rubattu et al (1996) which 
account in total for 28% of the overall phenotypic variance. Interestingly, both STR-2 and 
STR-3 appear to protect from stroke in the SHRSP as the SP/SP homozygotes had 
significantly greater latency to spontaneous stroke on a Japanese diet (high salt, low 
potassium and low protein) as compared to the SH/SH homozygotes. STR-2 localised in 
close proximity to the genes encoding atrial {Anp) and brain {Bnp) natriuretic peptides, both 
possessing important vasoactive properties.
Genome wide scans in two different crosses have revealed two different QTLs responsible 
for a proportion of left ventricular (LV) mass which are blood pressure independent. 
Pravenec et al (1995) studying recombinant inbred strains derived from the SHR and the 
normotensive Brown-Norway (BN) found a QTL around Drdla, a microsatellite marker 
within the dopamine la receptor gene on rat chromosome 17, to be linked to LV weight. 
The animals homozygous for the SHR allele at this locus had the lowest LV weight to body 
weight ratios whereas those homozygous for the BN allele had the highest LV weight. This 
suggests that the identified QTL plays an inhibitory or protective role during the 
development of LV hypertrophy in the SHR. By contrast, Innes et al (1998) identified a
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locus on rat chromosome 2 linked to relative LV mass with a LOD score of 4.3 in a cross of 
SHR and normotensive Donryu rats which accounted for 29.5% of the genetic variance. 
The average value for relative LV mass for rats homozygous for the SHR alleles at the 
central D2Mghl5 marker was approximately 7% greater than rats homozygous for the 
Donryu alleles. A QTL for left ventricular hypertrophy has not previously been searched for 
in the SHRSP.
1.4.4 Fine Genetic Mapping
It is recognised that the identification of large QTLs (20-3OcM) is only the first step 
towards understanding the fine genetic control of a trait. It is subsequently necessary to 
identify whether a QTL actually comprises a single genetic locus, and then locate the actual 
gene(s) involved. Darvasi et al (1993) have shown that confidence intervals for QTL 
mapping are approximately lOcM. Isolation of the DNA structure of an unknown disease- 
causing locus by positional cloning, however, requires the locus to be localised to within a 
1- to 2-cM region. It follows that the practise of first distinctly establishing the chromosome 
regions containing the QTL by using congenic strains, and then narrowing down these 
regions to 1-2 cM in size using congenic substrains containing progressively smaller 
chromosomal regions, has evolved to enable the final task of gene identification (Rapp & 
Deng, 1995).
A congenic strain is a strain in which a small portion of a chromosome from one strain has 
been selectively replaced by the homologous portion of the same chromosome of another 
strain. A classic genetic procedure, the use of congenic strains was originally pioneered by
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George Snell as a component of his Nobel Prize-winning strategy for the dissection of 
mouse histocompatibility and tumour resistance (Snell, 1948), and has been widely used in 
the study of genetic problems. Congenic strains are traditionally developed by repeatedly 
backcrossing a donor strain that harbours a QTL of interest with a recipient inbred strain 
{Figure 1.6). According to Mendel’s laws it is expected that, on average, half of the 
unrelated genomic material will be transmitted to a subsequent backcross generation. Ten 
generations of backcross matings results in animals heterozygous for the loci of interest that 
are approximately 99.90% recipient genome and carry an introgressed region. The 
introgressed region is then made homozygous by brother-sister mating, resulting in the 
congenic strain (Rapp & Deng, 1995). Congenic strains can be constructed in two 
directions {Figure 1.6)\ that is a plus allele which increases the phenotype can be transferred 
from a hypertensive to a normotensive strain, or a minus allele which decreases the 
phenotype can be transferred from a normotensive to a hypertensive strain. Whichever, the 
successful production of a congenic strain allows precise and unequivocal localisation of 
genes contributing to complex traits and removes the inherent ambiguity involving the 
statistical nature of QTL localisation.
The utility of congenic strains can be clearly seen in Table 1.7. Whilst no further dissection 
of the QTLs for left ventricular hypertrophy or spontaneous stroke has yet been achieved, 
several congenic lines have been successfully produced, all more precisely localising regions 
of linkage to blood pressure. For example, new data on the SHRSPneideiberg x WKY cross 
was generated via congenic strains which revealed that the BP/SP-1 locus on chromosome 
10 could be dissected into two loci, BP/SP-1 a linked to baseline blood pressure and BP/SP- 
Ib which cosegregated with blood pressure after salt-loading (Kreutz et al, 1995). These
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SHRS» X WKY
Qirl QiiiZ Qir 3 Q irlQ ir2Q ir3
Repeated
Backerosses
X X
FI Generation
II yy
Goi^enic Lines
Figure 1.6 Congenic breeding theory. Each congenic line represents a new strain which, 
through a series of repeated backcrosses, has replaced a small portion of a chromosome 
(here chromosome 2) from the recipient strain with the homologous portion of the same 
chromosome of the donor strain. The donor and recipient strains are interchangable, that 
is the chromosomal region of interest may be transferred from the WKY to the SHRSP
or vice versa.
Chr Congenic Strain Chromosomal
Region
Transferred
(cM)
BP
Change
(mmHg)
Reference
1 SHR.BN 22 -10 St. Lezin et at, 1997
Dahl SS.LEW 75 -26 Garrett et al, 1998
2 Dahl SS.WKY 41 -44 Denge/ûf/, 1997
Dahl SS.MNS 76 -29 Deng g/ a/, 1997
5 Dahl SS.LEW 70 -15 Garrett e/ûr/, 1998
7 Dahl SS.Dahl RR 16 -40 Cicila g/ aZ, 1997
8 SHR.BN {Lx) 31 -20 KreneZûfZ, 1997
9 Dahl SS.Dahl RR 21 -19 Rapp et al, 1998a
10 WKY.SHRSPHd 6 +5 Kreutz e/ aZ, 1995
Dahl SS.MNS (10a) 31 -42 Dukhanina eZ ûtZ, 1997
Dahl SS.LEW 60 -42 Garrett e/ûfZ, 1998
13 DahlRR. DahlS Sremw 19 -8 St. Lezin et al, 1996
Dahl S S. DahlRRremn 6 +27 Jiang g/ aZ, 1997
DahlS S .DahlRRre«j>7 24 -35 Zhange/ûrZ, 1997
Y SHR. WKY Whole -15 Turner eZ aZ, 1991
WKY. SHR Whole +35 Turner eZ aZ, 1991
Table 1.7 Congenic strains for blood pressure QTLs. Recipient strain cited first on all 
occasions, donor strain second.
loci map closely onto potentially relevant candidate genes, the inducible nitric oxide 
synthase (Nos2) gene (BP/SP-1 a) and the angiotensin I converting enzyme (Ace) gene 
(BP/SP-1 b). Subsequent studies by Dukhanina et al (1997) described four congenic strains 
constructed by introgressing various segments of chromosome 10 from the Milan 
normotensive strains (MNS) onto the background of the Dahl salt sensitive (SS) strain. The 
results not only confirmed the existence of a blood pressure QTL with a strong effect (35- 
42mmHg) on rat chromosome 10 but the overlapping congenic strains developed in this 
experiment allowed the authors to exclude the locus for Nos2 as a candidate.
All the congenic studies published so far have used the traditional breeding strategy which 
requires at least 8-10 backcrosses to obtain a 99% homogenous genetic background. 
However, theoretical calculations by Lander & Schork (1994) suggest that the production 
of a congenic strain can be expedited by repeated screening of microsatellite markers at 
multiple loci scattered throughout the recipient genome to ensure the choice of the breeder 
with the least donor alleles in the genetic background, concomitant with selection of the 
donor allele at the locus of interest. This novel “speed” congenic approach has recently 
proved feasible in mice (Markel et al, 1997), congenic strains having been constructed in 
only three or four generations. It has yet to be tested experimentally in the rat.
However a congenic strain is produced, the next stage in the refining and narrowing down 
of the QTL incorporates the concept of fine genetic substitution mapping (Figure 1.7) 
which has been used extensively in agricultural research (Paterson et al, 1990). The size of 
the new narrowed down QTL will depend on the density of microsatellite markers in the 
chromosomal region of interest (Dukhanina et al, 1997). It follows that an essential
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requirement of fine mapping is a very dense and detailed map of the rat genome otherwise 
there will be no way of scoring for chromosomal crossovers within the particular region of 
interest and the size of the refined QTL will be limited. With the steady progress of the Rat 
Genome Project and international collaboration on new marker development, the coverage 
of all chromosomal regions has been vastly improved. Several rat genomic database 
resources are available on the Internet and are beginning to yield very dense linkage maps. 
For example, whilst the first rat linkage map based on microsatellite markers reported by 
Serikawa et al (1992) contained just 125 microsatellites, an integrated genetic linkage map 
of the laboratory rat recently released by Brown et al (1998) contains 1164 markers. 
Despite this, the smallest blood pressure QTL reported in a rat so far is 6cM in size (Kreutz 
et al, 1995; Jiang et al, 1997) and hence the final task of positional cloning of the genes 
responsible remains elusive at this time.
When eventually QTLs of interest have been saturated with new markers and narrowed 
down to the order of IcM or less (approximately 1Mb of DNA), positional cloning of the 
causal gene(s) will be possible using yeast artificial chromosomes (YACs), bacterial artificial 
chromosomes (BACs), phage PI clones (PACs), cosmids, and bacteriophage clones to 
create a physical map of the relevant region. These tools are becoming increasingly available 
for the rat (Cai et al, 1997; Woon et al, 1998) and can be used in parallel to generate 
contigs (clusters of overlapping clones representing the contiguous DNA from a genomic 
region), initially by screening for clones containing the closest flanking genetic markers. The 
limit of this approach is the distance between the two closest recombination events in the 
congenic substrain. Once this limit is reached, an exhaustive search of the entire region is 
required to find coding sequences that are transcribed to produce mRNAs. One can expect
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that a region of 1 to 2cM will yield roughly 50 mRNAs. Finding these expressed sequences 
and assessing them as candidates for the phenotype under investigation will be a challenge 
and a combination of methods are currently thought possible, including exon trapping, 
cDNA selection, zoo blot analysis and direct sequencing (Collins, 1992). However 
identified, candidate genes will then have to be analysed both in vitro and in vivo to 
determine the presence of functional mutations which may be responsible for the phenotypes 
under study.
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1.5 Aims
The principal aim of this study is to use a genome wide scanning strategy combined with 
high fidelity phenotyping to identify QTLs containing genetic determinants of hypertensive 
cardiovascular and cerebrovascular disease in the Glasgow colony of SHRSP, followed by 
the development of appropriate congenic strains vrith which to narrow them down. It is 
hoped that this will subsequently lead to the positional cloning of the genes. The steps to be 
taken in order to achieve this aim include;
1. The completion of a total genome scan in a F2 SHRSP x WKY cross with multiple 
phenotypes including systolic, diastolic and mean arterial blood pressure at baseline and 
after salt-loading as measured continuously by radio-telemetry, as well as left ventricular 
hypertrophy. This will be the first genome scan to consider autosomal male and female 
responses to blood pressure, to use a radio-telemetry system in an entire F2 cross, and to 
consider the genetic aspects of left ventricular hypertrophy in SHRSP.
2. The completion of a second total genome scan in SHRSP x WKY F2 hybrids 
characterised by the volume of cerebral ischaemia following acute middle cerebral artery 
occlusion. This will be the first genome scan to search for the QTL(s) responsible for large 
infarcts in both male and female SHRSP, as well as testing the contribution of hypertension 
to the trait.
3. The beginning of fine genetic mapping of any QTLs identified by constructing “speed” 
congenic strains in both directions, i.e., by (A) transferring a plus allele which increases
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blood pressure, left ventricular mass or cerebral ischaemia from the SHRSP to the WKY 
genetic background and looking for an increment in phenotype and by (B) transferring a 
minus allele from the WKY to the SHRSP and looking for a decrement. This will be the first 
study to experimentally test the applicability of the speed congenic strategy in the rat by 
making full use of the increasingly detailed maps of the rat genome.
4. Direct sequencing of any strong candidate genes brought to attention by either genome 
scan in order to detect any functional mutations which may be related to phenotype. This 
will only be justified by highly significant linkage to a QTL and will also be used to 
supplement the fine genetic mapping.
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2. METHODS
2.1 General Laboratory Practice
All reagents and apparatus were of the highest quality commercially available. Appendix I 
provides a full list of solutions prepared, reagents used, and the sources of each. Laboratory 
coats and gloves (Healthline Products Ltd.) were worn and changed frequently throughout 
all experimental procedures. When deemed necessary by the hazard labelling of reagents 
laboratory spectacles, face masks and a fume cupboard/hood (Holliday, Fielding & 
Hocking, Ltd.) were utilised to fulfil the necessary safety requirements.
Weighing of reagents was performed on a Mettler AT250 (European Instruments Sales) 
balance up to five decimal places or a Mettler P2000 balance (European Instruments Sales) 
to three decimal places. Aqueous solutions were prepared in autoclaved glass-distilled water 
and mixed on a HB502 stirrer/hotplate (Bibby Sterilin Ltd.). Measurements of pH were 
performed using a C0720 digital pH meter (W.P.A., Cambridge) regularly calibrated with a 
solution of pH 7.0 prepared from buffer tablets. Volumes in the range of l-SOOOpl were 
transferred accurately using the appropriate Gilson pipettes (Gilson Medical Electronics) 
and sterile tips (Alpha Laboratories Ltd.). Centrifugation of up to 14000rpm was obtained 
using either a Centrifuge 5402 (Eppendorf) for small samples (~1500|il) or an lEC Centra- 
7R Reffidgerated Centrifuge (Life Sciences International (UK) Ltd.) for larger samples. All 
items of glassware were washed in solutions of the detergent Decon 75, rinsed with distilled 
water and dried in an oven at 37°C.
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2.2 Rat Strains and Cross Designations
All rats were housed under controlled conditions of temperature (21°C) and light (12-hour 
light/dark cycle; 7 AM to 7 PM) and maintained on normal rat chow (rat and mouse No. 1 
maintenance diet, Special Diet Services) and water ad libitum. Litters were weaned, sexed 
and ear-tagged (National Band and Tag Co.) for identification at 3 weeks of age and housed 
according to sibling group and sex thereafter.
2.2.1 Rat Strains
Inbred colonies of SHRSP and WKY rats have been established at the University of 
Glasgow since December 1991. These result from the strain-specific brother-sister mating 
of thirteen SHRSP and thirteen WKY (6 males and 7 females of each) which were a gift 
made by Dr. D.F. Bohr in the Department of Anatomy and Cell Biology at the University of 
Michigan, USA, where they have been maintained as inbred colonies for more than 15 
years. Their breeding stocks were originally obtained from the National Institutes of Health, 
Bethseda, U.S.A. Only SHRSP with adult blood pressures meeting 200-23OmmHg for 
males and 170-190mmHg for females, and WKY of 130-150mmHg (males) and 100- 
13 OmmHg (females), are selected as breeders in order to maintain the genetic integrity of 
the colony and its distinct hypertensive versus normotensive characteristics. As described 
later, regular microsatellite screens are also performed on the colony to confirm 
homozygosity at all loci and thus the purity of the inbred strains.
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2.2.2 FI and F2 Generations
To yield the FI and F2 rats utilised in both genome scans two large reciprocal genetic 
crosses were performed following the breeding protocol detailed in Figure 2.1. One male 
SHRSP was mated with 2 WKY females (cross 1) and 1 male WKY with 2 SHRSP females 
(cross 2) to produce the first filial (FI) generation. From the FI rats of each cross, 3 males 
and 6 females were brother sister mated to generate the second filial (F2) generation. 
Reciprocal crosses ensure that a Y chromosome of both hypertensive and normotensive 
origin is represented in any genetic analysis of the F2 generation.
2.2.3 Congenic Crosses
As discussed in Chapter 1.4.4 the traditional development of a congenic strain is a time 
consuming endeavour, requiring 8-10 generations of backcrosses. Following stages A to E 
outlined in Figure 2.2 a “speed” congenic breeding procedure previously untested in the rat 
was utilised in this study to enable the transfer of loci of interest as indicated by the genome 
scans from the donor SHRSP (black shading) to the genetic background of the recipient 
WKY (white shading) and vice versa over only 4 or 5 generations of backcrosses.
Stage A (Figure 2.2) involved the production of two reciprocal FI generations by mating 1 
male SHRSP with 2 WKY females (cross 1) and 1 male WKY with 2 SHRSP females 
(cross 2). Two reciprocal crosses were necessary to allow the bi-directional congenic strains 
to not only possess each recipient strain’s autosomal genetic background, but also the 
appropriate origin of sex chromosomes.
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Figure 2.1 F2 reciprocal crosses. Diagram shows cross 1 and cross 2 with the origin of 
each sex chromosome in a subscript; X, denotes X chromosome originating from the 
SHRSP, Yg denotes Y chromosome originating from the SHRSP, Xw denotes X 
chromosome originating from the WKY, Yw denotes Y chromosome originating from the 
WKY.
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Figure 2.2 Schematic representation of the bi-directional speed congenic strategy. Dark 
shading = SHRSP alleles; white shading WKY. Large rectangle is the chromosome 
containing the QTL of interest, the smaller two representative of the genetic background. 
Stages A-E described in text.
Having produced a FI generation, stage B {Figure 2.2) involved male FI hybrids from 
cross 1 being mated with the recipient SHRSP strain (one male to two females) and male FI 
hybrids from cross 2 mated to the recipient WKY strain (one male to two females). 
Microsatellite markers throughout the desired QTL, and an additional 53 broadly spanning 
the remaining genome, were genotyped in the resulting offspring. Those individuals 
identified as heterozygous (ws) for the marker alleles within the QTL, but mostly 
homozygous (ss or ww) for the recipient alleles (SHRSP and WKY respectively) 
everywhere else were selected as the “best” males for breeding and thus backcrossed again 
to the respective recipient strain to produce a second backcross (BC2 - stage C Figure 2.2). 
This procedure was repeated in all offspring after every backcross and thus allowed the 
number of generations necessary to eradicate the donor’s genetic background to be reduced 
to between BC4-BC5 whilst maintaining heterozygosity in the region of interest.
Having removed the donor’s background. Stage D {Figure 2.2) involved the intercrossing 
of two individuals heterozygous sw in the area of interest. As the offspring segregate 
lss:2sw;lww following Mendel’s laws, only individuals homozygous for the donor strains’ 
alleles were selected and bred together to fix the donor allele in the homozygous state on 
the recipient background, thereby finally producing the congenic strain (stage E Figure 2.2). 
The number of animals required to achieve this varied greatly depending on litter size and 
the size of the region (and thus number of microsatellite markers) being transferred.
A possible criticism of this “speed” approach is that no matter how complete the coverage 
of the genetic background achieved by microsatellite markers, it is still possible that a region 
of heterozygosity in the background will be missed and thus fixed along with the QTL in the
53
final production of the congenic strain. It follows that any phenotypic change observed may 
not be due to the QTL, but these hidden “stowaway” loci containing residual genetic 
material from the donor strain. In order to control for this, those animals which were found 
to be homozygous at stage D {Figure 2.2) for the recipients’ alleles in the QTL rather than 
for the donors’ alleles were also intercrossed to provide a “congenic control”. These 
individual’s have been through the same selection processes as the true congenics and whilst 
not containing the donor QTL they will contain in their genetic background the same, if any, 
residual heterozygosity. Whether or not these animals go on to display a change in 
phenotype similar to that observed in the true congenics will not only determine the validity 
of the QTL, but also the use of a speed congenic strategy in rats.
2.3 Phenotypic Analysis
All experiments were approved by the Home Office according to regulations regarding 
experiments in animals in the United Kingdom.
2.3.1 Tail-CufT Plethysmography
When the need for severe surgical procedures, such as the experimental occlusion of the 
middle cerebral artery (MCA), excluded the use of radio-telemetry to measure blood 
pressure, systolic blood pressure was measured both by the direct cannulation of the 
femoral artery during MCA occlusion {Chapter 2.3.6) and indirectly in conscious rats by tail 
plethysmography following the protocol of Evans et al (1994) overleaf.
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Immediately prior to measurement rats were held within well-aerated polystyrene boxes 
containing familiar bedding and pre-warmed to 36°C under a low blue light intensity for 30 
minutes in order to allow the vessels of the tail to become frilly dilated. The rat was then 
wrapped in a cloth and an inflation cuff, controlled using a current/pressure transducer 
(Hartmann & Braun type 2), placed around the tail along with a piezoceramic transducer for 
pulse detection. The cuff pressure could be controlled in ImmHg steps over a range of 0- 
300mmHg and the resulting pulsation signals detected by the piezoceramic transducer were 
amplified, filtered and then displayed on computer with the aid of IBM compatible software. 
The pulsation signal was visualised as a function of pressure and an estimate of the systolic 
pressure marked. An average of 12 readings were taken for each rat at each sitting and an 
average value calculated around a standard deviation of approximately 1 OmmHg. Visually 
confirmed artefactual data was removed. Special care was taken to perform measurements 
in both the morning and afternoon in each rat at a given age. At least three sittings were 
taken, and the average of all three sittings taken as the value for that age.
2.3.2 Radio-Telemetry
The Dataquest IV telemetry system (Data Sciences International) was used for the direct 
measurement of systolic pressure, diastolic pressure, mean arterial pressure, heart rate, and 
motor activity. The monitoring system consists of an implantable transmitter (radio 
frequency transducer model TAl IP A) which senses, processes, and transmits information 
digitally via telemetry from within the rat; a receiver panel which converts data to a form 
readily accessible by the Dataquest System; and a personal computer with accompanying 
software for collection and observation of data. Each implant was obtained in a sterile
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condition and used a maximum of 3 or 4 times following re-sterilisation in Cidex (activated 
glutaraldehyde solution) and 0.9% saline and re-verification that the calibrations provided 
by Data Sciences remained accurate to within 3mmHg.
Surgical implantation of each blood pressure transmitter within the peritoneal cavity of a rat 
took place under standard sterile conditions {Figure 2.3). Rats were anaesthetised with 
fluothane, and the abdominal cavity exposed by the temporary externalisation of the 
intestines. Sloops were placed round the aorta just below the renal arteries, and around the 
left and right iliac artery. On tightening of these sloops to reduce blood flow, a small hole 
(1mm diameter) was quickly made with a needle tip in the abdominal aorta just above the 
point at which it begins to branch into the iliac arteries. The flexible catheter of the 
transmitter was then inserted pointing upstream against the flow of blood. The catheter was 
surgically secured with the addition of a sterilised cellulose patch and VetBond and the 
sloops removed from around the arteries. The intestines were returned to the body cavity 
and the transmitter sutured to the abdominal wall.
On removal of the anaesthetic, rats were housed in individual cages and provided with 
antibiotics to prevent infection. Each cage was placed over a receiver panel connected to 
the personal computer for data acquisition. The rats were unrestrained and free to move 
within their cages. Haemodynamic data were sampled every 5 minutes for 10 seconds. 
Preliminary experiments showed that blood pressure and heart rate took up to 12 days to 
stabilise post-operatively. Experimental observations were therefore collected from day 12 
after surgery as “baseline haemodynamic measurements”.
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Figure 2.3 The Dataquest IV telemetry system. The radio-transmitter is implanted within 
the peritoneal cavity of the rat with the sensing catheter inserted into the abdominal aorta, 
(adapted from DataSciences International Brochure #SMD30000 REL02 1195).
2.3.3 Salt-Loading
Following baseline recording, rats on telemetry received 1% sodium chloride (NaCl) in their 
drinking water, and this was continued until they were euthanased. Measurements collected 
during this period were considered “salt-loaded haemodynamic measurements”.
2.3.4 Body Weight
The body weight of each rat was obtained to within two decimal places using a CT200V 
portable top pan balance (Ohaus Co-operation). Where necessary, a deduction of 9g was 
made to take account of the telemetry probe.
2.3.5 Heart Weight and Left Ventricular Weight
Immediately after euthanasia the thorax was opened and the heart removed, blotted with 
tissue paper, and weighed using a Mettler AT250 balance to within three decimal places. 
Both atria and the right ventricle were then removed, and the left ventricle and septum 
weighed. The ratios of heart weight to body weight and left ventricle plus septum weight to 
body weight were then determined in order to correct for differences in body size.
2.3.6 Occlusion of the Middle Cerebral Artery
All surgical procedures involving the occlusion of the middle cerebral artery were kindly 
performed by Drs. Gratton and Carswell at the Wellcome Surgical Institute, Glasgow.
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Anaesthesia was induced (5%) and maintained (1%) with fluothane in oxygen-nitrous oxide 
(30:70). Rats were intubated and mechanically ventilated via a small animal respirator pump 
and a femoral artery cannulated for chronic blood pressure recording and blood sampling. 
Normoxia (PaOz >100mmHg), normocapnia (PaCOi 34-42mmHg) and body temperature 
(rectal temperature 37°C) were maintained within physiological limits under anaesthesia 
(Blood Gas System; Ciba Diagnostics). Plasma glucose was recorded (Glucose Analyser; 
Beckman Instruments Inc.) and blood pressure monitored continuously under anaesthesia 
and again at 24hrs after ischaemia in conscious animals.
The distal portion of the left middle cerebral artery was surgically exposed via the 
subtemporal approach originally developed in Glasgow, with the zygomatic arch left intact 
(Tamura et al, 1981). Focal ischaemia was induced by microbipolar coagulation and 
division of a 2mm segment of the MCA just distal to the inferior cerebral vein {Figure 2.4). 
The temporalis muscle was then sutured, the wound closed and the anaesthetic withdrawn. 
The animals were maintained at 37°C until fully recovered from the anaesthesia.
Twenty-four hours after ischaemia, physiological variables were measured in the conscious 
animal before anaesthesia, decapitation and processing of tissue. Brains were frozen in 
isopentane (-42°C). Coronal sections (20pm) were cut semi-serially throughout the MCA 
territory on a cryostat (Bright Instrumentation Company Ltd.) and then stained with 
haematoxylin and eosin for histological verification of infarct volume. Areas of ischaemic 
damage and brain swelling were assessed, blind to rat strain or genotype, at eight pre­
selected coronal levels from 10.5mm to 1.0mm to the inter-aural line (Konig & Klippel, 
1963) with an MCfD computer assisted image analyser (Imaging Research, Ontario,
58
2mm occlusion
Inferior cerebral vein
Middle Cerebral Artery
Olfactory tract
Rhinal branch
Lenticulostriate branch
Figure 2.4 Schematic representation of the experimental occlusion of the middle cerebral 
artery in the rat.
Canada). The volume of infarct for each brain was then derived from integration of the 
areas of damage in the eight planes by use of the known stereotactic co-ordinates with 
endpoints for integration of 12.5mm anterior and 0.5mm posterior to the inter-aural line 
(Konig & Klippel, 1963; Osbourne et al, 1987). Comparison of the volumes of the 
ipsilateral and contralateral hemispheres provided a measure of brain swelling. Infarct 
volumes were expressed as a percentage of the ipsilateral hemisphere to account for brain 
swelling and differences in brain size between sexes and strains.
2.3.7 Tissue Harvest for DNA/RNA
For genotyping of F2 hybrids, livers and spleens were collected immediately after sacrifice 
and stored frozen at -70°C. For genotyping of congenic back-crosses, the animals were 
briefly anaesthetised at 4 weeks of age with fluothane and a 4mm tip from their tail removed 
into a 1.5ml Microfiige tube. The wound was immediately sealed with an electric cautériser 
(Engel-Loter lOOS) and the tails stored at -20°C.
2.4 Genetic Analysis
All experiments were undertaken following the safety guidelines set down by the Radiation 
Protection Service at the University of Glasgow.
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2.4.1 DNA Extraction
Genomic DNA was isolated using a simplified mammalian DNA isolation procedure 
described by Laird et al (\99\) which was modified slightly according to the source tissue 
used. This method yields high molecular weight DNA from large numbers of samples which 
is suitable for both PCR and Southern analysis.
In the case of the rat tail-tips for congenic genotyping, each was removed from the -20°C 
freezer (C & M Refridgeration Ltd.) and allowed to defrost completely in a 1.5ml microfiige 
tube. 700pl working tail solution (50mîvl Tris base pH 8.0; 0.5% SDS; lOOmM EDTA, pH 
8.0) was then added to each tube followed by 35pi of a lOmg/ml solution of proteinase K. 
This mixture was incubated at 55°C overnight in a hybridisation oven (Stuart Scientific) to 
allow gentle mixing until all tissue had dissolved.
Following overnight digestion, 700pl water-saturated phenol was added to each tube and 
the resulting solution vortexed briefly on a Fisons Whirlimixer (Fisons Scientific Equipment) 
followed by centrifugation at MOOOrpm for 3 minutes at 4°C. The top (aqueous) layer was 
recovered to a new microfiige tube taking care not to disturb the interface, and 700pl of an 
equal volume (1:1; v/v) of water saturated phenol and a chloroform isoamylalcohol (24:1; 
v/v) mixture added. The tubes were again vortexed briefly followed by centrifugation at 
MOOOrpm for 3 minutes at 4°C, the aqueous layer again recovered and 700pl of the 
chloroform isoamylalcohol mixture added. Centrifugation and separation of the aqueous 
layer was repeated as before followed by the addition of 70pl 3M sodium acetate (pH 6.0) 
and 700pl 100% ethanol to precipitate out the DNA on gentle shaking over 1 minute. The
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mixture was then centrifuged at MOOOrpm for 10 minutes to pellet the DNA at the bottom 
of each tube thereby allowing aspiration of the remaining supernatant. In order to wash the 
DNA and remove any last traces of SDS or phenol, 1ml 70% ethanol was added to each 
tube, vortexed vigorously and re-centrifuged for 5 minutes at the same conditions to re­
pellet the DNA and aspirate the supernatant. The pellet was allowed to air-dry upside down 
over a tissue for 20 minutes. All samples were resuspended in lOOpl TE solution (lOmM 
Tris, pH 8.0; O.lmM EDTA, pH 8.0) and stored at 4°C prior to further processing.
The extraction of DNA from livers and spleens for genome scan analysis differed from the 
above solely in terms of preparation and scale. The tissue was removed from -70°C to 
defrost fully and a 500mg sample removed. This was transferred to a sterile glass 
homogeniser with the addition of 4ml suspension buffer (lOOmM EDTA, pH 8.0; 50mM 
Tris, pH 8.0) and passed through 3 to 4 times only. The resulting solution was then 
removed to a 50ml Falcon polypropylene tube (Becton Dickinson & Co.) and 224pl 4M 
sodium chloride, 60pl of a 20mg/ml solution of proteinase K, and 1.2ml 10% SDS added, 
followed by gentle mixing and incubation at 37°C overnight. The resulting solution was 
then extracted three times with varying 6ml combinations of water saturated phenol and a 
chloroform isoamylalcohol mixture as described for the rat tails above, centrifuging between 
each stage at 2000rpm for 20 minutes at 4°C. The DNA was precipitated as a clump 
following the final extraction by the addition of 12ml 100% ethanol poured from a 
reasonable height. The DNA could then be hooked out of the polypropylene tube with a 
sterile heat sealed glass Pasteur pipette (Bilbate Ltd.) and transferred to a smaller tube for 
subsequent washing with 5ml 70% ethanol, drying, and resuspension and storage in 1ml TE 
at 4°C as above.
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In order to quantify the concentration of DNA in each sample a 5 pi aliquot of the extracted 
DNA was added to 995pi of sterile water (1 in 200 dilution) in a quartz cuvette. After 
mixing, the optical density of the sample was determined in triplicate at 260nm and 280nm 
in a Ultrospec 2000 UV/Visible spectrophotometer (Pharmaco-Biotech.) against a blank 
and the average values calculated. From the mean absorbance value at 260nm the amount of 
DNA in the sample (pg/pl) was calculated using the equation below:
[DNA]pg/pl= 200 X (OD260X 0.05)
The purity of the sample was established by means of the ratio of the absorbance at 
260:280nm. If this was found to approach 2.0 then UV absorption was due to residual 
traces of phenol. If below 1.0 other absorbing substances such as proteins probably remain. 
Both necessitate the discarding of that particular sample and a re-extraction. An ideal ratio 
to continue with was considered 1.8 and all such samples were adjusted to a working 
concentration of 20ng/pl and stored at -4°C.
2.4.2 Microsatellite Markers
Microsatellite markers are known di, tri, or tetra tandem nucleotide repeat elements {Figure 
2.5) which occur at random throughout the genome and are ubiquitous in eukaryotes. All 
the genetic markers used in this research were microsatellite markers. Selection of these was 
based on the need for a thorough coverage of the entire rat genome and/or supposed 
location around a locus of interest as well as a requisite dimorphism between SHRSPoiasgow 
and WKYoiasgow- Databases used to fulfil this selection included Ratmap: The Rat Genome
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Figure 2.5 Schematic representation of genotyping microsatellite markers in the SHRSP 
X WKY cross by PCR, polyacrylamide gel electrophoresis and autoradiography.
Database, Goteborg University, Sweden at http://ratmap.gen.gu.se/; The Whitehead 
Institute Center for Genome Research Rat Mapping Project, Boston, USA at 
http://www.genome.wi.mit.edu/rat/public/ which contains up-dates of the original genetic 
map of the rat published by Jacob et al (1995); The Wellcome Trust Centre for Human 
Genetics Genetic Linkage Maps of the Rat Genome (1997), Oxford, UK at 
http://www.well.ox.ac.uk/~bihoreau.
2.4.3 Polymerase Chain Reaction
The polymerase chain reaction (PCR) is an in vitro method for the enzymatic synthesis of 
specific DNA sequences using two oligonucleotide primers that hybridise to opposite 
strands and flank the region of interest in the target DNA. Originally described by Saiki et al 
(1985), repetitive series of cycles involving template dénaturation, primer annealing, and the 
elongation of the annealed primers by Taq DNA polymerase result in the exponential 
accumulation of a specific fragment whose termini are defined by the 5^nds of the primers. 
Because the primer extension products synthesised in one cycle can serve as a template in 
the next, the number of target DNA copies approximately doubles at every cycle. Thus 20 
cycles of PCR yields about a million-fold amplification.
Genotyping in both genome scans and congenic strategies was performed by PCR 
amplification of DNA around known dimorphic microsatellite markers from the total 
genomic DNA using the appropriate PCR primer pairs custom made by either Research 
Genetics (Huntsville, AL ), Genosys Biotechnologies (Europe) or obtained from the 
Wellcome Trust Centre for Human Genetics in Oxford (personal communication Drs.
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Marie-Therese Bihoreau and Dominique Gauguier). Owing to the large number of samples 
to be typed PCR was undertaken using 96 well Falcon 3911 Microtest III titer-assay plates 
(Fred Baker Scientific.) in a MJ Research PTC-200 Peltier Thermal Cycler (Genetic 
Research Instrumentation Ltd.).
Each reaction was set up by first aliquoting 5 pi of each DNA sample (20ng/pl) into the 
Falcon 96 well plate with the aid of a multichannel pipette, ensuring no cross contamination 
occurred at anytime. Once all samples had been aliquoted each was covered with a drop of 
mineral oil to prevent their evaporation during the PCR reaction and 5 pi of a previously 
prepared primer solution added (contains l.OpM of each primer and a few particles of 
tartrazine to aid identification). The Falcon 3913 Microtest III flexible lid (Fred Baker 
Scientific.) was placed on the plate, orientation of the samples marked, and loaded into the 
MJ Thermal Cycler to under-go a hot-start. This involved dissociation of the DNA template 
at 94°C for 4 minutes. Once complete, lOpl of PCR master mix (containing 2X Red, 2X 
recommended thermophilic buffer, 3mM magnesium chloride (MgCy, SO.OpM each dATP, 
dCTP, dGTP, and dTTP and 0.8 units of Taq polymerase) was added to each sample so 
that the final reaction volume in each well was 20pl containing lOOng of genomic template 
DNA, 45.0mM Tris, pH 8.8; ll.OmM (NH4)2S0 4 , pH 8.8; 1.5mM MgCl2; 6.7.0mM g- 
mercaptoethanol; 4.5 pM EDTA; 25.0 pM each dATP, dCTP, dGTP, and dTTP, 0.25 pM 
of each primer and 0.4U Taq polymerase. Each microsatellite marker was then amplified 
through 35 cycles of 94°C x 1 minute, 55°C or 60°C (annealing temperature) x 1 minute, 
and 72°C x 30 seconds (elongation temperature) followed by a final extension period of 
72°C for 10 minutes.
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To optimise the specific conditions for each pair of primers as outlined by the available 
databases, annealing temperatures were varied between 50°C and 68°C and concentrations 
of Mg^  ^between 1.0 and 2.0mM. For some primers a modified touchdown protocol was 
used which involved a 0.5°C reduction in annealing temperature during the initial cycles 
(5°C drop). The final annealing temperature was then used for the last 30 cycles.
Following PCR the validity of the products were tested on a 1% agarose gel. Agarose 
(0.5g) was mixed in 50ml 1 X TBE (89mM Tris Borate, pH 8.3; 20mM ETDA, pH 8.0) in 
a conical flask and dissolved for 2 minutes in a microwave with care. Ethidium bromide (Ipl 
of a lOmg/ml solution) was then added and the mixture cooled and poured into a gel tray. 
Once set (after 30 minutes) the gel was placed in a multi-purpose horizontal gel 
electrophoresis unit (Kodak International Biotechnologies, Inc.) and 8pi of several random 
samples from each titer plate mixed with 2 X formamide loading buffer (90% formamide; 
2.5% bromophenol blue/xylene cyanol dye) and ran against an appropriate molecular weight 
marker for 30 minutes at 90 volts with the aid of a programmable electrophoresis power 
supply (Kodak International Biotechnologies, Inc.). If successful, the PCR products could 
be visualised on a Chromato-VUE TM-20 Transilluminator (UVP Inc.) and the actual size 
compared to that expected.
2.4.4 Polyacrylamide Gel Electrophoresis and Autoradiography
If the PCR amplification had been successfiil samples could either be stored at 4°C until 
required or immediately prepared for separation by polyacrylamide gel electrophoresis on 
standard denaturing sequencing gels, blotting to nylon membrane and visualisation of the
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dimorphic differences by autoradiography {Figure 2.5). Preparation involved the transfer of 
5 pi of each sample using a multi-channel pipette (Gilson Medical Electronics) from the PCR 
titer plate to a Costar Thermowell thin-walled polycarbonate 96 well plate (Coming 
Incorporated) followed by the addition of 5 pi 2X formamide loading buffer to each sample 
using an electronic multi-dispense pipette (Rainin edp2). Due to the large number of 
markers required for a total genome scan, several different PCR products were prepared in 
the same Thermowell plate to allow multi-loading onto the polyacrylamide gel, providing 
they were all of a similar size (in base-pairs).
An initial 8% polyacrylamide gel mix was made with the ready-to-use SequaGel Sequencing 
System (National Diagnostics). To initiate polymerisation 60pl of TEMED and 700pl of 
10% ammonium persulphate (10% APS) were added to the mixture. The gel was 
immediately poured between two large pre-prepared vertical glass plates (Anachem Ltd.) 
with approximately 5 ml Sigmacote wiped over the inside of just one of the plates to ease 
plate separation later. Once set, the gel was loaded into a vertical STS-45 standard 
Thermoplate Sequencer gel electrophoresis unit (Kodak International Biotechnologies, Inc.) 
and both reservoirs filled with 1 X TBE buffer up to the levels of the gel stands to ensure 
completion of the electrical circuit. A 60 well comb (Kodak International Biotechnologies, 
Inc.) was inserted into the gel and the gel pre-run at 2000 volts (40mA, 70W) for 
approximately an hour to heat it up to the optimum temperature for loading of 50-60°C.
Immediately prior to loading the PCR samples were denatured for 4 minutes at 94°C in the 
MJR Thermal Cycler and placed on ice. 7|il of each sample was then loaded with the aid of 
a duck-billed pipette tip (Sorensen Bioscience Inc.) into the gel and the orientation noted to
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enable correct genotyping later. Depending on the size of the base sequence of the specific 
marker and their allelic differences between SHRSP and WKY, the length of time necessary 
to ensure complete separation of the dimorphic alleles was variable. Generally, PCR 
products of approximately 100 base-pairs (bp) in size were run until the slowest component 
of the loading dye had run down the gel 30cm, those ISObp in size 40cm, and those 200bp 
in size 50cm. It follows that by loading a set of markers which are large in size first, and 
then loading smaller markers 8cm after them, it was possible to gain the most utility out of 
one gel.
Once complete, the gel was cooled under running water and the plates split. A 28cm x 
28cm piece of Hybond->T nylon membrane previously soaked in 1 X TBE for 30 minutes 
was carefully placed on the gel, followed by two pieces of card, a glass plate and weights to 
allow blotting overnight. In the morning the membrane was carefully removed and fixed 
with 0.4M sodium hydroxide for 20 minutes without shaking, followed by 2 x 10 minute 
washes in 2 X SSC (300mM sodium chloride; 30mM sodium citrate, pH 7.0) with shaking. 
The membrane could now either be stored in a hybridisation tube (Stuart Scientific) at 4°C 
or immediately hybridised.
The membranes were hybridised with one of the primers radiolabeled with [a-^^P]dCTP by 
TdT (terminal deoxynucleotidyl transferase). Each labelling reaction contained 12.5p.l of 
sterile distilled water, 4pl of terminal transferase buffer, Ipl of usually the forward primer 
(5-lO^iM), l|uil of [a-^^P]dCTP and <0.5p,l TdT and required incubation at 37°C for 35 
minutes followed by 10 minutes dénaturation at 68°C to stop the reaction. The labelled 
probe was added to the pre-prepared 40ml hybridisation solution (24ml sterile water; 12ml
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20 X SSC; 4ml 10% SDS; O.lg powdered milk to prevent non-specific binding) which was 
in turn added to the hybridisation tube containing the appropriate membrane for 
hybridisation over at least 2 hours at either 55°C or 42°C in the hybridisation oven. On 
completion, the membrane was washed for 2 x 10 minutes in post-hybridisation wash 
solution (0.2% SDS; 2 X SSC), dried between two pieces of card, wrapped in Saran wrap 
(Dow Chemical Company) and directly exposed to autoradiography Hyperfilm (Amersham) 
in a Hypercassette (Amersham) for 2-14 hrs at -80 °C Films were subsequently developed 
in a film processor (Kodak International Biotechnologies, Inc.) and autoradiographs 
independently scored by two investigators who were unaware of the rat’s phenotypes. 
Figure 2.6 represents an typical example of such an autoradiograph produced in this study. 
In order to visualise the remaining markers loaded on the same gel, the membrane was 
stripped by 2 x 10 minute washes in boiling 0.4% SDS followed by 2 x 10 minute washes in 
2 X SSC and reprobed as before.
2.4.5 Sequencing
The enzymatic method of DNA sequencing developed by Sanger et al (1977) is based upon 
the use of specific terminators of DNA chain elongation: 2’,3 ’dideoxynucleoside-5 ’- 
triphosphates (ddNTP). These deoxynucleoside triphosphate (dNTP) analogues can be 
incorporated by a DNA polymerase into a growing DNA chain through their 5’- 
triphosphate groups. However, because these analogues lack a hydroxyl group at the 3’- 
position, they cannot form phosphodiester bonds with the next incoming dNTP and the 
chain extension terminates whenever an analogue is incorporated. Thus when a specific 
ddNTP is included along with the four different dNTPs normally required for DNA
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synthesis, the resulting extension products are a series of discrete length DNA chains that 
are specifically terminated at that dideoxy residue. To obtain sequence data, one reaction 
must be run for each of the four ddNTPs and when run together on a polyacrylamide gel the 
data provides complete sequence information.
A modified version of the Sanger method of sequencing in the form of a AmpliCycle™ 
Sequencing Kit (Perkin-Elmer) was used to sequence the coding regions of genes of interest 
in the SHRSP and WKY. This first demanded the high quality amplification by PCR of the 
large coding regions (130-900bp) using UITma DNA polymerase with an inherent 3’ to 5’ 
exonuclease proof-reading activity. The primers necessary for this were designed in-house 
from previously published sequences. PCR products were identified as such on 1.0% 
agarose gels and the bands cut-out with a sharp blade. DNA was extracted from the gel 
using a gel Nebulizer inserted into a Microcon microconcentrator (Amicon) centrifuged at 
MOOOrpm for 20 minutes at 4°C. Once the gel had broken up, the filtrate was washed 
through the Microcon by adding 20pl sterile distilled water followed by centrifugation at 
3000rpm for 24 minutes at 4°C. On inverting the Microcon the DNA could be collected and 
the concentration calculated with the aid of the DynaQuant fluorimeter (Hoefer).
Both forward and reverse sequencing primers were also designed in-house to cover between 
150-200bp of the amplified coding regions. Prior to running the sequencing reaction each 
primer was radio-labelled with [y-^^P]dATP to allow visualisation of the eventual sequence 
by autoradiography. Each labelling reaction contained l.l|il of sterile distilled water, O.ôpl 
of lOX kinase buffer, 0.5|il of the sequencing primer (20|iM), lp.1 of [y-^^P]dATP and 3 .0pl 
T4 polynucleotide kinase and required incubation at 37°C for 2 hours.
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For each sequencing reaction 2|il of each terminating ddNTP (G, C, A, & T) was added to 
separate wells in a titer-plate followed by the addition of 6|o,l of a sequencing master mix 
containing 20pl sterile water; 4.0pl cycling mix containing AmpliThr  ^ DNA polymerase; 
2.0|il PCR template (lOOfM); l.Opl dimethyl sulfoxide (DMSO); and l.Opl of the radio­
labelled primer mix. After the PCR template was dissociated for 4 minutes at 94°C the 
sequencing was completed through 35 cycles of 94°C x 1 minute, the annealing temperature 
of the specific primer (°C) x 1 minute, and 72°C x 1 minute (elongation temperature). Each 
reaction was stopped by the addition of 4 pi stop solution and could then be resolved on a 
standard 8% polyacrylamide gel after approximately 2 hours as described in Chapter 2.4.4. 
As the gel was radioactive it could be dried directly onto 3 mm Whatman filter paper 
(Whatman International Ltd.) using a slab Gel-Vac dryer (Hybaid), put directly down to 
film and the sequence subsequently read by two independent observers.
2.5 Statistical Analysis
Phenotypes which were found clearly not to be normally distributed were logarithmically 
transformed before inclusion in any statistical procedure as dependent variables. Phenotypes 
which were strongly bimodal due to sex differences, but the distribution for each sex 
separately were acceptably normal, were analysed separately by sex. Examination of 
phenotypic differences between groups was accomplished with the use of standard Mests. 
Confirmatory analysis of QTLs was performed by one-way and two-way ANOVAs with a 
conservative significance level of p < 0.01. In addition, a stepwise regression procedure was
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used to assess QTL effects while controlling for possible confounding and covariate effects 
(Schorke/a/, 1995).
2.5.1 Genetic Mapping - MAPMAKER/EXP 3.0
Genetic markers were mapped relative to each other using the MAPMAKER/EXP 3.0 
computer package with an error detection procedure (Lander et al, 1987; Lincoln & 
Lander, 1992). This is specifically designed for the construction of primary genetic linkage 
maps fi*om marker genotype data from F2 intercrosses in experimental populations. 
MAPMAKER/EXP considers all the available raw genotypic data simultaneously in order 
to produce a multitude of possible maps consisting of a specific marker order and map 
distances as calculated from estimates of recombination fractions with the Haldane mapping 
function. For each map suggested by MAPMAKER/EXP the level of probability that the 
map would give rise to the observed data was then computed and this probability called the 
likelihood of the map. The “best” map was then selected as the one with the highest 
likelihood.
2.5.2 Linkage Analysis - MAPMAKER/OTL 1.1
QTLs affecting a given phenotype were mapped relative to the genetic markers by using the 
MAPMAKER/QTL 1.1 computer package obtained fi’om Dr. Eric Lander (Whitehead 
Institute, Cambridge, Massachusetts). This program calculates the likely phenotypic effect 
of having the ss (SHRSP homozygotes) or ww (WKY homozygotes) genotype at a putative 
QTL. The strength of evidence for the existence of a QTL at any location is then provided
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by the maximum logio likelihood (LOD score) of the model at that point, and the proportion 
of the phenotypic variance explained by the model is also calculated (Lander & Botstein, 
1989). To correct for the effects of multiple hypothesis testing stringent thresholds were 
utilised for mapping loci that underlie complex traits, with LOD scores of between 2 and
3.3 required to establish suggestive linkage and greater than 3.3 indicative of significant 
linkage as described in Chapter 1.4.1 (Lander & Schork, 1994; Lander & Kruglyak, 1995).
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3. IDENTIFICATION OF QTLs FOR BLOOD PRESSURE 
AND LEFT VENTRICULAR HYPERTROPHY IN SHRSP
3.1 Introduction
That a substantial fraction of the variation in blood pressure between individuals is 
genetically determined has been well established, with estimates of heritability of 20-40% 
(Annest et al, 1979; Mongeau, 1989). However, as discussed in Chapter 1.2 the two major 
strategies developed for gene identification in human essential hypertension, linkage 
analyses in families segregating for rare Mendelian forms of hypertension and a candidate 
gene approach, both have significant limitations owing to the complex, multifactorial, and 
polygenic nature of the common form of the disease (Brand et al, 1998).
Some of the complexity inherent to the study of human subjects and families can be 
removed by inbred rat models of genetic hypertension. Hundreds of homogeneous progeny 
can be studied under controlled environmental conditions using high fidelity phenotyping. 
The stroke-prone spontaneously hypertensive rat (SHRSP) is one of the best such models as 
it is characterised by a number of vascular complications including left ventricular 
hypertrophy and a salt-sensitivity not dissimilar to the human disease state (Okamoto & 
Aoki, 1963; Yamori, 1982). Indeed it has already been utilised by several studies to confirm 
the polygenic inheritance of high blood pressure (Hilbert et al, 1991; Jacob et al, 1991; 
Nara et al, 1993; Davidson et al, 1995; Nara et al, 1996).
The major strategy used by these studies towards ultimate gene identification in the SHRSP 
has been the elucidation of quantitative trait loci (QTLs) by performing a total genome scan 
in F2 segregating populations obtained by crossing the SHRSP and the normotensive WKY 
rat. A QTL is a broad chromosomal region containing a gene or set of genes influencing a
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quantitative trait, such as blood pressure. Three QTLs were identified in the first 
SHRSPneideiberg X WKY cross: BP/SP-1 (or B p l\  a locus that mapped to chromosome 10; 
Bp2, a locus on chromosome 18; and BP/SP-2, a locus on the X chromosome (Hilbert et al, 
1991; Jacob et al, 1991). Multilocus linkage analysis performed in one of the two studies 
(Hilbert et al, 1991) showed that the rat angiotensin I converting enzyme (Ace) gene fell 
within the 10:1 odds region from BP/SP-1 in the analysis of blood pressure after salt- 
loading (1% NaCl in the rat’s drinking water) and within the 100:1 odds region for baseline 
blood pressure phenotypes. More recent data from SHRSPneideiberg x WKY congenic strains 
revealed that BP/SP-1 can be dissected into two loci: BP/SP-1 a, linked to basal blood 
pressure and containing the inducible nitric oxide synthase (Nos2) gene and BP/SP-lb, 
which co-segregates with blood pressure after salt-loading and maintains linkage with the 
Ace gene (Kreutz et al, 1995). Additional blood pressure QTLs have also been identified in 
the SHRSP(izumo) (Nara et al, 1993; Nara et al, 1996) on chromosome 1 (basal blood 
pressure only) around microsatellite markers within the genes encoding leukosianine (Lsn) 
and the myosin light chain (Myl2) and chromosome 3 (basal and salt-loaded) around the 
anonymous marker DSMghlô.
Whilst these initial studies have confirmed the utility of a genome wide QTL analysis none 
of the above can be considered wholly comprehensive due to severe limitations in 
experimental design. For example they have mostly concentrated on males only, whilst it is 
likely that autosomal sex-specific QTLs exist (Ely & Turner, 1990). They have also all 
failed to fully dissect hypertension into its component factors and sub-phenotypes, including 
left ventricular hypertrophy, which may have different or perhaps overlapping sets of 
genetic components. Tanase et al (1982) identified that heart weight increased in proportion
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to blood pressure only in hypertensive rat strains, with genetic variance accounting for 65- 
75% of the total variability in cardiac mass. Indeed, different hypotensive treatments that 
reduce blood pressure to the same degree have quite different effects on SHRSP heart size 
(Dominiczak et al, 1997) indicative of differing genetic control. This is analogous to the 
observation that the distribution of cardiac mass within human populations of unselected 
normotensive or hypertensive individuals appear to be continuous (Nunez et al, 1996; Weiss 
& Lundgren, 1978; Cutilleta et al, 1977; Cutilleta et al, 1978). Two genome scans in 
different rat crosses have previously revealed two QTLs on chromosomes 17 (Pravenec et 
al, 1995) and 2 (Innes et al, 1998) responsible for a proportion of left ventricular mass 
independently of blood pressure. No QTL for left ventricular hypertrophy has as yet been 
located in the SHRSP.
Similarly, all the genome scans on SHRSP have relied on methods of blood pressure 
measurement which introduce stress-related components into the study and cannot take 
account of diurnal variation which may possess separate genetic determinants. The 
development of an artefact-free direct system for monitoring blood pressure continuously 
over 24 hr periods in the form of radio-telemetry has already shovm benefits in genetic 
studies. Davidson et al (1995) identified that male F2 hybrids with a SHRSP grandfather 
had significantly higher average systolic, diastolic and mean arterial pressures compared 
with male F2 hybrids with a WKY grandfather. This led to the suggestion that the SHRSP 
Y chromosome contains a locus or loci that contributes to hypertension in this strain. Its 
overall advantage in a total genome scan remains to be investigated.
75
Recently published studies have provided a large number of newly developed microsatellite 
markers vastly improving the density of the rat genetic linkage map (Serikawa et al, 1992; 
Jacob et al, 1995; Pravenec et al, 1996; Bihoreau et al, 1997; Brown et al, 1998). These 
markers, together with high fidelity phenotyping should allow a more complete mapping of 
hypertension in the SHRSP. It follows that the current study was designed to perform a 
total genome search in both male and female F2 hybrids resulting from a SHRSP x WKY 
cross with multiple phenotypes, including direct systolic and diastolic blood pressure at 
baseline and after salt-loading, heart rate, and motor activity as measured by radio­
telemetry, as well as left ventricular hypertrophy.
3.2 Methods
Experimental Animals and Genetic Crosses
Inbred colonies of SHRSP and WKY rats have been established at the University of 
Glasgow since 1991. In order to yield two reciprocal crosses (Chapter 2.2.2), 1 male 
SHRSP was mated with 2 WKY females (cross 1) and 1 male WKY was mated with 2 
SHRSP females (cross 2). From the FI rats of each cross, 3 males and 6 females were 
brother-sister mated to generate F2 rats (57 in cross 1 with a male-to-female ratio of 28:29 
and 83 in cross 2 with a male-to-female ratio of 37:46).
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Radio-telemetry Measurements
The DATAquest IV telemetry system (Data Sciences International) was used for 
measurement of systolic and diastolic blood pressure, mean arterial blood pressure, heart 
rate and motor activity at baseline and after salt-loading following the protocol described in 
Figure 3.1. Rats at 16 weeks of age were implanted with radio-transmitters as described in 
Chapter 2.3.2 and housed in individual cages after the operation, each cage being placed 
over a receiver panel connected to the personal computer for data acquisition. The rats 
were unrestrained and free to move within their cages. Previous experiments had shown that 
blood pressure and heart rate took up to 12 days post-operatively to stabilise (Davidson et 
al, 1995). Therefore, experimental observations collected from days 12 to 16 after surgery 
were designated “baseline haemodynamic measurements”. On the evening of day 16 the rats 
received 1% (w/v) NaCl in their drinking water, and this procedure was continued until day 
28 when the rats were euthanased. Measurements collected between days 25 and 28 
constituted “salt-loaded haemodynamic measurements”. Systolic and diastolic blood 
pressure, heart rate and motor activity were calculated by DATAquest software. Mean 
values were calculated for 60-minute intervals and exported from the DATAquest program 
in ASCII format.
Evaluation o f Left Ventricular Hvvertrophv
Immediately after exsanguination the thorax was opened and the heart removed, blotted 
with tissue paper, and weighed to within three decimal places. Both atria and the right 
ventricle were then removed, and the left ventricle and septum weighed. The ratios of heart
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weight to body weight and left ventricle plus septum weight to body weight were 
determined. In addition, livers and spleens were also removed as a source of DNA and 
stored at -70°C until required for genotypic analysis.
Genetic Markers and Genotvvins
Genotyping was performed by PCR amplification of DNA around microsatellites markers as 
described in Chapter 2.4.3. The necessary PCR primers for typing the microsatellite 
markers were obtained from Research Genetics (Huntsville, AL.) and Genosys 
Biotechnologies (Europe), or obtained from The Wellcome Trust Centre for Human 
Genetics in Oxford (35 primer pairs from Dr. Mark Lathrop). PCR products were separated 
by electrophoresis on standard denaturing sequencing gels and transferred to nylon 
membranes as described in Chapter 2.4.4. The resulting membranes were hybridised with 
one of the primers radiolabeled with [a-^^P]dCTP by terminal transferase. After washing, 
the membranes were exposed to autoradiography film (X-OMAT AR, Eastman Kodak) for 
2-14 hrs at -80 °C. Autoradiographs were independently scored by two investigators, who 
were unaware of the rat’s phenotypes.
Genetic Linkage Analysis
As described in Chapter 2.5 genetic markers were mapped relative to each other by using 
the MAPMAKER/EXP 3.0 computer package with an error detection procedure (Lander et 
al, 1987; Lincoln & Lander, 1992). Genetic distances were calculated with the Haldane 
mapping function. QTLs affecting a given phenotype were mapped relative to the genetic
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markers by using the MAPMAKER/QTL 1.1 computer package obtained from Dr. Eric 
Lander (Whitehead Institute, Cambridge, Massachusetts). Compliant with the stringent 
statistical thresholds suggested by Lander & Kruglyak (1995, Chapter 1.4.1) LOD scores 
equal or greater than 3.3 were required to establish significant linkage and between 2 and
3.3 to establish suggestive linkage.
Phenotypic comparisons for different genotypes were performed by using a one-way 
ANOVA with a conservative significance level of p < 0.01. In addition, a stepwise 
regression procedure was used to assess QTL effects while controlling for possible 
confounding and covariate effects (Schork et al, 1995). Some QTLs showed possible sex 
specificity. In these instances a formal test was conducted for the difference in locus effects 
between sexes. This was accomplished by converting the LOD scores for the whole group, 
males, and females to likelihood ratios. The computed likelihood ratio statistic has a 
distribution with one degree of freedom. A value of >3.85 suggests that the sex difference in 
the LOD score is significant at the 0.05 level.
Certain phenotypes were clearly not normally distributed. Values for motor activity were 
positively skewed and so were logarithmically transformed before inclusion as dependent 
variables. The distributions of body, whole heart and left ventricular weights were strongly 
bimodal due to sex differences, but the distribution for each sex separately were acceptably 
normal, so these three phenotypes were analysed separately by sex.
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3.3 Results
All the significant phenotypic and genotypic data utilised in the genetic linkage analysis is 
given in Appendix II, as well as the primer sequences and optimum PCR conditions of each 
microsatellite marker used.
Radio-telemetry blood pressure measurements were obtained for 13 SHRSP (male:female = 
7:6), 12 WKY (male:female = 6:6), 22 FI (male:female = 13:9), and 140 F2 (male:female = 
65:75) rats at baseline and after salt-loading. Unfortunately salt-loaded blood pressure was 
unrecorded in the SHRSP males due to the very high mortality in this group.
The variance in the blood pressure of parental SHRSP, WKY and FI animals is due only to 
environmental factors as they are all genetically uniform. Therefore by subtracting the 
highest recorded blood pressure in either the parental or FI populations from the lowest, a 
measure of the environmental variance is gained. By comparison, genes are segregating in 
the F2 rats and thus the same calculation in this population gives a measure of the total 
(environmental and genetic) variance. It follows that by subtracting the environmental 
variance from the total variance a measure of genetic variance is given. The ratio of genetic- 
to-total variance provides a precise estimate of the degree of genetic determination in a F2 
population and, as such, is given for both baseline blood pressure and salt-loaded blood 
pressure phenotypes in both the male and female F2 cohorts in Table 3.1 where mortality 
rates allow.
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A total of 603 microsatellite markers were screened and of these 181 were found to be 
dimorphic between SHRSPoiasgow and WKYoiasgow, giving a 30% dimorphism rate. Using 
these markers and the MAPMAKER/QTL 1.1 computer package a QTL on rat 
chromosome 2 was identified with a significant LOD score of 3.3 for baseline systolic blood 
pressure and a LOD score of 3.4 for baseline diastolic blood pressure {Figure 3.2A andB). 
These two QTLs accounted for 12.9% and 13.8% of the variance in systolic and diastolic 
blood pressure respectively. The same analysis for salt-loaded blood pressures showed 
“suggestive” QTLs in the same chromosome region, with LOD scores of 2.9 and 2.7 
accounting for 12.3% and 12.0% of the variance respectively. On analysing male F2 hybrids 
only, a QTL in the same region of rat chromosome 2 was again revealed with LOD scores 
of 3.65 and 3.5 for baseline systolic and diastolic blood pressure which accounted for 25% 
and 24% of the respective variance in blood pressure {Figure 3.3A and B). Salt-loaded 
systolic and diastolic blood pressures in male F2 cohorts gave LOD scores of 3.4 and 3.2, 
accounting for 31% and 26% of the respective variance in blood pressure {Figure 3.4A and
B).
As D2MU6 is the closest marker linked to the QTL described above, the influence of this 
marker on a number of phenotypes was examined using a standard one-way ANOVA. 
Table 3.2 shows that the locus characterised by the D2MU6 had a strong effect on baseline 
systolic and diastolic blood pressure and a lesser but still significant effect on salt-loaded 
systolic and diastolic blood pressure in the combined data set (males and females analysed 
together). The same analysis for the male F2 hybrids alone shows a significant effect of the 
locus characterised by the D2MU6 marker on all four sub-phenotypes of blood pressure. 
This marker does not appear to significantly influence any of the other phenotypes {Table
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3.2). The D2MU6 locus affects blood pressure in a recessive manner, since homozygous ww 
and heterozygous ws rats have equivalent blood pressures, whereas homozygous ss rats 
have significantly elevated blood pressures {Table 3.2).
Further analysis of male F2 hybrids revealed a second potential QTL on rat chromosome 2, 
which was localised between markers D2MU14 and D2Mghl2. The LOD scores for this 
QTL were as follows: 2.0, 2.5, 2.3 and 3.1 for baseline systolic, baseline diastolic, salt- 
loaded systolic and salt-loaded diastolic blood pressures respectively {Figures 3.3A and B 
and 3.4A and B). The two dimorphic markers are on the downslope of the LOD plot and 
therefore a one-way ANOVA was deemed inappropriate to verify these results.
Data analysis for male F2 hybrids also revealed a QTL on rat chromosome 3, with 
D3Mghl6 being the closest marker to this QTL. Blood pressure phenotypes that showed 
significant LOD scores in this region {Figure 3.5A and B) were baseline and salt-loaded 
pulse pressures (LOD scores of 4.2 and 5.6 which contributed 32.2% and 39.8% of the 
variance in pulse pressure, respectively) and salt-loaded systolic and diastolic blood 
pressures (LOD scores of 4.4 and 3.3 which contributed 39.6% and 36.7% of the variance 
in blood pressure, respectively). These results were confirmed by one-way ANOVA, with 
baseline pulse pressure being of borderline significance according to the stringent criteria 
adopted {Table 3.3). Similar to D2MU6, the locus close to D3Mghl6 appeared to affect the 
blood pressure phenotypes in a recessive manner.
The two QTLs defined by the markers D2Mghl2 and D3Mghl6 showed possible sex 
specificity by being identified in male only analyses. A formal test for the difference in locus
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effect between the sexes was conducted using a simple likelihood-ratio test {Table 5.^. For 
each QTL localised close to D2Mghl2 and DSMghlô, the likelihood-ratio statistic was 
significant, thus confirming the sex difference in LOD scores.
A QTL on rat chromosome 14 for the ratio of left ventricular weight to body weight was 
also detected {Figure 3.6). This QTL covers a distance of 12.3cM between the markers 
D14MghS and R58. LOD scores for this phenotype were 3.7 for F2 males and 3.1 for F2 
males and females analysed together, which accounted for 32.3% and 12.3% of the variance 
in left ventricular weight to body weight ratio respectively. Similar to the “suggestive” male- 
only QTL on rat chromosome 2, the two dimorphic markers are on the downslope of the 
LOD plot and again a one-way ANOVA was deemed inappropriate to verify these results.
No other QTLs were detected in the genome scan. Specifically no QTLs for heart rate or 
motor activity were detected. A stepwise regression procedure with either baseline systolic 
blood pressure or salt-loaded pulse pressure as the dependent variable was therefore 
performed in order to assess the contribution of the individual QTLs identified in this study 
and the putative Y chromosome locus (Davidson et al, 1995) to the blood pressure 
phenotypes as measured by radio-telemetry {Table 3.5). The SHRSP Y-chromosome effect, 
D2Mit6 recessive effect and left ventricular weight to body weight ratio all markedly, but 
independently influenced baseline systolic blood pressure. Together they accounted for 
34.2% of the variance in total baseline systolic blood pressure. The D3Mghl6 recessive 
effect, the SHRSP Y chromosome effect, and the left ventricular weight to body weight 
ratio also all markedly, but independently influenced salt-loaded pulse pressure. Together 
they accounted for 28.9% of the total variance in salt-loaded pulse pressure.
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3.4 Discussion
The high estimated degree of genetic determination of both baseline and salt-loaded 
systolic, diastolic, and pulse pressure calculated in both the male and female F2 cohort 
suggests the existence of a gene or set of genes each with a relatively large contribution to 
the overall genetic variance of the blood pressure sub-phenotypes. It follows that the 
subsequent application of a genome wide scan approach did indeed identify two distinctly 
different putative blood pressure QTLs on rat chromosome 2. The most statistically 
significant (LOD > 3.3) of these was determined for both baseline and salt-loaded diastolic 
and systolic blood pressure and occurred in both male and female F2 cohorts, whether 
analysed separately or together. It lay ~9.8cM from the carboxypeptidase B gene {Cpb) 
with its peak close to the anonymous microsatellite marker D2mit6.
Other groups have previously suggested the presence of a blood pressure QTL on 
chromosome 2 in this region. Both systolic and pulse pressures recorded in an F2 
population derived from a cross of Lyon-hypertensive and Lyon-normotensive rats were 
significantly correlated with the Cpb gene (Dubay et al, 1993). As Cpb is located very close 
(~0.8cM) to the angiotensin type IB receptor {Atrlb) gene it is likely this QTL also 
corresponds to that previously identified in a Dahl salt sensitive (SS) x Milan normotensive 
(MNS) cross around Atrlb for salt-loaded blood pressure, although the statistical evidence 
for this QTL was merely suggestive at p = 0.014 (Deng et al, 1994). Most recently, Garrett 
et al (1998) identified a similarly suggestive (LOD = 2.9) QTL between and D2Mitl 
in a Dahl SS x Lewis rat cross. No corresponding QTL has ever been identified in a cross
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involving the SHRSP before and neither of these candidate genes (Cpb and Atrlb) have 
been investigated further for a role in hypertension.
The suggestive (LOD <3.3) second QTL identified on rat chromosome 2 by this study was 
localised -73 cM away from D2Mit6 and contributed to salt-loaded blood in the male F2 
cohort only. The QTL is localised chiefly between two anonymous markers, D2Mghl2 and 
D2MU14 with the latter being 13cM from the guanylyl cyclase AJ atrial natriuretic peptide 
receptor {Gca) gene. Jacob et al {\99\) also provided suggestive evidence (LOD 2.47) for 
a baseline systolic pressure QTL around Gca in a SHRSP(Hcideiberg) x WKY cross. However, 
as this study was conducted in males only it was unable to confirm or refute the sex- 
specificity of this suggestive locus identified in the current Glasgow S H R S P  x WKY cross. 
This sex specificity has been replicated, however, by Harris et al (1995) finding Gca to 
cosegregate with increased blood pressure in males, but not females, from reciprocal 
crosses between New Zealand genetically hypertensive and Brown-Norway normotensive 
rats.
Gca has been considered a candidate gene for blood pressure since the finding that young 
Dahl SS rats are hyporesponsive to the natriuretic and diuretic effects of atrial natriuretic 
peptide (ANP) which implies a receptor defect (Snajdor & Rapp, 1985; Hirata et al, 1984). 
However, whilst Gca has been shown to co-segregate with increased blood pressure (Deng 
& Rapp, 1992; Harris et al, 1995), caution has to be exercised while interpreting these 
results, especially as Gca is at the edge of this QTL for blood pressure identified in the 
current study. A positive cosegregation may have arisen solely because Gca is localised in 
close proximity to the real blood pressure gene on the same chromosome. Indeed,
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subsequent crosses involving both Dahl SS and SHR rats have localised this QTL to a 
region between the a l  isoform of the Na^K^ATPase (NaKATPaseal) and calmodulin- 
dependent protein kinase II A (Camk) genes (Deng et al, 1994; Schork et al, 1995; 
Pravenec et al, 1995; Samani et al, 1996) with Gca taking a similarly peripheral position to 
that observed in the current study.
Various isoforms of Na^^K^ATPase are involved not only in sodium handling by the kidney 
but also in regulation of vascular smooth muscle tone and cardiac contractility. It is not 
surprising therefore that Na^lCATPase genes have been given serious attention as strong 
candidates in essential hypertension. However, Na^lCATPase genes were found not to 
cosegregate with blood pressure in a Dahl SS x Dahl RR cross (Rapp & Dene, 1990) and 
no base changes between the two strains have been confirmed (Simonet et al, 1991). 
Lodwick et al (1998) also failed to find any evidence of co-segregation with blood pressure 
in a MNS x MHS cross despite the observation of differences in mRNA expression in the 
kidneys.
Camk, a major protein involved in intracellular calcium homeostasis, has received scant 
attention by comparison. It is interesting, however, that Vincent et al (1997) recently 
identified a similar QTL on rat chromosome 2 in a Lyon normotensive x hypertensive cross 
containing Camk which specifically influences the systolic (peak LOD score 4.4) and 
diastolic (peak LOD score 4.1) blood pressure responses to administration of a 
dihydropyridine calcium antagonist, PYl08-068.
8 6
Most recently two new strong candidate genes have been physically mapped in the region of 
this putative QTL. Soluble guanylyl cyclases (ot/p) are major constituents of the nitric oxide 
system which plays a prominent role in salt handling and regulation of blood pressure. The 
a l  and p i  gene loci have been mapped to rat chromosome 2 and are closely linked to 
Na^lCATPaseal and Camk (Azam et al, 1998). Interestingly, P subunits have been shown 
to be altered in Dahl SS rats (Gupta et al, 1997), although further analysis of their potential 
role in blood pressure regulation remains to be done. Indeed, whilst the existence of this 
QTL, in Dahl SS rats at least, has been recently confirmed by congenic strains in which the 
chromosomal segment contained all the above mentioned candidate genes in its 41cM 
(Deng et al, 1997), further congenic strains and sub-strains will be required in both the Dahl 
SS and SHRSP to narrow the region significantly in order to identify the true effective 
allele.
The current study also identified a second sex-specific blood pressure QTL on rat 
chromosome 3 in the region of the anonymous marker D3Mghl6. Again, this QTL was 
present in male F2 rats only and showed a significant likelihood-ratio test of the sex 
difference in LOD scores. No relevant candidate genes have been identified in this area 
hence the particular need for congenic strains of this region.
It is of interest that several other groups have also identified blood pressure QTLs on rat 
chromosome 3 in a SHRSP(izumo) x WKY cross. In particular, Nara et al (1996) found 
significant linkage of D3Mghl6 with basal systolic blood pressure in both male and females, 
whilst Matsumoto et al (1995 & 1996) determined a female only QTL for both salt-loaded 
diastolic and systolic blood pressure with the anonymous microsatellite marker D3Mghl2.
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The differences between these studies might be related to different methods of blood 
pressure measurement (radio-telemetry versus tail-cufFfemoral artery cannulation). The 
current study is the first to report the use of telemetry for phenotyping an entire F2 cohort 
in a linkage study. It is likely that such high fidelity phenotyping, in which the animals are 
free from catheters, tethers and stress from human contact, may affect the final results of 
QTL mapping. Alternatively, genetic heterogeneity between WKY controls from different 
sources as confirmed by both biochemical genetic markers (Matsumoto et al, 1991) and 
DNA fingerprinting techniques (Samani et al, 1989; Kurtz et al, 1989; Nabika et al, 1991) 
may be the culprit. This heterogeneity is believed to have occurred as a result of its world­
wide distribution prior to complete inbreeding (Kurtz & Morris, 1987) and must be borne in 
mind when making any comparison of experimental results obtained using WKY from 
different sources as in the case above. Indeed this genetic heterogeneity between groups 
may also be the reason why the current study was unable to detect the blood pressure QTLs 
previously reported on chromosomes 1,10 and 18 in SHRSP x WKY crosses (Hilbert et al, 
1991 ; Jacob et al, 1991; Nara et al, 1993), as well as why these other groups did not record 
a major QTL on rat 2 in the region of D2MU6 as this study did.
The majority of previous studies used F2 males only for linkage analyses. The current study 
used male and female F2 cohorts phenotyped with high fidelity methods to enable us to 
identify the male sex-specific QTLs on chromosomes 2 and 3. It is possible that these male 
only QTLs may have resulted from epistatic interaction with the Y chromosome blood 
pressure raising locus previously identified by Davidson et al (1995) in the Glasgow SHRSP 
X WKY cross. However, the stepwise regression procedures carried out for baseline and 
salt-loaded blood pressure phenotypes did not reveal such an interaction. Instead, the
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putative SHRSP Y chromosome effect and the D2MU6 or D3Mghl6 recessive effects were 
significant but independent influences on baseline and salt-loaded blood pressure. An 
alternative explanation which requires further investigation may be the existence of differing 
hormonal interactions at the transcriptional as well as post translational level of these 
hypertensive alleles.
In addition to the above blood pressure QTLs, the current study is notable for identifying 
the first QTL for left ventricular hypertrophy in SHRSP on rat chromosome 14. However, 
in view of the borderline significance (LOD 3.1) it should be considered as suggestive 
linkage only (Lander & Kruglyak, 1995) until congenic strains can confirm otherwise. 
Whilst no obvious candidate genes mapped in this region in the current study, the a-adducin 
gene has been mapped to rat chromosome 14 (Tripodi et al, 1995). This codes for one of 
the subunits of an o/p heterodimeric protein regulating cell-signal transduction through the 
actin cytoskeleton which appears to be involved in the regulation of renal tubular 
reabsorption and extracellular fluid homeostasis (Ferrari et al, 1991, 1992). Initially Bianchi 
et al (1994) identified point mutations in both the a  and p subunits of the adducin gene 
which accounted for up to 50% of the difference in blood pressure between the Milan 
hypertensive and normotensive rat strains. The same group went on to identify a functional 
mutation in the human a-adducin gene (Gly460Trp) and demonstrated significant linkage 
and association of the a-adducin locus with essential hypertension (Cusi et al, 1997). 
However, its relationship to left ventricular hypertrophy remains untested and examination 
of the a-adducin gene in the Glasgow colonies of SHRSP and WKY revealed no functional 
polymorphisms (G. Bianchi, personal communication).
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Previous genome scans have identified two other putative QTLs for heart weight on 
chromosome 2 (Innes et al, 1998) and chromosome 17 (Pravenec et al, 1995). The latter 
showed significant linkage of the microsatellite marker within the dopamine la receptor 
with left ventricular heart weight adjusted for body weight (Pravenec et al, 1995). In 
addition, several candidate genes have been shown to co-segregate with increased heart or 
left ventricular weight in crosses involving inbred hypertensive rat strains, including 
endothelin-3 on chromosome 3 (Cicila et al, 1994); Ace on chromosome 10 (Harris et al, 
1995; Zhang et al, 1996); AnplBnp on chromosome 5 (Zhang et al, 1997), heat shock 
protein HSP27 on chromosome 12 (Hamet et al, 1996) and renin on chromosome 13 
(Rapp, 1989). Unfortunately interpretation of all these studies may be confounded by as yet 
unidentified cardiac modifying genes on the same chromosome and thus, as for the blood 
pressure QTLs above, speculation about the functional role of specific variants in these 
regions should remain just that.
In conclusion, this was the first study to combine the use a genome wide scanning strategy 
with the high fidelity phenotyping of an F2 cohort. In doing so it identified several new 
QTLs containing genetic determinants of hypertension in the Glasgow SHRSP x WKY 
cross, particularly serving to highlight the relative prevalence of sex-specific QTLs which 
had been previously masked by the other groups’ exclusive use of males only. Both the 
blood pressure QTLs identified on chromosome 2 in this study have been identified 
separately in alternative hypertensive rat strains, indicating the important common role the 
gene(s) involved may play in the development of hypertension in the rat. By contrast, the 
QTL on chromosome 3 has only been replicated in other SHRSP x WKY crosses and is 
thus indicative of a SHRSP-specific hypertensive allele. This study also identified the first
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putative QTL for left ventricular hypertrophy in the SHRSP, thus adding to the wealth of 
evidence that so-called sub-phenotypes of hypertension are, at least partially, under 
independent genetic control. As all these chromosomal regions of interest are large 
however, and mostly without any clear candidate genes, the development of congenic 
strains with which to narrow them down is now appropriate {Chapter 5).
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4. IDENTIFICATION OF A QTL FOR ISCHAEMIC
STROKE IN SHRSP
4.1 Introduction
In the past it was generally believed that hypertensive end-organ damage was primarily due 
to the effects of hypertension and environmental factors while the role played by genetics 
was a negligible one. Recent discoveries, however, such as the identification of QTLs for 
left ventricular hypertrophy independent of blood pressure {Chapter 5; Pravenec et al, 
1995; Innes et al, 1998), along with advances in phenotyping such as radio-telemetry, have 
initiated the need to re-examine the role of genetics in other cardiovascular and 
cerebrovascular phenotypes.
Clinical and epidemiological studies reviewed by Alberts (1990) provided strong evidence 
for genetic influences in the development of stroke. This was supported by recent studies of 
Framingham offspring cohorts (Kiely et al, 1993) and twin pairs (Brass et al, 1992) which 
both suggested a strong familial aggregation of the disorder. In addition, several Mendelian 
traits featuring stroke have been described (Gunel & Lifton, 1996). Among these, the most 
relevant to ischaemic stroke is a syndrome of cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy (CADASIL) which has been mapped to 
human chromosome 19ql2 (Toumier-Lasserve et al, 1993) and appears to result from 
numerous mutations in the human NotchS gene (Joutel et al, 1996 & 1997).
While the genes and pathophysiological pathways involved in Mendelian forms of stroke are 
currently under intensive investigation, it seems likely that their involvement will account for 
only a very small fraction of the most common ischaemic stroke in man (Gunel & Lifton, 
1996). In this case, genetic analysis is hindered by the late onset of the clinically apparent
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disease and the mode of inheritance which is complex, polygenic, and multifactorial. 
Moreover the genetic background is heterogeneous, similar to most other epidemiologically 
important diseases such as diabetes, hypertension, and coronary heart disease.
An important approach to the study of such polygenic diseases is the use of appropriate 
animal models in which individual contributing factors can be both recognised and analysed 
(Lander & Schork, 1994; Dominiczak & Lindpaintner, 1994). During the establishment of a 
colony of spontaneously hypertensive rats (SHR) by Okamoto and Aoki (1963) several 
substrains developed a tendency for spontaneous cerebral infarction or haemorrhage 
(Hazama et al, 1975). The clustering of stroke in these strains suggested a genetic basis for 
stroke and Okamoto et al (1974) selected a stroke-prone substrain, the SHRSP, in which 
spontaneous strokes developed in 75-80% of rats.
Spontaneous stroke in SHRSP has a number of disadvantages for genetic studies: first, it 
develops late in the animal’s life (after 14-20 weeks of age); second, the stroke may or may 
not be lethal; third, it presents as multiple lesions resembling diffuse changes of malignant 
hypertension rather than defined ischaemic stroke (Hazama et al, 1975; Okamoto et al, 
1974). Despite this, Nagoaka et al (1976) studied latency to stroke (or age of stroke 
occurrence) on a high salt diet in SHRSP, F2 hybrids and back-crosses obtained by mating 
SHRSP with the stroke-resistant SHR. This phenotype, which could be related to stroke 
susceptibility in man, was characterised by a polygenic inheritance. More recently, Rubattu 
et al (1996) performed a genome wide scan in an F2 cross obtained by mating SHRSP and 
SHR where latency to stroke on a Japanese diet (high salt, low potassium and protein) was 
yet again used as a phenotype. This study identified three major QTLs, STRl-3, which
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together accounted for 28% of the overall phenotypic variance and were blood pressure 
independent. Two of these QTLs, STR-2 and -5, conferred a protective effect against stroke 
in the presence of SHRSP alleles and STR-2 co-localised with the genes encoding atrial and 
brain natriuretic peptides.
In addition to susceptibility to spontaneous stroke, SHRSP display significantly larger 
cerebral infarcts than their normotensive reference strain, the Wistar-Kyoto (WKY) rat 
(Gratton et al, 1998), following the experimental occlusion of their middle cerebral artery 
(MCA). This is a strong phenotype for genetic studies. The stringent control of 
physiological variables under anaesthesia, and the uniform precision in the point, origin, and 
length of the occlusion, increases the sensitivity of infarct volume to the influence of genetic 
factors and decreases variability induced by non-genetic factors. Furthermore, it is one of 
the most relevant animal stroke models to man as the MCA is reported to be the vessel 
most commonly affected in human stroke syndromes (Berkow & Fletcher, 1987; Mohr et 
al, 1986; Karpiake/a/, 1989).
Coyle et al (1984) performed a co-segregation study using focal ischaemia produced by an 
occlusion of the middle cerebral artery (MCA) to characterise the stroke-prone phenotype. 
They showed a bimodal distribution of this phenotype and suggested that a single recessive 
gene was responsible for the pathogenesis of stroke in the SHRSP (Coyle et al, 1984). 
Subsequently Gratton et al (1998) observed that the distribution of infarct volumes in the 
first filial (FI) generation produced by crossing in-bred SHRSP and WKY rats virtually 
matched that in parental SHRSP, strongly suggesting a dominant mode of inheritance for 
this phenotype. Possible reasons for the two different conclusions may include Coyle’s use
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of outbred normal Wistar rats in place of inbred WKY rats, and a less severe, more distal 
occlusion in much younger animals (Gratton et al, 1998). Whatever the reason for these 
differences, both studies showed clear evidence for the involvement of a major genetic 
component above and beyond the effects of hypertension.
It follows that the aim of the current research was to identify the genetic component(s) 
responsible for severity of cerebral ischaemia after MCA occlusion, and thus separate it 
from the genes contributing to hypertension identified in Chapter 3, by performing a second 
genome wide scan in a SHRSP x WKY F2 cohort phenotyped by experimental focal 
ischaemia.
4.2 Methods
Expérimental Animals and Genetic Crosses
The inbred colonies of SHRSP and WKY rats held at the University of Glasgow were 
utilised in the present study to yield the necessary reciprocal genetic crosses as previously 
detailed in Chapter 2.2.2. One male SHRSP was mated with 2 WKY females (cross 1) and 
1 male WKY was mated with 2 SHRSP females (cross 2). From the FI rats of each cross, 2 
males and 4 females were brother-sister mated to generate a cohort of 59 F2 rats for 
phenotyping (39 in cross 1 with a male-to-female ratio of 22:17 and 20 in cross 2 with a 
male-to-female ratio of 9:11).
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Blood Pressure Measurement
As it was not technically feasible to perform two surgical procedures on an individual rat, 
systolic blood pressures were measured indirectly by tail-cuff plethysmography at 12 weeks 
of age in parental and F2 rats rather than by radio-telemetry as described in Chapter 2.3.1. 
In addition, chronic mean arterial blood pressure was measured 24 hours after MCA 
occlusion by direct femoral artery cannulation as described in Chapter 2.3.6. Data provided 
by both methods of blood pressure measurement were verified by comparison with that 
obtained in the parental, FI and F2 litter-mates subjected to the continuous radio-telemetry 
recording in Chapter 3.
Occlusion o f the Middle Cerebral Artery
All surgical procedures involved in the occlusion of the middle cerebral artery were 
performed by Drs Gratton and Carswell at the Wellcome Surgical Institute, Glasgow. Male 
and female SHRSP (n = 8; M:F = 6:2); WKY (n = 12; M:F 8:4) and F2 (n = 59; M:F 33:26) 
underwent MCA occlusion following the technique of Tamura et al (1981) as previously 
described in Chapter 2.3.6. Infarct volumes were expressed as a percentage of the ipsilateral 
hemisphere to account for brain swelling and differences in brain size between sexes and 
strains.
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Genotvpins and Statistical Analysis
A total of 702 microsatellite markers were screened and of these 22% were found to be 
dimorphic. The microsatellite markers were obtained from both Genosys Biotechnologies 
(Europe) and Research Genetics (Huntsville, AL.). Genotyping was performed by PCR 
amplification of DNA around the microsatellites as previously described in Chapter 2.4.3.
Examination of phenotypes for sex differences in the parental strains was accomplished by 
the use of two-sample /-tests. Two-way ANOVA was employed to detect differences 
between crosses or sexes in the F2 cohort, or between genotype groups while correcting for 
sex.
Genetic markers were mapped relative to each other by using the MAPMAKER/EXP 3.0 
computer package with an error detection procedure (Lander et al, 1987; Lincoln & 
Lander, 1992). Genetic distances were calculated with the Haldane mapping function. QTLs 
affecting a given phenotype were mapped relative to the genetic markers by using the 
MAPMAKER/QTL 1.1 computer package obtained from Dr. Eric Lander (Whitehead 
Institute, Cambridge, Massachusetts). A purely phenotypic model (genetic parameters set to 
zero) was fitted initially to assess the likely contribution of sex as the only explanatory 
variable, and the corresponding percentage of variance explained. The full genetic model, 
representing free inheritance of the trait after correction for sex, was then fitted, as were 
models for dominant, recessive and co-dominant inheritance.
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A confirmatory analysis of the QTL near the Anp marker on chromosome 5 was carried out 
by two-way ANOVA for different phenotypes in terms of marker genotype and sex. Other 
possible confounding factors for size of infarct as a proportion of ipsilateral hemisphere 
volume were investigated by including them in a multiple regression model for the 
phenotype, then removing non-significant effects by backwards elimination (Rawlings, 
1988) whilst retaining the correction for sex differences.
4.3 Results
All the significant phenotypic and genotypic data collected by this study is given in 
Appendix III, as well as the primer sequences and optimum PCR conditions of each 
microsatellite marker used.
Initial experiments in parental SHRSP and WKY showed that volume of infarction after 
MCA occlusion was bimodally distributed {Figure 4.1). There was no correlation between 
indirect blood pressures measured before the occlusion of the middle cerebral artery (MCA) 
and infarct volume in the F2 hybrids {Figure 4.2). Moreover, there was no relationship 
between mean arterial blood pressure measured by direct femoral artery cannulation at 24 
hours after MCA occlusion and the volume of infarction {Figure 4.3). Two-sample /-tests 
provided evidence {Figure 4.1) of a difference in the infarct volume expressed as a 
percentage of the ipsilateral hemisphere between males and females in the WKY strain 
(means ±SD were 14.2+6.2 and 7.4±3.1%; t = 2.55, P = 0.031, 95% Cl 0.8 to 12.8%). The 
number of SHRSP females was too small for formal analysis of any sex difference. In the 
more relevant F2 cohort, a two-way ANOVA to examine the effect of sex and the origin of
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the cross (SHRSP grandfather versus WKY grandfather, Chapter 2.2.2) again showed that 
sex had a significant effect with male F2 hybrids having larger infarcts than females (means 
±SD were 25.2+6.8 and 20.2+7.8%; F = 6.73, P = 0.012, 95% Cl 1.1 to 8.8%), whereas 
the origin of the cross had no effect (F = 0.19; P = 0.67).
A major QTL on rat chromosome 5 with a sex adjusted LOD score of 16.6 (corresponding 
P = 1.0 X 10'^ )^ was identified which accounted for 67% of the infarct volume as a 
percentage of the ipsilateral hemisphere volume variance in the SHRSP x WKY cross 
{Figure 4.4). The likely contribution of sex as a sole explanatory factor was 1.44, which 
explained 10% of the phenotypic variance. The microsatellite marker in the centre of this 
QTL is Anp^ a marker within the gene coding for atrial natriuretic peptide. Moreover, in the 
rat, mouse and man, the gene for Anp co-localises with the gene for brain natriuretic peptide 
{Bnp\ Tamura et al, 1996). The influence of the Anp marker on a number of phenotypes 
was examined correcting for sex with a two-way ANOVA {Table 4.1). The effect of the 
Anp marker can be described as co-dominant, as the F2 hybrids homozygous for the 
SHRSP (ss) had the largest infarct volume with the heterozygotes (ws) falling between the 
F2 hybrids homozygous for the WKY allele (ww) and the ss homozygotes. Moreover, the 
Anp marker had no effect on any other phenotype tested; notably there was no significant 
difference in systolic blood pressure or mean arterial pressure between ss, ws and ww F2 
hybrids. The co-dominant character of the QTL on rat chromosome 5 was further 
confirmed by comparison of QTL models that were constrained to follow different models 
of inheritance. As shown in Figure 4.4, the co-dominant model presented a better fit for the 
QTL than the free inheritance model.
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As previous studies had revealed an important role of sex and putative loci on the Y 
chromosome for the blood pressure phenotype (Davidson et al, 1995) a backward 
elimination procedure was performed to confirm or refute the role of these and other 
possible confounders in the determination of the volume of cerebral infarction {Table 4.2). 
The possible confounders, which included systolic and mean arterial pressures, the effect of 
the SHRSP Y chromosome (Davidson et al, 1995), body weight and the grandparental 
origin of the cross, were all eliminated in this stepwise procedure, with the highly significant 
effect of the QTL centred around the Anp microsatellite marker being retained.
4.4 Discussion
The current study is the first to map the gene for severity of ischaemic brain damage 
following occlusion of the MCA in the SHRSP. The QTL on rat chromosome 5, centred 
around the Anp marker, showed highly significant linkage to size of infarction following 
MCA occlusion. There was no linkage between this QTL and any of the blood pressure 
phenotypes studied. Sex was the only additional contribution to the phenotypic variance and 
thus the final LOD score was sex adjusted. All other potential confounders such as body 
weight, the origin of the cross, or the Y chromosome effect (Davidson et al, 1995) were 
excluded. The QTL on rat chromosome 5 accounts for 67% of the infarct volume variance 
and no other QTLs contributing to the severity of ischaemic damage were detected.
These data are highly contrasting to those reported by Rubattu et al (1996). Firstly, the 
QTL on rat chromosome 5 detected in this study is characterised by a much higher level of 
significance. Secondly, the SHRSP allele at this locus contributes to a greater severity of
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ischaemic damage when compared to the WKY allele, whereas the locus confers a 
protective effect against latency to stroke as studied by Rubattu et al (1996). Lastly, the 
current study identified only one major locus, with no significant QTLs on rat chromosomes 
1 and 4. All three differences described above may be accounted for by the major contrast in 
the method of characterisation of the stroke-related phenotype between the two studies. 
The latency to stroke (or age of stroke occurrence) calculated from the time of 
commencement of the Japanese rat diet includes both ischaemic and haemorrhagic stroke 
and its analysis requires complex adjustments for age. The phenotype used for the current 
study is performed as a planned experimental procedure at 12 weeks of age, and is highly 
reproducible and pathophysiologically important. It therefore seems reasonable to suggest 
that the gene(s) responsible for the latency to stroke with a high salt diet may be quite 
independent from those which determine the size of infarct following cerebral vessel 
occlusion.
The discovery of one major QTL for sensitivity to experimental cerebral ischaemia in the 
SHRSP is in line with the previous findings of both Coyle et al (1984) and Gratton et al 
(1998) who, in performing purely phenotype-based co-segregation analyses, suggested a 
single autosomal gene was responsible for infarct susceptibility. The current study places 
two putative genes central to the LOD-support intervals of the QTL, Anp and Bnp, which 
have well established vasoactive properties including natriuresis, diuresis, vasodilatation and 
inhibition of the renin-angiotensin-aldosterone system (Levin et al, 1998) and therefore may 
be involved in the control of contraction, growth and remodelling in cerebral vessels. 
Several studies have indicated that SHR and SHRSP have elevated plasma ANP 
concentrations as well as alterations in the number of ANP-binding sites in the brain
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(Nagase et al, 1997; Grove et al, 1997; Saavedra et al, 1986). It follows that further 
research is warranted to ascertain whether the genes encoding ANP and BNP are really 
likely candidates for sensitivity to experimental cerebral ischaemia {Chapter 6).
A previous study localised a QTL for blood pressure near the endothelin and GlutB genes 
on rat chromosome 5 in Dahl salt-sensitive (SS) rats (Deng et al, 1994). In addition, Zhang 
et al (1996 & 1997) found evidence for a QTL determining mean blood pressure and heart 
weight on chromosome 5 between Anp and Bnp in a SHR x WKY cross. Most recently, 
Garrett et al (1998) described a QTL for blood pressure on chromosome 5 in a Dahl SS x 
Lewis F2 cross which lowered blood pressure by 15mmHg in a subsequent congenic strain. 
All these studies suggest the existence of a region on rat chromosome 5 which contributes 
primarily to high blood pressure with any physiological effects on the brain proving 
secondary to the elevated blood pressure. The single locus identified for sensitivity to 
cerebral ischaemia in the current study, however, was independent of blood pressure. This 
lack of a relationship between high blood pressure and large volume of infarction in SHRSP 
was further strengthened by the failure to identify QTLs for cerebral ischaemia in 
chromosomal regions overlapping those previously identified for blood pressure phenotypes 
in Chapter 3. These observations agree with the already well-documented concept that 
large infarcts are not secondary to hypertension (Coyle et al, 1986; Gratton et al, 1998). 
For example, SHRSPs suffer larger infarcts in early life (at 5 weeks of age), before either 
hypertension or cerebrovascular changes become established (Coyle & Jokelainen, 1983). 
Secondary forms of experimental hypertension such as DOCA-salt do not increase 
susceptibility to cerebral infarction (Coyle, 1984), and hypotensive treatment in the SHRSP 
reduces infarct size following MCA occlusion only minimally and never down to WKY size
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(Fujii et al, 1992). Indeed, elevated blood pressure during experimental stroke has been 
shown to reduce infarct size (Ogilvy et al, 1996) and vascular hypertrophy which develops 
alongside hypertension has been shown to reduce susceptibility to spontaneous stroke 
(Sadoshima e /ût/, 1981).
The complete dissociation between genes for severity of ischaemic damage and blood 
pressure might be extrapolated to human stroke. It has been shown that similar 
atherosclerotic occlusion of a major cerebral artery in humans may cause a catastrophic 
stroke or be entirely asymptomatic with an apparently continuous distribution of 
neurological damage in between (Allen, 1983; Jacewicz, 1992). This may be due to a stroke 
susceptibility or severity gene governing collateral blood flow as the anastomosing 
collaterals in SHRSP have significantly smaller internal diameter and a lesser ability to dilate 
as compared to age-matched WKY (Coyle & Heistad, 1991). Indeed, Arribas and co­
workers (1996) previously demonstrated geometric disorganisation of the medial layer of 
basilar arteries in the SHRSP using confocal microscopy, whereas Volpe et al (1996) 
showed impaired endothelium-dependent vasorelaxation in the aorta and basilar artery of 
the SHRSP.
Gender significantly influenced the outcome of ischaemia in rats, explaining 10% of the 
phenotypic variance seen in the F2 hybrids utilised in this study. Females displayed smaller 
infarcts following MCA occlusion then males, a finding which has been recently replicated 
by Alkayed et al (1998). In addition, the incidence of spontaneous stroke in SHRSP has 
been found to be lower in females than in males (Yamori et al, 1976b). Interestingly, 
Carswell et al (1998) found that female SHRSP in met-oestrus display larger experimentally
103
induced infarcts than those females taken at random, and also larger infarcts than males. As 
levels of oestrogen and progesterone fluctuate between 7pg/ml and 40-50pg/ml and 
between 5-lOng/ml and 45-50ng/ml, respectively, during the oestrus cycle (Smith et al, 
1975) it appears likely that the high levels of female hormones at different stages in the 4 
day cycle may be protecting against ischaemic damage and therefore clearly influencing 
stroke sensitivity. It is already known that ovariectomised female rats treated with 
oestrogen chronically before a focal cerebral insult suffer smaller infarcts than untreated 
ovariectomised females (Simpkins et al, 1997). Oestrogen has been reported to have anti­
inflammatory effects including decreasing levels of cytokines such as tumour necrosis factor 
(TNF) alpha and acting as a free radical scavenger (Goodman et al, 1996; Squadrito et al, 
1997). Oestrogen also decreases low density lipids and increases high density lipids (Crook,
1996) and promotes nitric oxide- (Pelligrino et al, 1997) and prostacyclin- (Gustafsson,
1997) mediated vasorelaxation by increasing nitric oxide synthase and prostacyclin 
production, respectively. Oestrogen has also been shown to inhibit endothelin-1 production 
thereby reducing the extent of endothelin-induced vasoconstriction (Wingrove & Stevenson, 
1997). Progesterone has also been shown to exert neuroprotection (Roof et al, 1993) 
perhaps by a potent anti-oedema effect on the brain (Betz & Coester, 1990).
In conclusion, this was the first study to use the experimental occlusion of the middle 
cerebral artery as a stroke-related phenotype for genome wide QTL analysis. It 
demonstrated a highly significant QTL on rat chromosome 5 which was blood pressure 
independent and possessed two putative candidate genes in its centre, the Anp and Bnp 
genes. Whilst there is ample evidence to support further investigation of these candidate 
genes for a role in the pathophysiology of stroke {Chapter 6) the concurrent establishment
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of congenic strains containing the large chromosomal region of interest remains the most 
positive method of ensuring progress is made towards the ultimate positional cloning of the 
gene(s) responsible for the severity of cerebral ischaemic damage in the SHRSP {Chapter
105
5. CONSTRUCTION OF SPEED CONGENIC STRAINS
5.1 Introduction
Genome wide linkage analysis, as successfully used in Chapters 3 and 4 to localise large 
chromosomal regions containing QTLs for high blood pressure, left ventricular 
hypertrophy and sensitivity to cerebral ischaemia in the SHRSP, is only a first step 
towards gene identification. Not only does the ultimate goal of positionally cloning the 
causal gene currently require the QTL to be narrowed to less than 2cM, but conclusions 
drawn from linkage analyses are prone to producing false positives (Rapp & Deng, 
1995). To confirm the existence of a QTL, and to narrow down the chromosomal region 
of interest, a more definitive and stringent genetic test is required in the form of congenic 
strain construction.
A congenic strain is one in which a portion of a chromosome from one strain (the 
recipient) has been selectively replaced by the homologous portion of the same 
chromosome of another strain (the donor). If the chosen phenotype, for example blood 
pressure, of the congenic strain is different from the recipient strain, one can conclude 
that this particular chromosomal fragment harbours a QTL that contributes to a 
difference in blood pressure between the donor and recipient strains. Congenic strains 
have been traditionally developed by serially backcrossing the donor strain that harbours 
the genomic region of interest with the recipient inbred strain, accompanied by selection 
for progeny heterozygous for the desired region in each backcross generation (Wakeland 
et al, 1997). This essentially leads to serial dilution of the donor genome into the 
recipient genome, with continuous maintenance of the QTL. As, according to Mendel’s 
laws, it is expected that half of the unrelated genomic material will be transmitted to a
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subsequent backcross generation, 8-10 generations of backcross matings should result in 
a congenic strain in which more than 99% of the genome unlinked to the target gene will 
be of recipient strain origin {Figure 5.1). The introgressed region is then made 
homozygous by intercrossing, and the resulting congenic strain theoretically possesses a 
genetic background identical to that of the recipient inbred strain with the exception of 
the introgressed region.
Whilst the above protocol for breeding congenic strains is simple, its weaknesses are that 
it requires at least 3-4 years to complete and the purity of the congenic strain for 
recipient genome is based purely on theoretical considerations, without any experimental 
assessment. Recent additions to the density of a microsatellite based rat map, however, 
(Bihoreau et al, 1997; Brown et al, 1998) may offer the opportunity to remove both 
these problems by permitting the utilisation of a so-called “speed” congenic strategy 
origin {Figure 5.1).
This strategy involves the analysis of dimorphic marker loci distributed throughout the 
genome in order to specifically select the male progeny at each backcross generation that 
carries the target genomic region whilst also possessing the lowest content of 
heterozygosity throughout the remaining genome. Breeding with these “best” males 
should theoretically allow the rate of donor genomic segment elimination to be 
dramatically accelerated, thereby reducing the number of generations necessary to 
construct a congenic strain. Computer simulations have indicated that a relatively modest 
selection effort (60 background markers, 25cM marker spacing, 16 males per generation) 
will typically reduce unlinked donor genome contamination to below 1% by four
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Figure 5.1 Cartoon showing the production of a congenic strain using the traditional 8 
backcrosses versus the speed congenic method utilised in the mouse (Markel et al,
1997). The dotted arrows indicate the equivalent backcrosses at which the background 
heterozygosity is theoretically the same.
backcross generations (BC4), roughly equivalent to backcrossing to BC8-10 using the 
traditional protocol (Wakeland et al, 1997) Indeed, the recent development of ten 
“speed” congenic mice strains carrying defined genomic intervals derived from non-obese 
diabetic (NOD) or NZM2410 strains on the C57BL/6 genome (Yui et al, 1996; Morel et 
al, 1996) provided results which closely paralleled these predicted outcomes.
Whilst the feasibility of a speed congenic approach remains to be tested in the rat, several 
rat congenic lines have been successfully produced using the traditional breeding strategy 
in order to more precisely localise chromosomal regions of linkage to blood pressure 
regulation. Of particular relevance, Deng et al (1997) confirmed the existence of a blood 
pressure QTL on rat chromosome 2 in the region corresponding to that identified in 
Chapter 3 of the current study between markers D2MU14 and D2Mghl2 by constructing 
two congenic strains introgressing the relevant region from the WKY rat or the Milan 
normotensive (MNS) rat into the Dahl salt-sensitive (SS) background. These strains had 
blood pressure 44mmHg and 29mmHg lower, respectively, than SS rats on a 2% NaCl 
diet (Deng et al, 1997).
Although the chromosome 2 region introgressed by Deng et al (1997) harbours several 
genes that could be construed as candidates for the blood pressure QTL, speculation as 
to the identity of the actual QTL is premature as the substituted region was very large 
(41cM) and thus requires still further investigation via congenic substrains. In addition, 
the results of Chapter 3 of the current study clearly indicated this appeared to be a sex- 
specific QTL occurring in males only, a matter Deng’s study (1997) was unable to 
address having been performed in a population of solely male rats. Moreover, the
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chromosome 2 congenic strains of Deng et al (1997) did not examine evidence for the 
second QTL on rat chromosome 2 identified in Chapter 3 around the D2MU6 marker 
and corresponding to that also identified by several other groups in various crosses 
(Dubay et al, 1993; Deng & Rapp, 1992; Deng et al, 1994; Garrett et al, 1998).
It follows that the purpose of the current study was to begin a more comprehensive 
congenic analysis of the whole of rat chromosome 2 and the QTLs identified therein. 
This is to be achieved by the production of an improved genetic linkage map for rat 
chromosome 2 between SHRSP x WKY and the first application of a speed congenic 
strategy in the rat, introgressing the genomic regions of interest in both directions; that is 
from the WKY to the SHRSP and vice versa, and into both males and females.
5.2 Methods
Expérimental Animals and Genetic Crosses
To improve the chromosome 2 genetic map achieved in Chapter 3, DNA from the same 
two F2 reciprocal crosses as described in Chapter 3 was utilised (57 in cross 1 with a 
male-to-female ratio of 28:29 and 83 in cross 2 with a male-to-female ratio of 37:46). In 
order to simplify the PCR reaction to one 96-well plate, however, genotype analysis was 
restricted per microsatellite marker to a random 94 samples from this F2 set and two 
parentals.
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Congenic strains were constructed by placing various segments of rat chromosome 2 
from WKY rats on the genetic background of the SHRSP and vice versa using a 
previously un-tested “speed” congenic breeding procedure as previously outlined in 
Chapter 2.2.3. The number of backcrosses necessary (BC3-BC5) varied from congenic 
strain to congenic strain and was dependent on the rate at which heterozygosity was lost 
from the genetic background as well as litter size. Once a male and female were 
identified in which all visible background heterozygosity had been removed, they were 
mated to obtain rats homozygous for the donor alleles throughout the chromosome 2 
region of interest. After the region was fixed, congenic strains were maintained by 
brother-sister mating.
Tail-Tipvins and DNA Extraction
For genotyping of congenic back-crosses, the animals were briefly anaesthetised at 4 
weeks of age with fluothane and a 4mm tip from their tail removed into a 1.5ml 
microfuge tube. The wound was immediately sealed with an electric cautériser (Engel- 
Loter lOOS) and the tails stored at -20°C. Genomic DNA was isolated from the tails 
using a simplified mammalian DNA isolation procedure involving serial phenol- 
chloroform extractions as described in Chapter 2.4.1. All samples were stored in lOOpl 
TE solution (lOmM Tris, pH 8.0; O.lmM EDTA, pH 8.0) and stored at 4°C prior to 
PCR analysis.
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Genotvpine and Statistical Analysis
A total of 33 new microsatellite markers for rat chromosome 2 were screened and of 
these 79% were found to be dimorphic between SHRSP(Giasgow) and WKY(Giasgow). These 
markers were obtained from both Genosys Biotechnologies (Europe) and Research 
Genetics (Huntsville, AL) and had been recently published by the Whitehead Institute 
Center for Genome Research Rat Mapping Project, Boston, USA at 
http://www.genome.wi.mit.edu/rat/public/ within an up-date of the original rat genetic 
map published by Jacob et al (1995). Genotyping was performed by PCR amplification 
of DNA around the microsatellites as previously described in Chapter 2.4.3. The 
genotypic results gained from these additional genetic markers were added to those 
previously collected in Chapter 3 and mapped relative to each other using the 
MAPMAKER/EXP 3.0 computer package with an error detection procedure (Lander et 
al, 1987; Lincoln & Lander, 1992) as previously described. On completion of the new 
map, the QTLs on rat chromosome 2 found to influence blood pressure phenotypes in 
Chapter 3 were re-mapped relative to the new genetic map by using the 
MAPMAKER/QTL 1.1 computer package obtained from Dr. Eric Lander (Whitehead 
Institute, Cambridge, Massachusetts).
In addition to the microsatellite markers on rat chromosome 2, an additional 53 {Table
5.1) broadly spanning the remaining genome were used for genotyping throughout the 
construction of the congenic strains, and were also obtained from both Genosys and 
Research Genetics. The “best” males identified as heterozygous (ws) for the marker 
alleles within the desired genomic region on chromosome 2, but mostly homozygous (ss
1 1 1
Marker Chromosome Marker Chromosome
DlMitl4 1 D10Wox3 10
GV30 1 DllMgh6 11
DlWox32 1 D12Mgh3 12
D lM itll 1 D12Wox2 12
DlMitl 1 D13Mghl 13
D3Mit4 3 D13Wox4 13
D3Woxl4 3 REP328 14
D3Mgh8 3 D14Wox5 14
D3Mghl6 3 D14Wox8 14
GV88 4 D15Mit2 15
D4Mghl6 4 D15Mgh3 15
D4Mgh7 4 D15Mgh6 15
D4Mitl4 4 D16Woxl2 16
NG56 5 R435 16
D5Woxl5 5 D16Mitl 16
D5Mghl5 5 D17Wox21 17
D5Mghl6 5 D17Woxl3 17
D6Wox21 6 D17WoxlO 17
D6Mgh5 6 D18Woxl2 18
D7MitlO 7 D18Woxl6 18
D7Mit7 7 D19Wox2 19
D8Wox22 8 D19Wox8 19
D8Mgh7 8 D20Wox3 20
D8Woxl3 8 D20Wox5 20
D8MghlO 8 DXWox3 X
D9Mitl 9
D9Woxl3 9
D9Mit4 9
Table 5.1 Micro satellite markers (n = 53) utilised to genotype the genetic background of 
all chromosome 2 congenic strains established.
or ww) for the recipient alleles (SHRSP and WKY respectively) everywhere else were 
selected and mated with the respective recipient strain to go on to the next backcross. In 
order to save resources, however, a full genome scan involving the analysis of the full 53 
background markers was only performed on a few animals at each backcross, followed 
by genotyping in subsequent backcrosses of only those markers identified as 
heterozygous in the previous generation.
5.3 Results
All the raw genotypic data newly collected by this study is given in Appendix IV, as well 
as the primer sequences and optimum PCR conditions of each microsatellite marker 
used. The raw phenotypic data utilised in the re-mapping of blood pressure QTLs on rat 
chromosome 2, and the original genotypic data used in the map construction is the same 
as that collected in Chapter 3 and is given in Appendix II.
A total of 26 new microsatellite markers on chromosome 2 were genotyped using the F2 
DNA and of these 9 were added to the original map obtained in Chapter 3 using the 
Haldane mapping function of the MAPMAKER/EXP 3.0 computer package {Figure
5.2). As a result the genetic map for the Glasgow F2 SHRSP x WKY cross expanded 
from 12 markers spanning 136.6cM {Chapter 5) to 21 markers covering 179.5cM, a 
distance comparable to that previously reported by several other groups (Andoh et al, 
1998; Bihoreau et al, 1997; the Whitehead Institute Center for Genome Research, 1998). 
The remaining 17 markers were excluded from the map by MAPMAKER. This is 
indicative of their preliminary placement in linkage groups on chromosome 2 by the
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Whitehead Institute Center for Genome Research along with the warning that they may 
have “multiple possible placements”.
Using the new map and the MAPMAKER/QTL 1.1 computer package both the 
significant QTL on rat chromosome 2 around the D2MU6 marker and the suggestive 
male only QTL between the markers D2MH14 and D2Mghl2 were again identified. 
Whilst the LOD scores obtained for the D2Mit6 QTL did not differ from those recorded 
in Chester 3, the LOD scores for the male only QTL now reach significant, rather then 
suggestive, linkage levels, in particular LOD = 4.1 for salt-loaded diastolic blood 
pressure {Figure 5.3).
Five congenic strains (SP.WKYgla2a-e) were produced by introgressing regions of 
chromosome 2 from WKY rats into the recipient SHRSP strain {Figure 5.4) and four 
congenic strains (WKY. SPgla2a-d) were produced by introgressing regions of 
chromosome 2 from SHRSP rats into the recipient WKY strain {Figure 5.5). In the 
names of the congenic strains, the first abbreviation refers to the recipient, the second the 
donor. The numbers/letters are arbitrary designations where 2 refers to chromosome 2, 
and a, b, c, d and e are arbitrarily assigned to each strain. The regions transferred have 
been designed to cover different genomic regions of interest on chromosome 2. 2a 
involves the transfer of the entire map of chromosome 2, and thus both blood pressure 
QTLs identified. Congenic strain 2b contains no QTLs. 2c also includes both QTLs but 
within a smaller chromosomal region than 2a. 2d and 2e contain only the one QTL each, 
around D2MU6 and D2Mghl2 respectively. Unfortunately, 2e has only been transferred 
from WKY on to the SHRSP background due to the low fecundity of the reciprocal
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strain. Animals found to be homozygous for the recipients’ alleles rather than for the 
donors’ alleles in the final step of fixing the 2a strains were also intercrossed to provide 
congenic controls. Termed SP.SPgla and WKY.WKYgla {Figure 5.6) these strains have 
been through the same selection processes as the true 2a congenic strains but do not 
containing the donor QTLs. They will, however, contain in their genetic background the 
same, if any, residual heterozygosity missed by the total genome scan with the 
background markers.
Tables 5.2A and B illustrate the number of generations of backcrossing required for each 
strain to achieve complete homozygosity of the background genetic markers in a best 
male which could then be utilised to fix the line. As is shown, this varied between BC3 
for congenic strain WKY.SPgla2b and BC5 for both WKY.SPgla2c and SP.WKYgla2e. 
In total 542 progeny were necessaiy for screening in order to produce the congenic 
strains, an average of 60 animals per strain, 15 animals per backcross. Table 5.3 shows 
the average reduction in background marker heterozygosity through subsequent 
backcrosses using the speed congenic strategy, figures which mirror those theoretically 
expected over BC8 generations utilising the traditional approach.
5.4 Discussion
The presentation in this study of nine congenic strains derived for rat chromosome 2 
clearly demonstrates the applicability of a speed congenic strategy in this species. It is 
hypothesised that following the future assessment of systolic and diastolic blood pressure 
at baseline and after salt-loading in these strains as measured by radiotelemetry they will
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Strain Generation Progeny
Screened
% Background Marker 
Heterozygosity of “Best” Male
S P .W K Y g l a 2 a B C l 5 6 2 8 .3
B C 2 1 6 1 3 .2
B C 3 2 3 1 .9
B C 4 3 4 z e r o
S P .W K Y g l a 2 b B C l 5 6 4 3 . 4
B C 2 1 5 2 4 . 5
B C 3 2 8 9 . 4
B C 4 2 7 z e r o
S P .W K Y g l a 2 c B C l 5 6 2 8 . 3
B C 2 1 6 1 1 .3
B C 3 1 7 7 .5
B C 4 3 6 z e r o
S P .W K Y g l a 2 d B C l 5 6 2 8 .3
B C 2 1 6 1 3 .2
B C 3 2 3 3 .8
B C 4 2 4 z e r o
S P .W K Y g l a 2 e B C l 5 6 2 8 .3
B C 2 1 6 1 3 .2
B C 3 2 3 7 .5
B C 4 3 1 5 .7
B C 5 1 8 z e r o
Table 5.2A Rat chromosome 2 congenic strains SP.WKYgla2a-e where SHRSP is the 
recipient strain and WKY the donor strain. The actual number of progeny screened 
represents those genotyped for heterozygosity on chromosome 2 and/or residual 
heterozygosity.
Strain Generation Progeny
Screened
% Background Marker 
Heterozygosity of “Best” Male
W K Y . S P g l a 2 a B C l 2 8 1 7 .0
B C 2 1 7 7 .5
B C 3 1 4 7 .5
B C 4 2 0 z e r o
W K Y .S P g l a 2 b B C l 2 8 1 7 .0
B C 2 1 7 7 . 5
B C 3 1 4 z e r o
W K Y . S P g l a 2 c B C l 2 8 3 5 . 8
B C 2 6 1 3 .2
B C 3 1 4 9 . 4
B C 4 1 2 5 .7
B C 5 11 z e r o
W K Y . S P g l a 2 d B C l 2 8 1 7 .0
B C 2 1 8 1 .9
B C 3 5 1 .9
B C 4 2 8 z e r o
Table 5.2B Rat chromosome 2 congenic strains WKY.SPgla2a-d where WKY is the 
recipient strain and SHRSP the donor strain.
Mean Background Marker Heterozygosity(%)
Generation Theoretical Recipient Recipient Recipient
SHRSP WKY SHRSP &
WKY
F I 5 0 . 0 5 0 . 0 5 0 . 0 5 0 .0
B C l 2 5 . 0 3 6 . 8 2 2 . 0 2 9 . 4
B C 2 1 2 .5 1 8 .9 1 1 .3 1 5 .1
B C 3 6 . 2 5 5 . 9 9 .1 7 .5
B C 4 3 . 1 2 5 5 .5 0 . 9 3 .2
B C 5 1 .5 6 1 .9 0 . 9 1 .4
B C 6 0 . 7 8
B C 7 0 . 3 9
B C 8 0 . 2
Table 5.3 Efficacy of background marker assisted congenic strain construction versus 
traditional theory. Data Avas only available from the current study up to BC5 as “best” 
males with no detectable background heterozygosity were identified in all strains by this 
stage.
further the evidence for, and the genetic dissection of, the QTLs involved. They should 
also allow further detailed analysis of sex specificity, epistatic and ecogenetic 
interactions, and candidate genes as well as the construction of sub-strains containing 
smaller relevant sections of chromosome.
Previous results of computer simulations comparing different speed congenic strain 
construction strategies in mice found that a relatively modest selection effort (60 
microsatellite markers, 25cM marker spacing, 16 males per generation) will typically 
reduce unlinked donor genome contamination to below 1% by four backcross 
generations (BC4), roughly equivalent to backcrossing to BC8-10 using the traditional 
protocol (Wakeland et al, 1997). These theoretical models have been borne out by 
practical experience with mice speed congenic strains (Yui et al, 1996; Morel et al, 
1996; Markel et al, 1997). The current study is the first to provide similar practical 
evidence in the rat. Selecting the best male at each generation, an average of only 15 rats 
per backcross were necessary to construct the strains within 3 to 5 backcrosses. 
However, it should be noted that with the exception of the “best” males which had no 
visible background heterozygosity by the final backcross of each strain, the average 
donor contamination did not fall below 1% by BC4 as observed in the mice studies. This 
is probably a reflection on the fact that due to time and labour restrictions a full genome 
scan using the 53 markers was not done in all the progeny produced at the beginning of 
the backcrossing program, but rather was staggered throughout the backcrosses. It 
follows that even better “best” males may have been overlooked in the initial generations 
which may have decreased the background heterozygosity at an even greater rate.
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Some level of contaminating donor genome in the genetic background is unavoidable, 
even when utilising the traditional protocol for construction of a congenic strain. 
Wakeland et al (1997) have estimated that the levels of undetected contamination 
present is roughly equivalent to that at BC8 or BCIO using the traditional protocol; that 
is below 1%. A potential problem with this, regardless of the congenic strategy, is that 
during the process of fixing the chromosome region of interest for the donor strain into 
the homozygous state, an unlinked “stowaway” QTL may happen to be trapped in the 
1% residual donor strain and thus could be carried along as a homozygote, or a 
heterozygote, or not at all. The presence or absence of the unknown and unlinked QTL 
could confound the interpretation that the blood pressure effect in the congenic strain is 
due to the intended QTL.
All previous studies involving the traditional construction of rat congenic strains 
containing blood pressure QTLs have ignored the problem of stowaway loci, citing the 
number of backcrosses involved as making the effect of background contamination 
negligible. However, the present study’s speed congenic strategy has provided the first 
opportunity to monitor this parameter in the rat. In genotyping the genetic background at 
each backcross there were several chromosomal “hotspots” evident at which donor 
alleles appeared to be preferentially conserved, including genetic loci on chromosomes 4, 
7 and 15. The utilisation of a speed congenic strategy enabled these loci to be monitored 
and “best” males to be selected which did not contain heterozygosity in these regions. 
However if, as in all the other studies utilising the traditional congenic method, an 
assessment of background heterozygosity had not been made, equivalent conservation 
may have been maintained through to generation BC8-10, which could thus have gone
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on to be a possible confounder of any blood pressure changes observed in the resulting 
congenic strains. It follows that it might be useful in all congenic strategies, regardless of 
the protocol utilised, to include at least some rudimentary assessment of the genetic 
background of the congenic strain.
On similar lines, the use of at least one of several possible congenic controls to positively 
establish that a phenotype detected in a congenic strain is due to the target genomic 
region rather than the effect of any residual loci is probably wise, even in addition to a 
background scan. Examples constructed in the current study included the 2b congenic 
strains. Containing a chromosomal region abutting, but not overlapping, the 
chromosomal segments including the two putative blood pressure QTLs on chromosome 
2, the 2b strains should not show a significant change in blood pressure unless stowaway 
loci are involved. Similarly, the congenic control strains SP.SPgla and WKY.WKYgla 
whilst not containing the donor QTL will contain in their genetic background the same, if 
any, residual heterozygosity as the true congenic strains. Whether or not these animals 
go on to display a change in phenotype similar to that observed in the true congenics will 
also determine the confounding importance of stowaway loci and hence use of a speed 
congenic strategy in rats. Finally, all the congenic strains were derived independently, 
making it very unlikely that they will all by chance contain the same genomic regions of 
residual donor-strain genetic backgrounds that could potentially effect blood pressure.
In constructing two congenic strains introgressing the region of rat chromosome 2 
corresponding to the D2Mghl2 marker from the WKY rat or the Milan normotensive 
(MNS) rat into the Dahl salt sensitive (SS) background, Deng et al (1997) observed that
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the resulting reduction in blood pressure of the WKY congenic strain was about 
15mmHg greater than that of the congenic MNS strain, despite the larger SS segment 
introgressed in the MNS congenic. This difference could have arisen if the QTL allele of 
the WKY rat was different from that of the MNS rat, if the WKY and MNS rats have the 
same QTL allele in the D2Mghl2 region but the larger substitution in the MNS congenic 
strain contains other genes modifying its effects, and/or if there is one or more additional 
blood pressure QTLs located in this region of chromosome 2. It is hoped that this is one 
question the congenic strains developed in the current study will begin to address, as well 
as having the potential to confirm the putative existence of a second QTL on 
chromosome 2 around the D2Mit6 marker as observed in Chapter 3 and by several other 
groups using different crosses (Dubay et al, 1993; Deng & Rapp, 1992; Deng et al, 
1994; Garrett et al, 1998). In addition, these strains should potentially begin to rule out 
some of the many candidate genes for blood pressure regulation on rat chromosome 2. 
They should also be able to confirm or refute the sex specificity of the QTL around the 
D2Mghl2 marker observed in Chapter 2, a task which has not been previously possible 
due to other groups reliance on male only studies.
It is noticeable that whilst Deng et al (1997) maintained the use of tail-cuff 
plethysmography in phenotyping their chromosome 2 congenics, several other groups 
have turned to radio-telemetry in order to phenotype their congenics for chromosomes 1 
(St. Lezin et al, 1997), 8 (Kren et al, 1997) and 13 (St. Lezin et al, 1996). By 
recognising the need for a more accurate and direct method capable of measuring all the 
components of blood pressure studies, along with a reliability in detecting small changes 
and diurnal variations, radio-telemetry analysis of the chromosome 2 congenics derived
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in the current study should make them more suitable as a research tool with which to 
progress further towards identifying the gene(s) at the centre of each putative QTL.
A further utility of these congenic strains was recently highlighted by Rapp et al (1998b) 
in describing the construction of a double congenic strain containing the low blood 
pressure QTL alleles from both chromosomes 2 and 10 on the Dahl SS rat genetic 
background. Analysis of the blood pressure of this double congenic strain and its 
comparison with the relevant single congenic strains, and the SS strain, provides 
evidence for a strong epistatic interaction on blood pressure of the QTLs on 
chromosomes 2 and 10. This is the first described epistatic interaction on a quantitative 
trait in mammalian genetics. It follows that congenics hold much potential for addressing 
new aspects concerning the genetic regulation of blood pressure and that an ability to 
construct congenics, sub-strains and double congenics over fewer generations using the 
speed strategy can only prove advantageous.
One aspect of this research area which is currently threatening to slow progress via 
congenic sub-strains to positional cloning is the availability of adequately detailed maps 
of the rat genome. As was observed by the current study, the ability to place markers in 
order to improve the quality of the genetic map of chromosome 2 was limited by the 
paucity of precisely mapped markers. Only 9 new markers joined the existing map. 
Indeed, the majority of newly available markers had even yet to be precisely mapped by 
the Whitehead Institute Center for Genome Research themselves, and were issued on the 
Internet with a disclaimer reflecting doubts over their precise location.
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Physical mapping methods are beginning to be developed which will provide a firmer 
base for future positional cloning strategies then genetic mapping. For example, radiation 
hybrid (RH) mapping is a somatic cell hybrid technique that was developed to construct 
high resolution, contiguous maps of mammalian chromosomes and which does not hold 
marker dimorphism as a prerequisite (Cox et al, 1990). Now commercially available 
(Research Genetics), rat whole genome RHs have been generated by taking a donor cell 
line (RatFR, a diploid fibroblast cell line derived from skin biopsy of a foetal Sprague- 
Dawley rat) and exposing it to 3000 rad of x-rays and then fusing with non-irradiated 
thymidine kinase deficient hamster (A23) recipient cells. Loci that are further apart on a 
chromosome are more likely to be broken apart by radiation and to segregate 
independently in the RH cells than loci that are closer together. By screening the RH 
panel to test for the retention or loss of specific donor chromosome markers a map can 
be constructed statistically. This has already provided detailed physical maps of both rat 
chromosome 4 (Al-Majali et al, 1998) and 5 (Brosnan et al, 1998) with their superior 
resolution resolving most of the ambiguities in distance and location of markers on a 
chromosome. This technique has also been used to physically map two new strong 
candidate genes to rat chromosome 2 (Azam et al, 1998), soluble guanylyl cyclases a  
and p, as discussed in Chapter 3, although no complete map of this region has been 
produced as yet.
In conclusion, the successful production of congenic strains on chromosome 2 using a 
“speed” strategy should promote its use in the construction of other congenics, thereby 
significantly increasing the pace of research towards positional cloning of the genes 
involved in tandem with the production of detailed physical maps. Additionally it is
1 2 0
hoped that following radio-telemetry analysis these strains themselves will begin to 
unravel the genetic basis of blood pressure regulation on rat chromosome 2 as well as 
bringing to attention the importance of testing the influence of stowaway loci 
experimentally.
1 2 1
6. SEQUENCING ANALYSIS OF GENES ENCODING 
ATRIAL AND BRAIN NATRIURETIC PEPTIDES AS 
CANDIDATES FOR SENSITIVITY TO CEREBRAL 
ISCHAEMIA IN SHRSP
6.1 Introduction
The natriuretic peptide (NP) family exerts potent natriuresis/diuresis and vasorelaxation 
(Levin et al, 1998) and consists of three peptides; Atrial-NP (ANP), Brain-NP (BNP) 
and C-type NP (CNP). ANP and BNP are cardiac hormones stored and secreted from 
the atrium and ventricle respectively (Ogawa et al, 1991), whereas CNP is produced and 
secreted from vascular endothelial cells, monocytes, and chondrocytes (Nagase et al, 
1997). Natriuretic peptides activate the cGMP cascade through the two particulate 
guanylate cyclases, ANP-A (Gca) and ANP-B (Gcb) receptors (Suga et al, 1992). 
Although ANP and BNP show high affinity for the ANP-A receptor, CNP selectively 
binds to the ANP-B receptor.
The genes encoding ANP and BNP co-localise in human, mouse and rat on 
chromosomes 1, 4 and 5 respectively (Tamura et al, 1996) whereas CNP has a different 
location on mouse chromosome 1 (Ogawa et al, 1994) consistent with its divergent 
pattern of tissue specific and inducible expression. Indeed, the Anp and Bnp genes show 
particular sequence homology to one another with only four amino acids being different 
in the 17 amino acid ring structure common to both peptides (Vesely, 1992) and both 
have a fairly simple organisation with three exon (coding) sequences separated by two 
intron (intervening) sequences. (Figure 6.1).
The stroke-prone spontaneously hypertensive rat (SHRSP) is a good model for studying 
genetic determinants of stroke, being characterised by a high frequency of spontaneous 
strokes (Okamoto et al, 1974) as well as an increased sensitivity to experimentally
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induced focal cerebral ischaemia (Coyle & Jokelainen, 1983). Rubattu et al (1996) 
identified three QTLs for susceptibility to stroke which were localised to rat 
chromosomes 1, 4 and 5 in a F2 cross obtained by breeding SHRSP(Heideiberg) and SHR. 
The latter two of these conferred a protective effect against stroke in the presence of two 
SHRSP alleles and the QTL on chromosome 5 co-localised with the genes encoding 
ANP and BNP. In Chapter 4 a highly significant QTL on rat chromosome 5 was 
identified for sensitivity to experimentally induced middle cerebral artery occlusion in the 
Glasgow SHRSP x WKY F2 cross close to that identified by Rubattu et al (1996). It 
follows that Anp and Bnp have become putative candidates for susceptibility to stroke in 
the SHRSP.
For either Anp or Bnp to be considered valid candidate genes for being the QTL on rat 
chromosome 5 there would have to be a significant nucleotide difference between either 
of the genes of the SHRSP and the WKY. This difference would be such that it could 
cause the differing genes of the SHRSP and WKY to function differently. It was 
therefore the aim in this chapter to ascertain whether the genes encoding ANP and BNP 
are likely candidates for sensitivity to cerebral ischaemia by performing sequencing 
analysis of the coding regions of the Anp and Bnp genes.
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6.2 Methods
Seauencin2
The AmpliCycle™ Sequencing Kit (Perkin-Elmer) was used to sequence the coding 
regions of Anp and Bnp in both SHRSP and WKY following the cartoon protocol 
illustrated in Figure 6.1. Following the extraction of DNA from tail biopsies of 4 male 
SHRSP and 4 male WKY rats as previously described in Chapter 2.4.1, high quality 
amplification of the exonic regions of Anp and Bnp was achieved from this DNA by PCR 
as described in Chapter 2.4.5 using intronic specific primers (Table 6.1) designed in- 
house from sequences lodged at http ://www. ncbi. nlm. nih. gov/Web/S earch/index. html in 
GenBank (accession numbers K02062 and M60266 respectively). The 750 base pair 
amplicon containing exons 1 and 2 oïAnp was obtained using primers lA and 5 A. Exon 
3 was generated with 7A and 8A. The first two exons of Bnp were generated with IB 
and 4B whilst the third exon used 7B and 8B. The products from the PCR amplification 
were electrophoresed with molecular weight markers on either 1.5 or 2% agarose gels 
and the bands containing the DNA was excised from the gels and electroeluted. The 
DNA obtained was quantified using the DynaQuant Fluorimeter (Hoefer) and used to set 
up sequencing reactions.
Both forward and reverse sequencing primers were also designed in-house to cover 
between 150-200bp of the amplified coding regions of both Anp and Bnp (Table 6.1). 
Sequencing reactions were set up and run as described previously in Chapter 2.4.5. Each 
reaction was stopped with the addition of 4|il stop solution and then 5pi of each
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Primer Sequence Coverage
lA/F ACAGAATGGGGAGGGTTC (561-578) Exon 1
2A/R TTGGACACCGCACTGTAC (805-824) Exon 1
3A/F GTACAGTGCGGTGTCCAA (805-824) Exon 2
4A/F GAGGTGCCTCCCTGGAC (1062-1078) Exon 2
5A/R ATCCCGTTTCACCCGCAG (1288-1305) Exon 2
6A/R GTCCAGGGAGGCACCTC (1062-1078) Exon 2
7A/F TGAAGGTAGATCATCAGACCG (1628-1648) Exon 3
8A/R ACCGCAAGGCTTGGGATCTT (1709-1729) Exon 3
IB/F AGACAAGAGAGAGCAGGACACC (1088-1110) Exon 1
2B/R CCAAAACCCTTCAGGCAGGCT (1300-1320) Exon 1
3B/F CTGAGGTCTGGGCTTCCC (1457-1474) Exon 2
4B/R AGACTGTCGGTAAGGTAGAGG (1817-1838) Exon 2
5B/F TCCAGGAGAGACTTCGAA (1611-1628) Exon 2
6B/R TTCGAAGTCTCTCCTGGA (1611-1628) Exon 2
7B/F GGAAGCTCAGCTCCTGCCTCA (2107-2127) Exon 3
8B/R AAGAGCCGCAGGCAGAGT (2217-2234) Exon 3
Table 6.1 PCR and sequencing primers for Anp (1A-8A) and Bnp (1B-8B). All were 
designed in house from sequences lodged in GenBank (K02062 and M60266 
respectively). F refers to a forward primer, R to a reverse primer.
sequencing reaction resolved on a 6-8% polyacrylamide gel and electrophoresed for 
approximately 2 hours. The gel was then dried onto a large Whatman filter paper and 
placed against film for 4-8 hours. After this the film was developed and scored by two 
independent observers.
6.3 Results
Sequencing the coding region of the Anp and Bnp genes revealed no difference between 
the SHRSP and the WKY strains. Figure 6.2 shows a comparison between the Sprague- 
Dawley rat sequence of the Anp gene (GenBank accession number K02062) and those 
sequences in the SHRSP and WKY. There were four substitutions (two silent) within the 
coding region of the Anp gene as compared to the Sprague-Dawley sequence but no 
differences between SHRSP and WKY (Table 6.2). Figure 6.3 shows a comparison 
between the Rattus norvegicus sequence of the Bnp gene (GenBank accession number 
M60266) and those sequences in the two Glasgow strains. No sequence differences for 
the Bnp gene were detected.
6.4 Discussion
As discussed in Chapter 4, recent evidence utilising the SHRSP has implicated both the 
Anp and Bnp genes as putative candidate genes for stroke. Sequencing of the coding 
regions of both Anp and Bnp genes in the current study revealed no significant nucleotide 
differences between SHRSP and the WKY strains that are potentially important to their
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Exon 1 (727-846)
Sprague-Dawley
^^ Y(Gla)
SHRSP(Gla)
Sprague-Dawley
WKY(Gla)
SHRSP(Gla)
ATGGGCTCCTTCTCCATCACCAAGGGCTTCTTCCTCTTCCTGGCCTTTTGGC
ATGGGCTCCTTCTCCATCACCAAGGGCTTCTTCCTCTTCCTGGCCTTTTGGC
ATGGGCTCCTTCTCCATCACCAAGGGCTTCTTCCTCTTCCTGGCCTTTTGGC
TCCCAGGCCATATTGGAGCAAATCCCGTATACAGTGCGGTGTCCAACACAG
TCCCAGGCCATATTGGAGCAAATCCCGTATACAGTGCGGTGTCCAACACAG
TCCCAGGCCATATTGGAGCAAATCCCGTATACAGTGCGGTGTCCAACACAG
Sprague-Dawley ATCTGATGGAi i iCAAG 
WKY(Gia) ATCTGATGGATTTCAAG
SHRSP(Gia) ATCTGATGGATTTCAAG
Exon 2 (951-1277)
Sprague-Dawley
WKY(Gla) 
SHRSP(Gla)
Sprague-Dawley
WKY(Gla)
SHRSP(Gla)
Sprague-Dawley 
WKY(gu) 
SHRSP(Gla)
Sprague-Dawley 
WKY(Gla) 
SHRSP(Gla)
AACCTGCTAGACCACCTGGAGGAGAAGATGCCGGTAGAAGATGAGGTCATG
AACCTGCTAGACCACCTGGAGGAGAAGATGCCGGTAGAAGATGAGGTCATG
AACCTGCTAGACCACCTGGAGGAGAAGATGCCGGTAGAAGATGAGGTCATG
CCTCCG‘°°^CAGGCCCTGAGCGAGC‘“ ^AGACCGATGAAGCGGGGGCGGCAC
CCTCCA’°°^CAGGCCCTGAGCGAGA*°^^AGACCGATGAAGCGGGGGCGGCAC
CCTCCà‘°°^CAGGCCCTGAGCGAGA’°^^AGACCGATGAAGCGGGGGCGGCAC
TTAGCTCCCTCTCTGAGGTGCCTCCCTGGACTGGGGAAGTCAACCCGTCTCA
TTAGCTCCCTCTCTGAGGTGCCTCCCTGGACTGGGGAAGTCAACCCGTCTCA
TTAGCTCCCTCTCTGAGGTGCCTCCCTGGACTGGGGAAGTCAACCCGTCTCA
GAGAGATGGA‘*°®GGTGCTCTCGGGCGCG” ^^GCCCCTGGGACCCCTCCGATA 
GAGAGATGGC' “^ GGTGCTCTCGGGCGCA’ '^^GCCCCTGGGACCCCTCCGATA 
GAGAGATGG£"°®GGTGCTCTCGGGCGCA* ‘^ ^GCCCCTGGGACCCCTCCGATA
Sprague-Dawley GATCTGCCCTCTTGAAAAGCAAACTGAGGGCTCTGCTCGCTGGCCCTCGGA 
WKY(Gia) GATCTGCCCTCTTGAAAAGCAAACTGAGGGCTCTGCTCGCTGGCCCTCGGA
SHRSP(Gia) GATCTGCCCTCTTGAAAAGCAAACTGAGGGCTCTGCTCGCTGGCCCTCGGA
Sprague-Dawley GCCTGCGAAGGTCAAGCTGCTTCGGGGGTAGGATTGACAGGATTGGAGCCC 
WKY(gu) GCCTGCGAAGGTCAAGCTGCTTCGGGGGTAGGATTGACAGGATTGGAGCCC
SHRSP(Gia) GCCTGCGAAGGTCAAGCTGCTTCGGGGGTAGGATTGACAGGATTGGAGCCC
Sprague-Dawley AGAGCGGACTAGGCTGCAACAGCTTCCGG 
WKY(Gia) AGAGCGGACTAGGCTGCAACAGCTTCCGG
SHRSP(Gia) AGAGCGGACTAGGCTGCAACAGCTTCCGG
Exon 3(1669-1680)
Sprague-Dawley TACCGAAGATAA 
WKY(Gia) TACCGAAGATAA
SHRSP(Gia) TACCGAAGATAA
Figure 6.2 The sequences of the coding regions of Anp in the Glasgow SHRSP and 
WKY compared with the rat Genbank sequence for the Sprague-Dawley rat (K02062). 
The position of substitutions are highlighted in bold.
Substitutions
qioot 1^007 _ Proline (CCG) -> Proline (CCA) 
C1023 1^023 _ Glutamine (CAO) -> Lysine (AAG)
Aiios ^  çiios _ Glycine (QGA) -» Glycine (GGC) 
G "“  -> A "“  = Glycine (GGC) ^  Serine (AGC)
Table 6.2 The four substitutions identified within the exon 2 of the Anp gene in both the 
Glasgow SHRSP and WKY as compared to the Sprague-Dawley sequence. The 
substitutions at position 1007 and 1109 are silent.
Exon 1 (1143-1268)
Rattus norvegicus ATGGATCTCCAGAAGGTGCTGCCCCAGATGATTCTGCTCCTGCTTTTCCTTA 
WKY(Gia) ATGGATCTCCAGAAGGTGCTGCCCCAGATGATTCTGCTCCTGCTTTTCCTTA
SHRSP(Gia) ATGGATCTCCAGAAGGTGCTGCCCCAGATGATTCTGCTCCTGCTTTTCCTTA
Rattus norvegicus ATCTGTCGCCGCTGGGAGGTCACTCCCATCCCCTGGGAAGTCCTAGCCAGT 
WKY(Gia) ATCTGTCGCCGCTGGGAGGTCACTCCCATCCCCTGGGAAGTCCTAGCCAGT
SHRSP(Gia) ATCTGTCGCCGCTGGGAGGTCACTCCCATCCCCTGGGAAGTCCTAGCCAGT
Rattus norvegicus 
W K Y (G la)
SHRSP(Gla)
CTCCAGAACAATCCACGATGCAG
CTCCAGAACAATCCACGATGCAG
CTCCAGAACAATCCACGATGCAG
Exon 2 (1487-1709)
Rattus norvegicus AAGCTGCTGGAGCTGATAAGAGAAAAGTAGAGGAAATGGCTCAGAGACAG 
WKY(Gia) AAGCTGCTGGAGCTGATAAGAGAAAAGTAGAGGAAATGGCTCAGAGACAG
SHRSP(Gia) AAGCTGCTGGAGCTGATAAGAGAAAAGTAGAGGAAATGGCTCAGAGACAG
Rattus norvegicus CTCTCAAAGGACCAAGGCCCTACAAAAGAACTTCTAAAAAGAGTCCTTAGG 
W K Y (G la)
SHRSP(Gla)
CTCTCAAAGGACCAAGGCCCTACAAAAGAACTTCTAAAAAGAGTCCTTAGG
CTCTCAAAGGACCAAGGCCCTACAAAAGAACTTCTAAAAAGAGTCCTTAGG
Rattus norvegicus TCTCTCAAAGGACCAAGGCCCTACAAAAGAACTTCTAAAAAGAGTCCTTAG 
WKY(Gia) TCTCTCAAAGGACCAAGGCCCTACAAAAGAACTTCTAAAAAGAGTCCTTAG
SHRSP(Gia) TCTCTCAAAGGACCAAGGCCCTACAAAAGAACTTCTAAAAAGAGTCCTTAG
Rattus norvegicus GTCTCATAGTTCAAGCTGCTTTGGGCAGAAGATAGACCGGATCGGCGCAGT
WKY(Gla)
SHRSP(Gla)
Rattus norvegicus 
W K Y (G la)
SHRSP(Gla)
GTCTCATAGTTCAAGCTGCTTTGGGCAGAAGATAGACCGGATCGGCGCAGT
GTCTCATAGTTCAAGCTGCTTTGGGCAGAAGATAGACCGGATCGGCGCAGT
TCAGTCGCTTGGGCTGTGACGG
TCAGTCGCTTGGGCTGTGACGG
TCAGTCGCTTGGGCTGTGACGG
Exon 3 (2168-2184)
Rattus norvegicus GCTGAGGTTGTTTTAG 
WKY(gu) GCTGAGGTTGTTTTAG
SHRSP(Gia) GCTGAGGTTGTTTTAG
Figure 6.3 The sequences of the coding regions of Bnp in the Glasgow SHRSP and 
WKY compared with the rat Genbank sequence for Rattus norvegicus (M60266).
function. As a consequence the Anp and Bnp genes are not supported by the current data 
as candidates for the QTL causing a difference in cerebral infarct size between SHRSP 
and WKY.
Despite the absence of nucleotide differences between SHRSP and WKY there were four 
substitutions (two silent) within exon 2 of the Anp gene compared with the rat sequences 
entered into Genbank. One of these substitutions, the G —> A substitution at position 
1125 resulting in a serine instead of glycine has been previously reported to be present in 
the SHRSP(Heideibcrg) by Rubattu et al (1997). They suggested that this substitution 
together with their observation of a 3 fold lower expression of Anp mRNA in the brain of 
SHRSP(Hdi) as compared to SHR(Hdi) was consistent with a putative role for Anp in the 
pathogenesis of cerebrovascular disease in the SHRSP. Indeed, based on this animal 
work Rubattu et al (1998) have recently presented preliminary data describing the 
association of a G —> A transition at position 664 in exon 1 of the human ANP gene with 
a 2-fold increase in the incidence of stroke, suggesting these findings are consistent with 
a direct contributary role of the ANP gene to the pathogenesis of stroke in humans.
This hypothesis is not supported by the current study where coding sequences of both 
Anp and Bnp genes were identical between the Glasgow SHRSP and the non-infarcting 
WKY strain. In addition, Brosnan et al (1998) identified that the brain mRNA expression 
of both Anp and Bnp did not differ between the Glasgow SHRSP and the WKY prior to, 
or 24 hours after, occlusion of the middle cerebral artery.
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The positive evidence for Anp as a candidate for stroke in both the rat and human 
(Rubattu et al, 1997 & 1998) against the present study’s negative data in the rat could 
perhaps be most simply explained by the different nature of the stroke phenotype being 
studied. The major phenotype used in the current study is the volume of infarction 
following permanent occlusion of the middle cerebral artery, whereas Rubattu et al 
(1996, 1997 & 1998) are considering both spontaneous ischaemic and haemorrhagic 
stroke. It follows that the candidate genes for each phenotype might be different despite 
the two QTLs being localised on rat chromosome 5. Indeed it is conceivable that the 
relatively large QTLs identified by the genome wide scanning strategy contain more than 
one gene causally linked to the phenotype under study.
These discrepancies between the current study and rat data presented by Rubattu et al
(1997) could also be explained by differences between colonies and diet. It has been well 
established by both biochemical genetic markers (Matsumoto et al, 1991) and DNA 
fingerprinting techniques (Samani et al, 1989; Kurtz et al, 1989; Nabika et al, 1991) that 
genetic heterogeneity between WKY and SHRSP from different sources exists, a fact 
which must be borne in mind when making any comparison of experimental results 
obtained between groups. Alternatively, the Japanese style diet (high in sodium and low 
in potassium and protein) utilised by Rubattu et al (1997) to induce spontaneous stroke 
in their SHRSP may provide a major contribution to endothelial dysfunction leading to 
spontaneous stroke. Previous studies have shown that salt-induced hypertension in rats 
is associated with endothelial dysfunction which is reversed by antihypertensive 
treatment (Luscher et al, 1987). Indeed, this latter difference may explain why Russo et 
al (1998) in examining vasorelaxant responses to ANP and BNP in aortae, basilar and
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carotid arteries found them to be attenuated in the SHRSP(Hdi) as compared to the 
SHR(Hdi) and the WKY(Hdi), whilst Brosnan et al (1998) demonstrated no differences in 
maximum relaxation to A N P  between the Glasgow SH R S P  and the WKY in the middle 
cerebral artery.
In addition to the negative results of the sequencing, and the mRNA expression and the 
functional studies performed by Brosnan et al (1998) on the Glasgow SHRSP and the 
WKY, it has emerged that the position of the Anp marker in the genetic map obtained in 
Chapter 4 is discordant with other genetic maps (Shepel et al, 1998; Bihoreau et al, 
1997; Rubattu et al, 1996; Klina-Levan et al, 1997). Chapter 4 places this marker central 
to the chromosome, whilst the other maps place it in the telomeric region of rat 
chromosome 5 in the vicinity of the anonymous D5Mghl6 marker. This latter position 
has subsequently been confirmed by Brosnan et al (1998) by utilising two methods of 
physical mapping the relevant region of rat chromosome 5, radiation hybrid analysis and 
fluorescence in situ hybridisation (FISH) on cells isolated from the Glasgow SHRSP and 
the WKY. Whilst the physical placement of the Anp marker outwith the QTL influencing 
susceptibility to cerebral ischaemia in the Glasgow SHRSP does not alter its significance, 
it does serve to largely exclude both Anp and Bnp as candidates for sensitivity to cerebral 
ischaemia. This in turn demonstrates the lessons to be learned from concentrating on a 
single candidate gene within a large chromosomal region with purely statistical evidence 
for linkage, rather than focusing on the construction of the appropriate congenic lines 
and sub-lines in order to narrow down the chromosomal region of interest.
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Several additional candidate genes for stroke have been identified with some relation to 
rat chromosome 5 which may be responsible for large cerebral infarcts in the SHRSP, 
including the potent vasodilator endothelin-2, the glucose transporter Glut-B, and 
elastase-2. However, like ANP and BNP, little evidence exists to warrant their further 
investigation until congenic strains suggest so. Of most interest perhaps is 
methylenetetrahydrofolate reductase (MTHFR) which catalyses the conversion of 5,10 
methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine 
remethylation to methionine. The Mthjr gene has been mapped to the chromosomal 
region lp36.3 in human and the distal region of mouse chromosome 4, syntenic regions 
with rat chromosome 5 (Goyette et al, 1998). Mild MTHFR deficiency (35-50% of 
control values) is present at a high frequency in the general population and is associated 
with mild hyperhomocysteinemia, which frequently leads to ischaemic stroke in young 
adults (Engbersen et al, 1995; Frosst et al, 1995). Indeed, one common variant in the 
Mthjr gene has been weakly implicated in occlusive vascular disease and in patients with 
transient ischaemic attack or minor stroke (Frosst et al, 1995; Lalouschek et al, 1998) 
suggesting the need for more research in this area.
Of similar interest to Mthjr, the total genome scan produced by Rubattu et al (1996) 
revealed that the QTL on rat chromosome 5 showed an epistatic interaction with that on 
chromosome 1, the interaction term accounting for an additional 3% of the phenotypic 
variance. It has emerged that a strong candidate gene within this region of rat 
chromosome 1 is adrenomedullin (personal communication - Klaus Lindpaintner, 
Boston). This is a recently discovered peptide that was initially identified from human 
pheochromocytoma (Kitamura et al, 1993) and exhibits potent vasodilator activity in
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vitro and in vivo (Ishiyama et al, 1993; Nuki et al, 1993; Perret et al, 1993). Not only 
does adrenomedullin produce substantial dilatation of cerebral arterioles in vivo (Lang et 
al, 1997), Wang et al (1995) have reported both the upregulation of adrenomedullin 
mRNA expression and peptide production following experimentally induced focal 
cerebral ischaemia and the exacerbation of focal ischaemic injury following 
intracerebroventricular administration of adrenomedullin. Whilst recent research argues 
the opposite finding (Dogan et al, 1997) both studies suggest a significant role for 
adrenomedullin in the evolution of stroke. Indeed, ANP has been shown to increase 
adrenomedullin four-fold in the circulation of healthy humans (Vesely et al, 1996), 
suggesting that effects previously attributed to ANP may actually be partially due to 
adrenomedullin, especially as all the described effects are similar to those of ANP 
(Vesely, 1992).
In conclusion, whilst there may be unidentified regulatory regions either located in the 5^ - 
end or the 3 -^end, or in the intronic regions of Anp and Bnp genes which could still be 
potentially important in differentially regulating the Anp and Bnp gene expression 
between the two rat strains, the sequencing data obtained in the present study, the 
functional data of Brosnan et al (1998), and the discordant genetic map strongly suggest 
that any further research into Anp and Bn^ would be presumptive and only warranted if 
subsequent congenic strains suggest so. Indeed, despite the preliminary human data of 
Rubattu et al (1998) and the knowledge for many years that plasma levels of both BNP 
and ANP increase substantially with ventricular hypertrophy in malignant hypertension 
(Kohno et al, 1987 & 1994), abnormalities of genes for the natriuretic peptides or their 
receptors have not historically been strongly linked to cardiovascular
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disease in human study (Wilkins et al, 1997). Furthermore, as ischaemia and the resulting 
hypoxia and oedema have been shown to be some of the strongest stimuli for gene 
induction in the brain, with more than 80 different mRNAs having been found to be 
induced by brain ischaemia so far, any candidate approach is potentially hazardous and 
time-wasting (Koistinaho & Hokfelt, 1997). It follows that the current study clearly 
illustrates the correct research route towards the ultimate positional cloning of the true 
gene(s) involved in susceptibility to experimentally induced cerebral ischaemia; namely 
the construction of appropriate congenic strains as in Chapter 5, aided by physical 
mapping of the specific chromosomal region.
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7. GENERAL DISCUSSION
Essential hypertension and its complications in man, such as stroke and left ventricular 
hypertrophy, are due to the interaction of many genes and environmental factors. 
Previously used strategies such as linkage analysis in families segregating for rare 
Mendelian forms of these conditions or exploration of candidate genes have had a limited 
success in identifying their major genetic determinants. The methodological difficulties in 
directly studying genetic determinants of such complex traits have given a major impetus 
for the development of similar but inherently simpler paradigms in experimental animal 
models. In particular crosses between hypertensive and a normotensive inbred rat strains 
have begun to yield chromosome regions containing QTLs for blood pressure and its 
related phenotypes.
The research described in this thesis incorporated the use of two genome wide scans 
combined with high fidelity phenotyping to identify QTLs containing genetic 
determinants of hypertensive cardiovascular and cerebrovascular disease in F2 crosses 
derived from the Glasgow colonies of SHRSP and WKY. The first genome scan 
{Chapter 3) identified three blood pressure QTLs: two on rat chromosome 2 and one on 
rat chromosome 3. It also identified a QTL for left ventricular hypertrophy on rat 
chromosome 14. The second scan {Chapter 4) identified a highly significant QTL on rat 
chromosome 5 for the increased sensitivity to experimentally induced focal cerebral 
ischaemia.
There were several features of these QTL mapping strategies which make them 
particularly appropriate for congenic production, fine genetic mapping and ultimately 
positional cloning of the causal genes. Firstly, in contrast to previous studies which used
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male F2s only, both males and females were analysed which allowed the first 
identification of sex specific blood pressure QTLs. Secondly, the use of the radio­
telemetry system for physiological monitoring, and the experimental occlusion of the 
middle cerebral artery, were the first in an F2 population, thereby providing the means 
for the high fidelity phenotyping of subsequent congenic strains and sub-strains. Thirdly, 
the identification of blood pressure independent QTLs for “sub-phenotypes” of 
hypertension illustrated the existence of separate genetic factors, an appreciation of 
which will be essential if a full understanding of the genetics of hypertension and its 
vascular complications is to be achieved. Finally, the current study is the first to have 
established the applicability of a speed congenic strategy in the rat (Chapter 5) with 
which to quicken the dissection of the QTLs identified.
Given the results of the current study, the demonstrable predisposition of the rat for high 
fidelity phenotyping and the rapidly increasing availability of appropriate genetic 
resources for the rat, including dense genetic and physical maps, YACs, BACs, PACs, 
cosmids and bacteriophage clones, there can be little doubt that these QTLs will be 
completely dissected given time and a continued advancement in methodology (Rapp & 
Deng, 1995). However, it has been hotly debated over the last few years whether the 
genetic information obtained in these inbred animal models will be directly applicable to 
human cardiovascular disease (Dominiczak & Frohlich, 1996). For example, whilst the 
information on the chromosomal regions containing QTLs can be used to examine 
candidate genes in both rats and humans, very little success has been made in taking this 
approach, as demonstrated by the examination of the genes encoding Anp and Bnp in 
Chapter 6.
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Fortunately, a recent strategy based on the assumption that like many other genes, QTLs 
are likely to be conserved between species during the course of evolution, has had some 
success in transferring the common or reproducible rat QTLs to candidate regions for 
human essential hypertension. For example, by utilising the major rat QTL on 
chromosome 10 (Hilbert et al, 1991; Jacob et al, 1991) to investigate the homologous 
region on human chromosome 17 in familial essential hypertension (518 affected sib- 
pairs) Julier et al (1997) found strong evidence for linkage with two microsatellite 
markers (D17S183 and D17S934) v/hich are 18cM proximal to the ACE gene {Figure 
7.1). Whilst the final identification of the gene or genes responsible will require a 
systematic investigation of the region in both species, this study illustrates the potential 
of using reproducible rat QTLs as candidate regions for polygenic human disorders. It 
also serves to validate the performance of genetic studies in experimental models of 
hypertensive cardiovascular disease. Indeed, combining the use of all the complementary 
genetic resources available for the human, mouse and rat can only enhance the 
productivity of this strategy, and will become even more productive on the completion of 
The Human Genome Project.
A further inter-relationship between human and experimental genetics is likely to include 
pharmacogenetic approaches. It has been recognised for several years that the 
heterogeneity of essential hypertension extends to the blood pressure response to 
hypotensive medication. Moreover, at least part of this variability is genetic as 
documented by the resistance of some racial sub-groups to particular classes of 
hypotensive drugs. Several studies showed that compared to white subjects, black 
hypertensives show a much poorer response to treatment with angiotensin converting
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Figure 7.1 Comparative mapping of the blood pressure QTL on rat chromosome 10 
(adapted from Julier et al, 1997). Markers D178183'^ and D17S934* on human 
chromosome 17 indicate the significant area of linkage to essential hypertension.
enzyme inhibitors or beta blockers (Materson et al, 1993). Vincent et al (1997) studied 
the cosegregation of genetic loci with acute cardiovascular responses to drugs involved 
in the renin-angiotensin system, the sympathetic nervous system and calcium metabolism 
in the Lyon model of genetic hypertension. A QTL was identified and mapped on rat 
chromosome 2 that influenced systolic and diastolic blood pressure responses to the 
administration of a dihydropyridine calcium antagonist. These findings provide strong 
support for the contention that genetic factors may influence the response to hypotensive 
drugs. This may ultimately lead to the successful treatment of patients with drugs that 
will control blood pressure at very low doses and with great tolerability by being 
specifically targeted to the genetic defect, or its pathway.
In conclusion, the successful dissection of the QTLs identified in this study as involved in 
the pathogenesis of hypertension, left ventricular hypertrophy and the severity of cerebral 
ischaemia in the SHRSP should allow, via congenic strains, positional cloning and 
comparative mapping to human chromosomes, the translation of this information from 
the experimental model to human cardiovascular and cerebrovascular disease, as well as 
an increased understanding of the pathological pathways involved. This will in turn 
hopefully improve prospects for the prevention and/or improved treatment of these 
complex traits which are the major causes of morbidity and mortality in the UK.
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APPENDIX I
Reagents Source
Agarose
Ammonium persulphate
AmpliTh^ DNA polymerase
Bromophenol blue
Buffer tablets
Cellulose patchs
Chloroform
Cidex
Concentrated hydrochloric acid 
Cresol Red 
Decon 75
dNTPs/deoxynucleoside triphosphates 
ddNTPs/dideoxynucleoside triphosphates 
Dimethyl sulfoxide 
EDTA
100% Ethanol
Ethidium bromide
Formamide
Fluothane
Glacial acetic acid
Haematoxylin-eosin stain
Hybond-N^ membrane
Isoamylalcohol
Isopentane
lOX kinase buffer
Magnesium chloride/MgCli
Mineral Oil
[a-^^P]dCTP
[y-” P]dATP
Phenol, water-saturated in Tris buffer
Powered milk
Proteinase K
0.9% Saline
20X SSC
SDS (sodium dodecyl sulphate) powder 
20% SDS
SequaGel Sequencing System
Sigmacote
Sodium acetate
Sodium chloride
Sodium hydroxide pellets
Stop solution
Sucrose
T4 polynucleotide kinase
Gibco BRL 
BDH
Perkin-Elmer
Sigma
BDH
Data Sciences Int.
Fisher Scientific 
Johnson & Johnson 
BDH 
Aldrich
Decon Laboratories Ltd.
Promega
Perkin-Elmer
Sigma
Bio-Rad
Joesph Hills
Sigma
BDH
Zeneca Ltd.
Fisher Scientific 
Surgipath (Europe) Ltd. 
Amersham 
BDH
Fisher Scientific
Promega
Promega
Sigma
Amersham
Amersham
Life Sciences
Premier Beverages
Sigma
Baxter
National Diagnostics
Bio-Rad
Bio-Rad
National Diagnostics
Sigma
Sigma
Fisher Scientific 
Fisher Scientific 
Perkin-Elmer 
Fisher Scientific 
Perkin-Elmer
Taq DNA polymerase Promega
Tartrazine Sigma
lOXTBE National Diagnostics
TEMED Sigma
Terminal deoxynucleotidyl transferase/TdT Promega
TdT buffer Promega
lOX Thermophilic buffer Promega
Tris base Bio-Rad
UITma DNA polymerase Perkin-Elmer
VetBond 3M Animal Care Products
Xylene cyanol Sigma
Solutions
1. 10% Ammonium Persulphate (lOmB
Ig APS dissolved in 10ml sterile distilled water. Store at 4°C.
2. Chloroform Isoamvlalcohol mixture (250ml)
240ml chloroform mixed with 10ml isoamylalcohol. Store at 4°C wrapped in light 
resistant bottle.
3. 2.5mM dNTPs (200u)
5 pi each of dGTP, dATP, dTTP and dCTP (all provided in lOOmM stock solutions) 
added to 180pl sterile distilled water. Store frozen.
4. 0.5M EDTA.pH 8.0(lU
186.1g EDTA dissolved in IL sterile distilled water. pH adjusted with sodium hydroxide 
pellets. Sterilised by autoclave.
5. 70% Ethanol (lOOmB
70ml 100% ethanol mixed with 30ml sterile distilled water.
6. 2X Formamide Loading Buffer (lOmB
9ml formamide, 160pl bromophenol blue, 160pl xylene cyanol, 680pl sterile distilled 
water. Store at 4°C.
7. PCR Master Mix (lOpl. n=ll
Contains 4pl 5X Red, 2pl lOX recommended thermophilic buffer, 1.2pl 25mM MgCl%,
1.1 pi 2.5mM dNTPs, 1.6pl sterile distilled water and and O.OSpl Taq polymerase. The 
Taq was added immediately prior to the PCR reaction to avoid dénaturation. Can be 
stored frozen until required.
8. Phenol choroform isoamvlalcohol (2Q0ml)
100ml water saturated phenol mixed with 100ml chloroform isoamylalcohol mixture. 
Store at 4°C in light resistant bottle.
9. 8% Polvacrvlamide Gel Mix (lOOml)
32ml SequaGel concentrate, 58ml SequaGel diluent, and 10ml SequaGel buffer mixed 
together.
10. Post-Hvbridisation Wash Solution (ILl
10ml 20% SDS, 20 X SSC and 890ml sterile distilled water mixed together.
11. Primer Solution f5ul. n=D
0.8pl of each 6 pM primer (A and B) mixed with 3.4pl sterile distilled water. Final 
addition of a few particles of tartrazine to aid identification. Can be stored frozen until 
required.
12. 5XRednOml^
6.5g sucrose dissolved in 10ml sterile distilled water. Addition of Ipl cresol red for 
colour. Store at 4°C.
13. 0.4% SDS r500mB
2g SDS powder dissolved in 500ml sterile distilled water by heating to 68°C in 
microwave.
14. 10% SDS (ID
500ml 20% SDS mixed with 500ml sterile distilled water.
15. 3M Sodium Acetate. pH 6.0 (IL)
408.1g sodium acetate dissolved in IL of sterile distilled water. pH adjusted with glacial 
acetic acid. Sterilised by autoclave.
16. 1% Sodium Chloride (ID
lOg sodium chloride dissolved in IL sterile distilled water.
17. 4M Sodium Chloride
117g sodium chloride dissolved in 500ml sterile distilled water. Sterilised by autoclave.
18. 0.4M Sodium Hydroxide HL")
16g sodium hydroxide pellets dissolved with stirring in IL sterile distilled water.
19. 2 X SSC fULl
100ml 20 X SSC mixed with 900ml sterile distilled water.
20. Suspension Buffer (500ml)
25ml IM Tris (pH 8.0), 100ml 0.5M EDTA (pH 8.0), and 375ml sterile distilled water 
mixed together.
21. I X T B E r i L ^
100ml lOX TBE mixed with 900ml sterile distilled water.
22. TE gOml)
200|j.l IM Tris (pH 8.0), 40|il 0.5M EDTA (pH 8.0), and 19.76ml sterile distilled water 
mixed together.
23. IM Tris. pH 8.0 (ID
121.1 g Tris base dissolved in IL sterile distilled water. pH adjusted with concentrated 
hydrochloric acid. Sterilised by autoclave.
24. Working Tail Solution (20ml^
1ml IM Tris (pH 8.0), 100ml 0.5M EDTA (pH 8.0), 1ml 10% SDS and 14ml sterile 
distilled water mixed together.
APPENDIX II
Chromosome 2 Primers
M a r k e r P r im e r  S e q u e n c e s T m  ( ° C ) S i z e  (b p ) M g " *
( m M )
D 2 M g h l 2 L  -  A A T A A C C A A T A A A g g A C A T g C T C C  
R  -  A g g A g g A A A A g A g T T g A g T C C C
6 0 - 5 5 1 5 6 1 .5
D 2 W o x 5 ,
R C A 5 1 .0 3
L  -  C A C T g C T T T T C T C A C C A A A C C  
R  -  C T C T T C T g T T C T C T g T g A g C g
6 0 - 5 5 1 6 0 1 .5
D 2 W o x l 5 ,  
C p b ,  R 1 3 2
L  -  g g T g C T A g T A g A C A A T A A g A T A g A T  
R  -  T T C A T g A g l T i r C A C T g T T T g C
5 5 1 4 5 1 .0
D 2 W o x 3 ,
R C A 1 2 . 4 3 A
L  -  g C C A g C A g g g T T A g A g A g A  
R  -  C T A A g A A A g A A T A T g T g A A g g T T g
5 5 9 2 1 .5
D 2 W o x 9 ,
R C A 5 4 . 0 6
L  -  C T g A g g A C C A A T C A T g T T C A C  
R  -  C C A g g T T A C A g T g A g T T C C
6 3 - 5 8 1 4 6 1 .7 5
D 2 M i t l 4 ,
M i t r 3 6 0
L  -  A T g A g A g g T C A A A g C T T C T C A  
R  -  A g  A C C T  g g g  A C  A g g g T C C T
6 3 - 5 8 1 0 2 1 .5
D 2 M Ü 6 ,
M i t l 5 5
L  -  T g T C A A A g g C A g g A A T C A A C  
R -  A C C C C T T T T g A g A T A g C g C T
5 5 - 5 0 1 9 0 1 .5
D 2 M i t 5 ,
M i t 3 8 2
L  -  C A g C A g g T g g A A A C A A g T C A  
R  -  g g g A g g g A T T T g A T g g A g A T
5 5 - 5 0 1 8 4 1 .5
D 2 M i t 2 1 ,  G c a L  -  g T T g A C T T g A T C C T C T g g C T g  
R  -  g g g A g g g A g T g T C T g T C C A
5 5 X 2 1 5 6 2 . 0
D 2 w o x l 3 ,  F s t ,  
R 2 3 9
L  -  C C T C C T C C A g A g C C T T C A  
R  -  g A g g A A C A T C C A C T T C A g T C C
5 5 X 2 1 8 2 1 .7 5
D 2 M i t 3 ,  
R 3 0 8 ,  M t l p b
L  -  A C A g A C A g A C A A g C A A g g A C  
R  -  C C A A A A T g A g g C T T C T g C A A
6 0 2 0 0 1 .5
D 2 W o x l 9 ,  
R 3 4 ,  P k lr
L  -  C C T T T C T A T g A g g A T g T T C C C  
R  -  C A C C C C C A g T A C A g A g g A g
5 5 X 2 1 3 3 1 .0
Chromosome 3 Primers
M a r k e r P r im e r  S e q u e n c e s T m  ( ° C ) S i z e  (b p ) M g " *
( m M )
D 3 M g h 6 L  -  g C A g A C A A A T g T T C A A T C A A g g  
R  -  C C T T T A C T T C A T C T C C A T T C A A A
5 5 - 5 0 1 0 7 1 .5
D 3 W o x 3 ,  
R C A  0 7 . 1 1
L  -  T C A A G G A T C A A C T g g g A g A T T A g  
R  -  C A C T T C A A g A A T g T g T g C A g g
5 5 - 5 0 1 0 0 1 .5
D 3 W o x 2 ,  
R C A  1 6 .1 1
L  -  C T A A g T A A A T T T C C C T g T C C C  
R  -  g T g g g C A A T g T T C A T g T g
5 8 - 5 3 1 5 2 1 .5
D 3 M g h l 6 L  -  A g T C A g g g C T A T g T A T T g A g A A C C  
R  -  C C T C T g A C C C C T A C A T g g g
5 5 1 2 0 1 .5
D 3 W o x 4 ,
G n a s
L  -  g T T A g g C T T C T g T g g A g T T T g T  
R  -  T g g g A g g T C g g A A T g A C T A T g
5 5 - 5 0 1 7 7 1 .5
D 3 M i t l O ,
M i t 5 4 6
L  -  C A T A C A C A g g C A g g g C T T C T  
R  -  C C T g A A A C T g A g C g T g A A C A
6 0 - 5 5 2 0 9 1 .5
Chromosome 14 Primers
M a r k e r P r im e r  S e q u e n c e s T m
( ° C )
S i z e  (b p ) M g " *
( m M )
D 1 4 W o x l 2 ,
R 4 2 6
L  -  C C A A C T g C T A T g A C A C C A g g  
R  -  A A C T g g g A g T A g T A g g T g A C T T g g
6 0 1 9 4 1 .0
D 1 4 W o x l O ,  
R 5 8 ,  A l b
L  -  T C C n T g g T g A T g A T T A A T A T C A C  
R  -  A T A A g g A T T C T C A g A T g C A A A T g
5 5 9 0 1 .5
D 1 4 M g h 3 ,  D b p L  -  C A A g C A C A C C g T A g T A g A g g g  
R  -  A A T g g C T A g C T A T C T A T T g T g C g
5 5 - 5 0 1 2 0 1 .5
D 1 4 W o x 8 ,  
R 4 3 ,  A f p
L  -  A A g C A T A g C A g T g A A T T g g T g  
R  -  T T C A T C A T C C T T T C A T A A A g g C
6 0 1 5 1 1 .0
D 1 4 W o x l 4 ,  
C s n a ,  R l O l
L  -  A C T T g A T T A C A C A C A C A A A C A C A g A  
R  -  C T T T g C T T T C  r r n A g C C A T T T
5 5 1 2 6 1 .0
Raw Phenotypic Data
Codes are as follows: Cross G refers to  those F2 hybrids (n = 140) with a SHRSP 
grandfather; Cross H  a W KY grandfather. LV/Bod is the left ventricular weight to  body 
weight ratio; mean SBP, mean baseline systolic blood pressure; mean DBP, mean 
baseline diastolic blood pressure; mean PP, mean baseline pulse pressure.
Cross Sex LV/Bod meanSBP
(mmHg)
meanDBP
(mmHg)
meanPP
(mmHg)
G 1 F 4 . 8 1 4 0 . 5 2 9 9 1 . 2 4 4 9 . 2 8 9
G 2 F 2 . 6 6 1 6 9 . 9 8 1 1 1 9 . 7 4 3 5 0 . 2 3 8
G 3 F 2 . 7 9 1 6 4 . 0 9 7 1 1 3 . 5 4 8 5 0 . 5 4 9
G 4 F 2 . 8 1 1 5 2 . 5 8 3 1 0 5 . 1 6 7 4 7 . 4 1 6
G 5 F 2 . 7 1 1 6 5 . 1 5 5 1 1 3 . 5 3 7 5 1 . 6 1 8
G 6 2 . 7 2 1 7 5 . 0 5 6 1 2 1 . 3 6 5 5 3 . 6 9 1
G 7 F 3 . 1 2 2 0 3 . 7 7 9 1 4 2 . 8 7 6 6 0 . 9 0 3
G 8 F 2  8 2 1 6 5 . 5 4 1 1 5 . 2 2 3 5 0 . 3 1 7
G 9 F 2 . 7 3 1 5 0 . 9 9 2 1 0 3 . 3 0 5 4 7 . 6 8 7
G 1 0 M 2 . 3 7 1 6 3 . 9 5 1 1 1 2 . 6 1 1 5 1 . 3 4
G 1 1 M 2 . 6 1 1 7 8 . 0 6 4 1 2 4 . 0 3 1 5 4 . 0 3 3
G 1 2 M 3 . 3 3 1 8 8 . 8 7 5 1 2 9 . 2 7 9 5 9 . 5 9 6
G 1 3 M 3 . 1 6 1 9 5 . 7 9 4 1 3 7 . 5 1 3 5 8 . 2 8 1
G 1 4 M 3 . 3 1 8 9 . 0 9 4 1 2 7 . 5 8 3 6 1 . 5 1 1
G 1 5 M 3 . 2 2 2 0 0 . 1 6 2 1 3 7 . 8 5 4 6 2 . 3 0 8
G 1 6 M 2 . 7 9 1 9 4 . 0 3 9 1 3 4 . 6 1 4 5 9 . 4 2 5
G 1 7 F 3 . 3 1 6 1 . 8 9 2 1 1 0 . 8 8 5 5 1 . 0 0 7
G 1 8 F 3 . 5 1 7 1 . 1 8 8 1 1 7 . 2 4 5 5 3 . 9 4 3
G 2 1 M 3 . 2 2 1 6 7 . 9 5 5 1 1 6 . 3 2 2 5 1 . 6 3 3
G 2 2 M 2 . 7 6 1 7 7 . 6 6 5 1 2 2 . 8 2 5 5 4 . 8 4
G 4 3 F 3 . 6 8 1 4 8 . 5 1 5 9 7 . 5 7 3 5 0 . 9 4 2
G 4 4 F 3 . 0 7 2 2 3 . 0 1 1 5 9 . 2 2 2 6 3 . 7 8 8
G 2 6 F 3 . 6 9 1 7 7 . 6 1 9 1 3 0 . 5 5 6 4 7 . 0 6 3
G 2 7 F 2 . 8 1 4 8 . 1 4 9 9 6 . 4 2 8 5 1 . 7 2 1
G 2 8 F 4 . 0 5 1 9 3 . 3 3 2 1 3 6 . 5 9 4 5 6 . 7 3 8
G 3 0 F 2 . 7 4 1 6 5 . 6 0 6 1 1 5 . 6 8 8 4 9 . 9 1 8
G 3 2 F 2 . 9 2 1 6 4 . 5 7 1 1 3 . 7 1 3 5 0 . 8 5 7
G 3 3 F 3 . 5 1 1 7 1 . 5 8 1 1 5 . 2 9 3 5 6 . 2 8 7
G 3 4 M 2 . 7 1 8 3 . 2 2 3 1 2 7 . 5 7 1 5 5 . 6 5 2
G 3 5 M 2 . 6 9 1 7 1 . 9 4 2 1 1 6 . 9 0 3 5 5 . 0 3 9
G 3 6 M 3 . 2 2 2 2 0 . 7 7 6 1 5 4 . 0 3 3 6 6 . 7 4 3
G 3 7 M 3 1 9 6 . 7 6 2 1 3 5 . 3 7 7 6 1 . 3 8 5
G 3 9 M 2 . 7 7 1 7 6 . 5 0 1 1 2 0 . 9 4 7 5 5 . 5 5 4
G 4 0 M 2 . 6 1 7 0 . 6 2 7 1 1 5 . 7 5 6 5 4 . 8 7 1
G 4 1 M 2 . 6 5 2 0 0 . 0 2 1 4 0 . 7 5 4 5 9 . 2 6 6
G 4 5 F 3 . 6 6 1 6 4 . 1 4 3 1 1 1 . 5 4 8 5 2 . 5 9 5
G 4 6 F 3 . 3 3 1 7 8 . 9 5 4 1 2 2 . 8 3 3 5 6 . 1 2 1
G 4 8 M 3 . 1 4 1 8 2 . 1 0 2 1 2 2 . 3 3 4 5 9 . 7 6 8
G 4 9 M 3 . 0 8 1 9 3 . 8 3 9 1 2 9 . 9 6 3 . 9 3 9
G 5 0 M 2 . 5 8 1 7 2 . 8 4 2 1 2 0 . 1 2 6 5 2 . 7 1 6
G 5 1 F 3 . 4 1 6 2 . 1 5 1 0 9 . 8 1 2 5 2 . 3 3 8
G 5 2 F 3 . 4 3 1 7 6 . 3 5 8 1 1 7 . 4 5 9 5 8 . 8 9 9
G 5 3 F 2 . 7 3 1 5 1 . 3 8 4 1 0 4 . 6 3 9 4 6 . 7 4 5
G 5 4 M 3 . 2 7 1 9 6 . 2 3 1 1 3 4 . 6 3 4 6 1 . 5 9 7
G 5 5 M 2 . 7 9 1 8 1 . 3 6 5 1 2 2 . 2 5 9 . 1 6 5
G 5 7 F 3 . 0 6 1 5 6 . 8 4 7 1 0 8 . 1 5 2 4 8 . 6 9 5
G 5 8 F 2 . 9 1 1 6 2 . 2 1 8 1 1 0 . 9 9 7 5 1 . 2 2 1
H 1 M 2 . 4 1 7 5 . 1 3 8 1 1 6 . 1 5 5 5 8 . 9 8 3
H 2 M 2 . 6 6 1 6 3 . 4 8 5 1 0 9 . 3 6 3 5 4 . 1 2 2
H 3 F 3 .1 1 6 4 . 9 2 9 1 1 2 . 3 1 1 5 2 . 6 1 8
H 4 M 2 . 4 2 1 6 6 . 2 2 3 1 1 6 . 6 5 5 4 9 . 5 6 8
H 5 M 2 . 6 4 1 6 2 . 1 1 1 1 1 . 8 3 7 5 0 . 2 7 3
H 6 M 2 . 9 9 1 6 9 . 6 6 7 1 1 5 . 4 2 9 5 4 . 2 3 8
H 7 M 2 . 7 1 7 7 . 0 5 6 1 2 4 . 3 1 1 5 2 . 7 4 5
H 8 M 2 . 5 2 1 6 8 . 4 9 9 1 1 7 . 4 6 9 5 1 . 0 3
H 9 F 3 1 6 3 . 6 4 1 1 1 7 . 9 8 7 4 5 . 6 5 4
H 1 0 M 2 . 6 2 1 7 0 . 9 2 4 1 1 9 . 2 6 4 5 1 . 6 6
H 1 1 M 2 . 8 3 1 9 4 . 4 1 3 2 . 6 1 9 6 1 . 7 8 1
H 1 2 M 3 . 2 8 1 7 4 . 8 5 7 1 1 4 . 6 4 1 6 0 . 2 1 6
H 1 3 F 2 . 8 3 1 5 3 . 6 0 7 1 0 2 . 7 9 5 0 . 8 1 7
H 1 4 F 2 . 8 2 1 6 2 . 7 7 1 1 0 . 2 2 8 5 2 . 5 4 2
H 4 1 M 2 . 5 7 1 6 6 . 1 2 5 1 1 2 . 0 4 4 5 4 . 0 8 1
H 4 2 M 2 . 5 7 1 7 5 . 7 9 5 1 1 9 . 4 3 5 6 . 3 6 5
H 1 7 F 2 . 7 9 1 6 3 . 4 1 7 1 1 1 . 3 4 4 5 2 . 0 7 3
H 1 8 F 2 . 7 7 1 6 1 . 9 2 4 1 1 2 . 9 2 8 4 8 . 9 9 6
H 1 9 F 2 . 4 1 4 6 . 7 5 8 1 0 2 . 1 0 9 4 4 . 6 4 9
H 2 0 M 2 . 3 1 1 6 1 . 7 7 9 1 1 2 . 8 4 4 8 . 9 3 9
H 2 1 M 2 . 6 8 1 8 9 . 3 7 5 1 2 7 . 6 6 7 6 1 . 7 0 8
H 2 2 F 2 . 5 8 1 5 2 . 4 4 1 0 6 . 0 0 8 4 6 . 4 3 2
H 2 3 F 2 . 3 3 1 3 9 . 1 0 3 9 9 . 8 3 3 9 . 2 7 3
H 2 4 F 2 . 4 6 1 5 3 . 1 2 3 1 0 7 . 0 2 9 4 6 . 0 9 4
H 2 5 F 2 . 5 9 1 4 9 . 6 7 4 1 0 1 . 5 3 8 4 8 . 1 3 6
H 2 8 M 2 . 6 8 1 7 2 . 8 1 2 1 1 6 . 7 8 8 5 6 . 0 2 4
H 2 9 M 1 . 9 7 1 6 8 . 9 1 2 1 1 4 . 6 7 2 5 4 . 2 4
H 3 0 M 2 . 7 1 7 9 . 6 8 6 1 1 8 . 3 9 8 6 1 . 2 8 8
H 3 1 M 2 . 3 1 1 6 7 . 4 4 4 1 1 4 . 5 8 8 5 2 . 8 5 6
H 3 2 F 2 . 2 9 1 6 5 . 3 5 2 1 1 0 . 3 6 8 5 4 . 9 8 4
H 3 3 F 2 . 4 3 1 5 1 . 8 5 2 1 0 5 . 4 9 4 4 6 . 3 5 8
H 3 4 M 2 . 3 4 1 6 5 . 2 6 1 1 4 . 5 9 8 5 0 . 6 6 2
H 3 5 F 2 . 7 1 5 3 . 9 7 1 0 8 . 8 6 4 4 5 . 1 0 6
H 3 6 F 2 . 8 3 1 7 2 . 3 0 8 1 2 0 . 1 2 8 5 2 . 1 8
H 3 7 F 2 . 3 6 1 6 2 . 7 8 4 1 1 3 . 3 4 9 4 9 . 4 3 5
H 3 8 F 2 . 5 7 1 5 4 . 0 6 9 1 0 4 . 5 7 4 4 9 . 4 9 5
H 3 9 F 2 . 7 6 1 5 8 . 4 2 9 1 0 8 . 6 7 8 4 9 . 7 5 1
H 4 0 F 2 . 8 1 1 7 5 . 4 2 2 1 1 8 . 9 5 5 5 6 . 4 6 7
H 4 3 2 . 2 2 1 5 6 . 5 6 4 1 0 9 . 0 5 9 4 7 . 5 0 5
H 4 4 F 3 . 0 4 1 6 5 . 1 4 3 1 1 4 . 0 0 3 5 1 . 1 4
H 4 5 F 2 . 6 7 1 6 1 . 4 4 9 1 1 0 . 4 3 8 5 1 . 0 1 1
H 4 6 F 2 . 3 2 1 6 0 . 0 9 8 1 1 2 . 8 4 3 4 7 . 2 5 5
H 4 7 F 2 . 4 8 1 6 6 . 7 3 9 1 2 2 . 0 4 7 4 4 . 6 9 2
H 4 8 2 . 7 9 1 4 2 . 9 2 4 1 0 1 . 5 3 6 4 1 . 3 8 8
H 4 9 2 . 7 3 1 8 2 . 6 3 4 1 0 9 . 7 2 8 7 2 . 9 0 6
H 5 0 F 2 . 3 6 1 4 3 . 9 1 3 9 5 . 7 0 9 4 8 . 2 0 4
H 5 1 F 2 . 4 2 1 5 7 . 1 2 5 1 0 8 . 2 2 1 4 8 . 9 0 4
G 5 9 F 2 4 8 . 2 6 7 1 7 6 . 4 0 7 7 1 . 8 6
G 6 0 F 3 .1 1 5 3 . 7 3 4 1 0 5 . 2 9 4 8 . 4 4 4
G 6 1 F 3 . 3 1 3 1 3 0 . 4 9 5 8 2 . 9 0 5 4 7 . 5 9
G 6 2 F 2 . 8 6 6 1 6 8 . 2 7 1 1 3 . 9 2 3 5 4 . 3 4 7
G 6 4 M 2 . 9 0 6 1 6 9 . 0 7 6 1 1 7 . 1 8 3 5 1 . 8 9 3
G 6 5 M 3 . 2 0 8 2 3 2 . 8 2 4 1 6 9 . 0 0 5 6 3 . 8 1 9
G 6 6 M 2 . 7 7 5 1 8 2 . 9 0 6 1 2 5 . 7 6 5 7 . 1 4 6
G 6 7 M 2 . 9 3 8 1 9 1 . 5 7 5 1 3 1 . 6 0 5 5 9 . 9 7
G 6 8 M 2 . 9 2 7 1 8 4 . 4 4 7 1 2 7 . 4 0 4 5 7 . 0 4 3
G 7 1 M 3 . 4 4 8 1 9 5 . 1 5 6 1 3 2 . 8 4 1 6 2 . 3 1 5
H 5 2 M 2 . 2 5 1 6 9 . 5 7 4 1 1 5 . 7 7 5 3 . 8 0 4
H 5 3 M 2 . 4 8 1 7 8 . 8 5 4 1 2 2 . 4 9 6 5 6 . 3 5 8
H 5 5 F 2 . 3 9 1 5 4 . 1 1 8 1 0 7 . 1 8 5 4 6 . 9 3 3
H 5 6 F 2 . 9 5 1 6 2 . 8 1 5 1 1 1 . 4 3 7 5 1 . 3 7 8
H 5 7 F 2 . 6 6 1 5 9 . 8 2 1 1 0 9 . 2 1 5 5 0 . 6 0 6
H 5 8 F 2 . 7 4 1 5 0 . 1 3 7 1 0 2 . 0 8 4 8 . 0 5 7
H 5 9 F 2 . 7 7 1 7 6 . 0 8 7 1 2 3 . 5 9 8 5 2 . 4 8 9
H 6 0 M 2 . 4 2 1 6 7 . 8 9 7 1 1 6 . 8 0 1 5 1 . 0 9 6
H 6 1 M 2 . 6 1 1 6 4 . 3 2 1 1 1 . 9 5 9 5 2 . 3 6 1
H 6 2 M 2 . 4 8 1 8 2 . 7 7 6 1 2 9 . 2 9 2 5 3 . 4 8 4
H 6 3 F 2 . 6 2 1 8 3 . 2 9 7 1 3 0 . 6 5 6 5 2 . 6 4 1
H 6 4 F 2 . 9 3 1 8 4 . 8 2 5 1 3 0 . 3 2 2 5 4 . 5 0 3
H 6 5 M 2 . 4 1 6 2 . 6 7 3 1 1 2 . 6 5 2 5 0 . 0 2 1
H 6 6 F 2 . 3 3 1 4 9 . 8 7 2 1 0 4 . 0 9 9 4 5 . 7 7 3
H 6 7 F 2 . 7 1 1 6 3 . 2 2 7 1 1 3 . 3 6 4 4 9 . 8 6 3
H 6 8 M 2 . 7 3 1 7 8 . 6 9 3 1 2 4 . 2 3 8 5 4 . 4 5 5
H 6 9 M 3 . 1 5 1 6 9 . 0 4 8 1 2 1 . 7 8 4 4 7 . 2 6 4
H 7 0 M 2 . 5 2 1 6 1 . 4 4 2 1 1 4 . 8 4 9 4 6 . 5 9 3
H 7 1 M 2 . 8 5 1 5 0 . 0 2 4 1 0 2 . 8 2 5 4 7 . 1 9 9
H 7 2 M 2 . 4 3 1 4 2 . 9 9 3 1 0 1 . 0 7 9 4 1 . 9 1 4
H 7 3 M 2 . 5 1 1 5 3 . 9 8 5 1 0 6 . 8 4 3 4 7 . 1 4 2
H 8 0 F 2 . 6 9 1 8 1 . 1 1 8 1 2 8 . 4 4 3 5 2 . 6 7 5
H 8 1 F 3 . 0 4 1 9 1 . 8 5 7 1 2 9 . 5 5 3 6 2 . 3 0 4
H 8 2 F 2 . 8 2 1 7 9 . 6 6 7 1 1 9 . 4 3 6 0 . 2 3 7
H 8 8 F 2 . 6 2 1 7 7 . 0 4 9 1 2 3 . 1 2 7 5 3 . 9 2 2
H 7 4 2 . 7 9 1 8 5 . 9 2 3 1 2 6 . 9 7 3 5 8 . 9 5
H 7 5 F 2 . 8 6 1 5 7 . 8 6 6 1 0 9 . 2 6 4 4 8 . 6 0 2
H 7 6 F 2 . 5 2 1 4 4 . 8 6 7 1 0 2 . 6 4 7 4 2 . 2 2
H 7 7 F 2 . 5 9 1 4 7 . 6 0 5 1 0 2 . 3 3 3 4 5 . 2 7 2
H 7 8 F 2 . 9 1 6 5 . 1 0 5 1 1 3 . 9 8 8 5 1 . 1 1 7
H79 F 2.8 166.289 113.328 52.961
H84 F 2.66 137.874 96.994 40.88
H86 F 2.52 153.019 107.574 45.445
H91 F 1.94873 151.7 104.55 47.15
H89 M 2.60888 163.74 112.19 51.55
H90 M 2.59057 151.7 114.84 36.86
Codes are as follows: Cross G refers to those F2 hybrids (n = 140) with a SHRSP
grandfather; Cross H a W KY grandfather; saltMSBP, mean salt-loaded systolic blood
pressure; saltMDBP, mean salt-loaded diastolic blood pressure; saltMPP, mean salt-
loaded pulse pressure.
Cross Sex saltMSBP saltMDBP saltMPP
(mmHg) (mmHg) (mmHg)
G1 F 147.93 100.07 47.86
G2 F 173.3 120 53.3
G3 F 168.56 115.73 52.83
G4 F 163.95 112.8 51.15
G5 F 171.57 117.94 53.63
G6 M 181.96 126.13 55.83
G7 F 211.33 146.46 64.87
G8 F 173.61 119.66 53.95
G9 F 154.98 105.26 49.72
G10 M 168.69 116.4 52.29
G11 M 182.11 125.52 56.59
G12 M 194.9 132.74 62.16
G13 M 209.57 146.95 62.62
G14 M 193.91 130.44 63.47
G15 M 196.82 132.08 64.74
G16 M 204.7 141.06 63.64
G17 F 181.66 126 55.66
G18 F 203 147.03 55.97
G21 M 182.6 128.11 54.49
G22 M 183.01 126.24 56.77
G43 F 159.54 104.61 54.93
G44 F 235.43 166.98 68.45
G26 F 178.47 134.1 44.37
G27 F 153.41 105.07 48.34
G28 F 229.25 162.76 66.49
G30 F 165.65 112.18 53.47
G32 F 167.62 112.33 55.29
G33 F 175.99 115.19 60.8
G34 M 193.36 134.83 58.53
G35 M 177.07 120.62 56.45
G36 M 223.34 155.43 67.91
G37 M 199.14 132.27 66.87
G39 M 177.33 119.71 57.62
G40 M 173.83 117.53 56.3
G41 M 206.23 143.5 62.73
G45 F 170.2 114.64 55.56
G 4 6 F 1 8 1 . 5 6 1 2 2 . 7 2 5 8 . 8 4
G 4 8 M 1 9 9 . 5 3 1 3 4 . 4 6 6 5 . 0 7
G 4 9 M 2 1 8 . 6 1 1 4 7 . 9 7 0 . 7 1
G 5 0 M 1 7 0 . 9 9 1 1 5 . 6 5 5 5 . 3 4
G 5 1 F 1 7 3 . 2 2 1 1 6 . 5 4 5 6 . 6 8
G 5 2 F 1 9 4 . 4 4 1 3 1 . 1 6 3 . 3 4
G 5 3 F 1 5 9 . 6 8 1 1 0 . 6 3 4 9 . 0 5
G 5 4 M 2 4 4 . 0 1 1 7 0 . 6 7 3 . 4 1
G 5 5 M 1 8 9 . 8 5 1 2 7 . 7 1 6 2 . 1 4
G 5 7 F 1 6 6 . 2 1 1 4 . 0 1 5 2 . 1 9
G 5 8 F 1 6 2 . 6 3 1 0 8 . 5 5 5 4 . 0 8
H 1 M 1 8 2 . 4 4 8 1 2 1 . 3 6 6 1 . 0 8 8
H 2 M 1 7 3 . 9 1 1 6 . 3 8 5 7 . 5 2
H 3 F 1 7 0 . 9 8 3 1 1 4 . 6 1 5 6 . 3 7 3
H 4 M 1 6 7 . 8 9 4 1 1 6 . 8 3 5 1 . 0 6 4
H 5 M 1 7 1 . 0 2 3 1 1 8 . 0 1 5 3 . 0 1 3
H 6 M 1 7 4 . 9 6 9 1 1 8 . 2 5 6 . 7 6 9
H 7 M 1 8 0 . 5 0 2 1 2 5 . 2 4 5 5 . 2 6 2
H 8 M 1 7 7 . 2 1 1 2 3 . 5 9
H 9 F 1 6 6 . 4 4 1 1 5
H 1 0 M
H 1 1 M 1 9 7 . 2 4 1 3 1 . 1 6 6 . 1 4
H 1 2 M 1 8 0 . 0 5 1 1 8 . 2 7 6 1 . 7 8
H 1 3 F 1 5 4 . 6 9 9 . 6 4 5 4 . 9 6
H 1 4 F 1 7 0 . 4 3 1 1 5 . 4 5 5 . 0 3
H 4 1 M 1 7 1 . 4 1 1 1 5 . 3 8 5 6 . 0 3
H 4 2 M 1 8 4 . 2 9 1 2 6 . 1 4 5 8 . 1 5
H 1 7 F 1 7 1 . 5 8 1 1 6 . 2 9 5 5 . 2 9
H 1 8 F 1 7 1 . 9 2 1 1 6 . 8 8 5 5 . 0 4
H 1 9 F 1 5 1 . 3 5 1 0 5 . 2 2 4 6 . 1 3
H 2 0 M 1 6 7 1 1 6 . 3 9 5 0 . 6 1
H 2 1 M 1 9 9 . 7 4 1 3 5 . 8 4 6 3 . 9
H 2 2 F 1 6 0 . 8 5 1 0 9 . 0 1 5 1 . 8 4
H 2 3 F 1 4 2 . 8 3 9 9 . 8 2 4 3 . 0 1
H 2 4 F 1 6 1 . 8 8 1 1 1 . 9 3 4 9 . 9 5
H 2 5 F 1 5 8 . 5 8 1 0 6 . 1 5 5 2 . 4 3
H 2 8 M 1 8 9 . 7 1 1 2 9 . 9 7 5 9 . 7 4
H 2 9 M 1 8 3 . 3 1 1 2 4 . 1 5 9 . 2 1
H 3 0 M 1 9 6 . 1 8 1 3 2 . 3 2 6 3 . 8 6
H 3 1 M 1 8 1 . 1 9 1 2 5 . 5 3 5 5 . 6 6
H 3 2 F 1 6 9 . 3 1 1 2 . 1 4 5 7 . 1 6
H 3 3 F 1 6 3 . 6 1 1 1 2 . 3 3 5 1 . 2 8
H 3 4 M 1 7 0 . 3 7 1 1 7 . 7 8 5 2 . 5 9
H 3 5 F 1 6 4 . 0 9 1 1 4 . 4 6 4 9 . 6 3
H 3 6 F 1 8 0 . 3 4 1 2 4 . 3 4 5 6
H 3 7 F 1 6 8 . 4 1 1 1 7 . 2 2 5 1 . 1 9
H 3 8 F 1 5 9 . 3 5 1 0 8 . 2 5 5 1 . 1
H 3 9 F 1 6 3 . 2 4 1 0 9 . 4 1 5 3 . 8 3
H 4 0 F 1 8 7 . 2 5 1 2 6 . 5 1 6 0 . 7 4
H 4 3 1 7 1 . 4 8 1 1 6 . 4 9 5 4 . 9 9
H 4 4 F 1 7 0 . 5 1 1 1 5 . 8 9 5 4 . 6 2
H 4 5 F 1 6 9 . 0 7 1 1 5 . 2 4 5 3 . 8 3
H 4 6 F 1 5 7 . 0 2 1 0 7 . 1 2 4 9 . 9
H 4 7 F 1 6 8 . 8 1 2 0 . 5 4 8 . 3
H 4 8 M 1 4 8 . 1 3 1 0 3 . 5 4 4 4 . 5 9
H 4 9 M 1 8 9 . 1 8 1 1 3 . 1 1 7 6 . 0 7
H 5 0 F 1 4 7 . 8 9 9 9 . 0 1 4 8 . 8 8
H 5 1 F 1 5 7 . 8 4 1 0 7 . 6 8 5 0 . 1 6
G 5 9 F 2 7 9 . 4 4 2 0 8 . 5 4 7 0 . 9
G 6 0 F 1 6 5 . 2 4 1 1 3 . 7 5 5 1 . 4 9
G 6 1 F 1 4 0 . 8 8 8 . 8 9 5 1 . 9 1
G 6 2 F 1 6 9 . 8 8 1 1 3 . 3 2 5 6 . 5 6
G 6 4 M 1 7 6 . 3 5 1 2 1 . 1 2 5 5 . 2 3
G 6 5 M 2 3 4 . 6 8 1 6 9 . 9 5 6 4 . 7 3
G G G M 1 8 7 . 5 2 1 3 0 . 5 5 5 6 . 9 7
G 6 7 M 2 0 5 . 5 4 1 4 3 . 4 6 2 . 1 4
G 6 8 M 1 9 2 . 6 2 1 3 5 . 6 2 5 7
G 7 1 M 2 0 9 . 0 8 1 4 3 . 0 5 6 6 . 0 3
H 5 2 M 1 7 0 . 1 2 1 1 5 . 1 7 5 4 . 9 5
H 5 3 M 1 8 3 . 1 3 1 2 3 . 7 5 9 . 4 3
H 5 5 F 1 5 7 . 9 9 1 0 6 . 3 9 5 1 . 6
H 5 6 F 1 6 0 . 7 2 1 0 5 . 8 5 5 4 . 8 7
H 5 7 F 1 6 1 . 6 8 1 0 9 . 3 7 5 2 . 3 1
H 5 8 F 1 4 9 . 0 4 9 8 . 2 5 0 . 8 4
H 5 9 F 1 7 0 . 8 4 1 1 5 . 6 5 5 . 2 4
H 6 0 M 1 7 2 . 2 1 1 1 8 . 8 5 3 . 4 1
H 6 1 M 1 7 4 . 5 7 1 1 9 . 1 5 5 . 4 7
H 6 2 M 1 8 5 . 0 4 1 3 0 . 0 9 5 4 . 9 5
H 6 3 F 1 9 5 . 4 5 1 3 6 . 9 4 5 8 . 5 1
H 6 4 F 1 8 0 . 2 1 1 2 3 . 6 8 5 6 . 5 3
H 6 5 M 1 7 2 . 5 1 1 1 9 . 7 7 5 2 . 7 4
H 6 6 F 1 5 4 . 3 3 1 0 6 . 8 7 4 7 . 4 6
H 6 7 F 1 6 2 . 8 5 1 1 1 . 9 2 5 0 . 9 3
H 6 8 M 1 8 7 . 5 6 1 3 0 . 4 9 5 7 . 0 7
H 6 9 M 1 7 4 . 5 3 1 2 3 . 9 8 5 0 . 5 5
H 7 0 M 1 6 3 . 6 4 1 1 3 . 4 7 5 0 . 1 7
H 7 1 M 1 5 9 . 6 4 1 0 8 . 6 1 5 1 . 0 3
H 7 2 M 1 6 0 . 6 8 1 1 4 . 1 2 4 6 . 5 6
H 7 3 M 1 6 0 . 1 4 1 0 8 . 8 7 5 1 . 2 7
H 8 0 F 1 8 8 . 2 8 1 3 1 . 8 7 5 6 . 4 1
H 8 1 F 2 0 8 . 6 5 1 4 0 . 7 4 6 7 . 9 1
H 8 2 F 1 8 5 . 9 1 2 0 . 9 1 6 4 . 9 9
H 8 8 F 1 9 4 . 0 2 1 3 4 . 9 6 5 9 . 0 6
H 7 4 1 9 7 . 8 2 1 3 6 . 7 3 6 1 . 0 9
H 7 5 F 1 6 5 . 6 6 1 1 3 . 8 9 5 1 . 7 7
H 7 6 F 1 4 8 . 5 7 9 9 . 6 8 4 8 . 8 9
H 7 7 F 1 5 0 . 9 1 0 1 . 9 4 4 8 . 9 6
H 7 8 F 1 6 6 . 1 6 1 1 1 . 0 4 5 5 . 1 2
H 7 9 F 1 8 3 . 0 2 1 2 4 . 5 8 5 8 . 4 4
H 8 4 F 1 4 1 . 4 8 9 6 . 4 9 4 4 . 9 9
H 8 6 F 1 5 6 . 5 1 1 0 6 . 0 3 5 0 . 4 8
H 9 1 F 1 5 6 . 0 5 1 0 6 . 4 3 4 9 . 6 2
H 8 9 M 1 7 2 . 2 7 1 1 8 . 9 9 5 3 . 2 8
H 9 0 M 1 7 2 . 9 2 1 1 8 . 5 8 5 4 . 3 4
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APPENDIX III
Chromosome 5 Primers
M a r k e r P r im e r  S e q u e n c e s T m  ( ° C ) S i z e  (b p ) M g " *
( m M )
D 5 W o x 7 ,
R 1 8 2
L  -  g A C C C T g A C T T g g A A A g T g A A  
R  -  T g T g C A C g g T C T T C A A g g T A
5 0 1 6 9 1 .5
D 5 M g h 6 L  -  C T C A C A A A A C T T g A C T g A A A T T g C  
R  -  T C A A g A T g C T A T g g A A A A g C C
6 0 - 5 5 1 5 5 1 .5
D 5 M i t 2 ,
M i t r 9 8 0
L  -  T C T g C A T T g A A A C T A A T C T A A A T C C  
R  -  T T g C A C A C A T T g g A A T g T C A
6 3 - 5 8 2 0 1 1 .5
D 5 W o x l 6 ,  
R e p 1 9 8
L  -  C A g C C T T C A T T C T C A C A C  
R  -  T g A C T T C T g T g A g C T C C T A C
5 5 - 5 0 1 6 0 1 .5
D 5 M i t 9 ,
M i t 7 3 5
L  -  C T A T g T g C A A A A A C g C A T g C  
R  -  T C A C A g g T A A T g g T A g A A A C g T T
5 0 1 2 7 1 .5
D 5 W o x 4 ,
R C A 1 4 . 1 2
L  -  C C T g C T g T T T C T g A C T C C C  
R  -  A g C A T C C A A g A C T g g g T g C
6 0 - 5 5 1 5 7 1 .5
D 5 W o x l 5 ,
R e p l 4 2
L  -  g g T A g A g g T g A g T g g A A T g A A  
R  -  C C T C C T C A g C T C T g C T A g T C
6 0 - 5 5 1 1 8 1 .5
D S W o x l O ,
A n p ,
R 2 4 1
L  -  g g g A C T g A T A C A T g T g g g T A T g  
R  -  g g T C T C T g T A C C T C A A T g T T g C
5 5 1 6 1 1 .5
D 5 W o x l 4 ,
R e p 5 6
L  -  T g g g T A g g T C g T g T C T T C T C  
R  -  C C T g g T T A g A g g A g g g A g T C
5 5 - 5 0 2 2 7 1 .5
D 5 M g h l 5 L  -  C A C C T C g A C C A A C A C C A A C  
R  -  T T A A T C C C A A C T g T g A C A T T C g
6 0 - 5 5 1 5 9 1 .5
D 5 M g h l 6 L  -  g C A T A C A g C T T T A C A g T g C T g C  
R  -  A g A C A A g g g A C A T g C T C g A g
6 0 - 5 5 1 3 3 1 .5
Raw Phenotypic Data
Codes are as follows: Cross G refers to those F2 hybrids (n = 140) with a SHRSP 
grandfather; Cross H  a WKY grandfather. IHVol is the ipsilateral hemisphere volume; 
CHVol is the contralateral hemisphere volume; InfarctV is the infarct volume; IF/IH is 
the infarct volume expressed as a percentage o f  the ipsilateral hemisphere volume.
Zross Sex Weight
(g)
IHVol
(mm^)
CHVol
(mm^)
InfarctV
(mm^)
IF/IH (»/!
G77 F 200 589.3 547.2 60.5 10.27
G78 F 202 581.6 542.1 55.7 9.58
G79 F 214 680.5 580.7 130.3 19.15
G80 F 193 667.9 558.2 141 21.11
G81 M 318 598.8 507.7 115.7 19.32
G82 M 314 730.9 599.1 188.6 25.8
G83 M 294 653.6 538.6 139.6 21.36
G84 M 294 701.7 585.6 149.1 21.25
G85 M 283 681.1 554.8 225.3 33.08
G86 M 309 697.6 571.9 199.2 28.56
G87 M 322 719 570.6 201.5 28.03
G88 F 213 644.2 535.7 126.5 19.64
G89 F 216 699.3 561.9 142.6 20.39
G90 F 188 640.6 533.5 177 27.63
G91 M 340 777.7 665.1 159.9 20.56
G108 F 187 619.7 552.7 139.4 22.49
G109 F 198 468.9 438.4 40.2 8.57
G112 F 182 746.2 654.3 216 28.95
G113 M 312 705.5 617.4 161.3 22.86
G114 M 287 703.6 584.9 195.6 27.8
G115 M 303 668.2 567.7 148.8 22.27
G116 M 330 676.3 586 98.2 14.52
G117 F 195 701.8 558.1 177.7 25.32
G118 F 184 665.8 562.9 171.5 25.76
G119 F 197 742.4 640 161.6 21.77
G120 F 202 608.2 521.4 138.5 22.77
G121 F 201 733.7 629.2 188.7 25.72
G122 F 184 723 632 120.1 16.61
G123 M 290 767.8 656.9 165.6 21.57
G125 M 290 597.2 518.1 62.7 10.5
G126 M 276 828.2 608.7 332.9 40.2
G127 M 281 654.6 542.4 147.8 22.58
G128 M 300 725.7 543.7 190.6 26.26
G129 M 280 663.3 589.8 152.9 23.05
G130 M 320 620 576.9 32.6 5.26
G131 M 308 621.1 547 147.1 23.72
G132 F 183 657 520.3 208.9 31.8
G133 M 282 683.5 547 240.5 35.19
G134 M 307 661.5 523.9 226.5 34.24
H115 F 198 747.3 627 192.3 25.73
H116 F 197 647.1 539.1 162.2 25.07
H117 F 197 589.7 539.8 53.2 9.02
H118 F 197 574.1 547.4 23.6 4.11
H119 F 215 638.1 576.1 48.5 7.6
H121 F 190 652.8 578.9 103.2 15.81
H122 M 303 764.1 602.2 218.5 28.6
H123 M 308 726.2 585 213.2 29.36
H124 M 308 703.4 604.8 168.2 23.91
H125 M 386 677.8 562.4 197.3 29.11
H126 F 189 644.9 532 186.9 28.98
H131 M 279 614 483.4 165.1 26.89
H132 M 279 649.7 547.5 182.9 28.15
H134 M 288 712.9 599.1 214 30.02
H138 M 276 650.6 560.5 142.3 21.87
H139 M 290 643.1 544.4 190.5 29.62
H140 F 182 684.2 586.3 141.3 20.65
H141 F 215 658.3 530.2 202 30.69
H142 M 271 726.4 595.9 210.1 28.92
H143 M 282 648.1 562.4 169.4 26.14
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APPENDIX IV
New Chromosome 2 Primers
M a r k e r P r im e r  S e q u e n c e s T m  C O S i z e  (b p ) M g " *
( m M )
D 2 R a t l 6 7 L  -  g g T A A C C T g A C A g A T C A C C T C C  
R  -  T C C A A A T T T T C C l T T i ' g g T T T T
55-50 2 1 5 1 .5
D 2 R a t 4 9 L  -  A T C C C T g g T g A g g g A A A A g T  
R  -  C T T A T T g T A T T T A C A T g T g C A C g C
55-50 1 2 5 1 .5
D 2 M i t l 8 ,
M i t 3 8 0
L  -  g g g g A T g T T C T g C T g g T A g A  
R  -  T T C C A A T T C T g g A g g A C C T g
55-50 1 9 8 1 .5
D 2 R a t l 4 L  -  g C T A A A T g g g A C A C C T g g A A  
R  -  A A A C C A A A g T C T g T g g C T C C
55 1 3 9 1 .5
D 2 R a t l 8 L  -  g g A g T g A T C T g T T T C g T A T A A A T g C  
R  -  C T T C T C T T C C T C A C C C T C C C
55 1 2 9 1 .5
D 2 R a t 2 8 L  -  g A g T g C A A A g C C C A g T C T T C  
R  -  C C A C A T g C C T T T C A g T T T C C
55-50 2 3 0 1 .5
D 2 R a t 5 8 L  -  A C T g T A T T C C A C C A C C A C C C  
R  -  T g A A g A C C T T T C g g T g T g T g
55 1 2 5 1 .5
D 2 W o x 2 6 ,  
R 4 0 5 ,  N k a a l b
L  -  T g g C T g T A A T C C C T C A T g g  
R  -  C A g C A C C T g g g A C T C A A g
60 1 9 4 1 .0
D 2 W o x 3 8 ,
R 4 8 7
L  -  T C A g A g g C A g C C A T C A A C  
R  -  T C T A A T A C A T C A g C A C A g g A g C
55-50 2 0 0 1 .0
Background Primers
M a r k e r P r im e r  S e q u e n c e s T m  C O S i z e  (b p ) M g " *
( m M )
D l M i t l 4 L  -  T C T g C C T T C T C A C A T g A A C A  
R  -  T T C C A T C T A C T g C T g T T T A g g g
55-50 1 1 2 1 .5
G V 3 0 L  -  T C T T C C T T T T C T A g C A C T C C A  
R  -  T g T A g g T T g T A T T C g T g T A T g C
60-55 1 4 1 1 .5
D l W o x 3 2 L  -  g C T A C T g C C T T g C C C T C A  
R  -  T C A C A T T T A C C T g T A g T T g g A A
55-50 1 8 8 1 .5
D l M i t l l L  -  A T A A g C C A g C C C C C A T T C  
R  -  C C T A C T g A A A g T g A  A A T g T C T g g
58-53 2 7 5 1 .5
D l M i t l L  -  g g g g A A g T I l T  A g g A A g T C C C  
R  -  A g g g  A A T  g  A A A A T  A C  A A C  A C g C
55-50 1 4 6 1 .5
D 3 M i t 4 L  -  A A A A A A C C A A C C C C C T T C C  
R  -  g C A A A g A g A T g C A A C A T C T g g
6 3 - 5 8 1 9 1 1 .5
D 3 W o x l 4 L  -  g C A T T g C C T g A g T A g g A T g T  
R  -  g T T T g g C T g T A A T T g g C g
5 5 - 5 0 2 6 2 1 .5
D 3 M g h 8 L  -  g C T g A A C g g A T g C T g A g A g  
R  -  g g g A T T C C T A A g A C A g T T g C C
5 5 - 5 0 1 5 6 1 .5
D 3 M g h l 6 L  -  A g T C A g g g C T A T g T A T T g A g A A C C  
R  -  C C T C T g A C C C C T A C A T g g g
5 5 1 2 0 1 .5
G V 8 8 L  -  ggAgCATgTgCmTAATACTT 
R  -  CAggggCTgTggCTgTAA
6 0 - 5 5 1 0 0 1 .5
D 4 M g h l 6 L  -  C A g g A g C T g T C T g g g A C T T C  
R  -  g  A A C  A C T  A g  A g  A A A C T  A g g C  A g g C
6 0 - 5 5 2 5 9 1 .5
D 4 M g h 7 L  -  g A T C C A g C T C A C A T C T A A T C C C  
R  -  C C A A A T g C T C T T g C A g T C A A
6 0 - 5 5 1 4 5 1 .5
D 4 M i t l 4 L  -  A g g A C A g g T T T T T g g g C T T T  
R  -  T C T g C C g C C A C C T T A g A g
5 5 - 5 0 1 5 0 1 .5
N G 5 6 L  -  T g g g T A g g T C g T g T C T T C T C  
R  -  C C T g g T T A g A g g A g g g A g T C
5 5 - 5 0 2 2 7 1 .5
D 5 W o x l 5 L  -  g g T A g A g g T g A g T g g A A T g A A  
R  -  C C T C C T C A g C T C T g C T A g T C
6 0 - 5 5 1 1 8 1 .5
D 5 M g h l 5 L  -  C A C C T C g A C C A A C A C C A A C  
R  -  T T A A T C C C A A C T g T g A C A T T C g
6 0 - 5 5 1 5 9 1 .5
D 5 M g h l 6 L  -  g C A T A C A g C T T T A C A g T g C T g C  
R  -  A g A C A A g g g A C A T g C T C g A g
6 0 - 5 5 1 3 3 1 .5
D 6 W o x 2 1 L  -  T T g A g A A g C g T T A A A A T A T g T g  
R  -  T T g g T T T A C A g g g T g A g A A
5 5 - 5 0 1 2 0 1 .5
D 6 M g h 5 L  -  C  A g T T  A g C  A T  A g A A A g C  A A A g g g  
R  -  A T  A g g  A A T  A A A g  A g T  g C  A C g T T T  g
5 5 - 5 0 1 0 4 1 .5
D V M it lO L  -  T g C C C C A A A A A g g A A A A A C  
R  -  T C A g C T T C A T A C g g A A g C A A
6 0 - 5 5 1 7 1 1 .5
D 7 M i t 7 L  -  A C A g C T g g A A T C C T C T g g g  
R  -  g A g C T A g C C A T g C A g g A A A C
6 0 - 5 5 2 6 0 1 .5
D 8 W o x 2 2 L  -  g C A g T g T g A g A g g A A A g T g T C  
R  -  g A A g T C C T C A C C T g T g T T C A g
6 0 - 5 5 1 8 1 1 .5
D 8 M g h 7 L  -  T g A A g A g T T T T A C T g g g T A g C T C C  
R  -  T g g A C C A g g C A A g T T C T C T T
6 0 - 5 5 1 9 1 1 .5
D 8 W o x l 3 L  -  C A T C T g g g T C T g T g g T A A g g  
R  -  T C T g g g A A g g A C T C l T g g A
6 0 - 5 5 1 7 4 1 .5
D 8 M g h l O L  -  C T T T g A T A C T g T A C C A A C A g C A C C  
R  -  A A T g T C A g g A T g g C A g A g A C
5 5 1 4 4 1 .5
D 9 M i t l L  -  g C T T T C A A A C A C C A C A g g g T  
R  -  A C A A C T C C C A T C T C T T g A g A g g
5 5 - 5 0 1 3 0 1 .5
D 9 W o x l 3 L  -  C C T T T g C g g g g T g T T g T A  
R  -  A C C A A C A A T g C g A C A g A g A A T
5 5 - 5 0 2 7 8 1 .5
D 9 M i t 4 L  -  g C A T A A T g g A A g A A g A C A A C T A C C  
R  -  T C C A T g C A T g T g T A T C T g C A
5 5 2 0 0 1 .5
D 1 0 W o x 3 L  -  g A A g T C T T C A C T T T T A C T T g T g g  
R  -  g A C C C T T T T g A g A g A A C l T T T g
6 0 1 7 6 1 .5
D l l M g h 6 L  -  A A C A g T C A A A A g A g A T A T C C A g g g  
R  -  A A A C A A A T g A T g T A C A T g C A T A C A
6 0 - 5 5 1 0 0 1 .5
D 1 2 W o x 2 L  -  T A A C C T C C A A A g g A C C T C T C  
R  -  C T A g A T A A g g T g T A T g T g g C T C
6 0 1 9 4 1 .0
D 1 2 M g h 3 L  -  T T C A A C A A C C A C C T C A C T T C C  
R  -  g g  A T T  g  A g g g T  g g g g T  A A g T
6 0 - 5 5 1 2 4 1 .5
D 1 3 M g h l L  -  A g A g  A A A A T  A T  g T  g g A C  A g  A A g C C  
R  -  C A C T T C C C A A A T g C T A g C g T
6 0 - 5 5 1 4 9 1 .5
D 1 3 W o x 4 L  -  C C T g g A C A C T A A T C C T A T C T T g  
R  -  g g g T A g g T C T g A g g g A A g g
5 5 1 8 0 1 .0
R E P 3 2 8 L  -  A A g C C T g C T C C A C T C C A C  
R  -  g C A g A g g g g A g A g g T A A T A A
6 0 - 5 5 2 5 7 1 .5
D 1 4 W o x 5 L  -  C A g g A A g A g A A A g g g A g T T g g  
R  -  g T C T g A A g T g g T T g T g A g T T C C
6 3 - 5 8 1 5 4 1 .5
D 1 4 W o x 8 L  -  A A g A A T A g C A g T g A A T T g g T g  
R  -  T T C A T C A T C C T T T C A T A A A g g C
6 0 1 5 1 1 .0
D 1 5 M i t 2 L  -  T A C A T g g A A g C C A A A T g C A A  
R  -  T A C T g A g A A A A T g g g T C T g C
5 5 - 5 0 1 4 0 1 .5
D 1 5 M g h 3 L  -  A g A C C C A g g g T A g g C A T T T T  
R  -  g A T T A C A A T T C T g T C C A A g T C A C g
5 5 - 5 0 1 4 6 1 .5
D 1 5 M g h 6 L  -  A g C A g C g g T A T C T C C A g T g T  
R  -  g g g T g A C g g A g C A g A g A A A
5 5 - 5 0 2 1 6 1 .0
D 1 6 W o x l 2 L  -  T  A g C  A g g  A T  g T T  g T  A g g T  g C  
R  -  C C A g g g T A T T A A g g T C g g A C
6 0 2 3 0 1 .0
D 1 6 M i t l L  -  g g C T T g T g T g g A C A C C T g T A  
R  -  A A A g A g C A g g g A A g A g A C A g g
5 5 - 5 0 1 6 4 1 .5
R 4 3 5 ,
D 1 6 W o x l O
L  -  A g g C T T T g A T T g C A g g A A g  
R  -  A A A g A g C T g T C g T C C A C A A C
6 0 1 1 8 1 .5
D 1 7 W o x 2 1 L  -  T A A g g A C C C C T g A T A C T C T g g  
R  -  A g A T C T T T g T C A A A T T C A T g g C
6 0 - 5 5 1 5 3 1 .5
D 1 7 W o x l 3 L  -  A g T A g A C A g g A g T g g g A A g g A  
R  -  C T C T T T g g g C A g C T T A C A T T
6 0 1 3 4 1 .0
D 1 7 W o x l O L  -  A T C T g T g T g C g A g T g C g T  
R  -  C T g g C g A A g T g A C g T g A g
6 0 1 4 7 1 .0
D I 8W 0X I 2 L  -  C A C A T g T T T A C T T T C T A A g C A T T T g  
R  -  C C C C T C T T C T g g A C T T C A T A g
6 0 1 4 8 1 .5
D 1 8 W o x l 6 L  -  T C A C A A T A A A A A A C T C C T C C A A C  
R  -  A g T C T g T g C C C T g T T C C C A
6 0 - 5 5 1 5 2 1 .5
D 1 9 W o x 2 L  -  g g T A T g g g A g T A A C A T g A C C T C  
R -  g g A C A C A T A C g g T A A g C A C A T g C
6 3 - 5 8 1 2 9 1 .5
D 1 9 W o x 8 L  -  T g C C C g T C T C T g T T A C T C A T  
R  -  C A A g A A C C C T g A g g C A A T A A
6 0 1 1 1 1 .0
D 2 0 W o x 5 L  -  g A A A A A T A C T T C C A C A C A C T A A T g  
R  -  A A A g T C A A g C C C T g g A g T g
6 0 - 5 5 2 5 9 1 .0
D 2 0 W o x 3 L  -  AggAAAtGGGtttCAgrrCC 
R  -  CAggATTCTgTggCAATCTg
5 5 1 2 5 1 .0
D X W o x 3 L  -  g A T C g T C C A g C A T C g T g g  
R  -  g T T g g T g C T A C T C A A g A T C g g
6 0 1 3 0 1 .5
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